<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>JP4913588B2 - 
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/JP4913588B2/en">
    
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
       ">
    <meta name="DC.date" content="2004-01-21" scheme="dateSubmitted">
    <meta name="DC.description" content="">
    <meta name="citation_patent_application_number" content="JP:2006500437A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/87/b4/b6/f1b8cba6116e64/JP4913588B2.pdf">
    <meta name="citation_patent_number" content="JP:4913588:B2">
    <meta name="DC.date" content="2012-04-11" scheme="issue">
    <meta name="DC.contributor" content="ブライアン  オー バックマン" scheme="inventor">
    <meta name="DC.contributor" content="ジェイムス  ビー ムカルピン" scheme="inventor">
    <meta name="DC.contributor" content="エマヌエル ザゾプロス" scheme="inventor">
    <meta name="DC.contributor" content="クリス  エム ファーネット" scheme="inventor">
    <meta name="DC.contributor" content="マームード ピレー" scheme="inventor">
    <meta name="DC.contributor" content="Thallion Pharmaceuticals Inc" scheme="assignee">
    <meta name="DC.relation" content="US:5541181" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result" hidden="">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"></section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12N9/93"><a id="link" href="#" class="style-scope state-modifier">C12N9/93</a></state-modifier>
                  <span class="description style-scope classification-tree">Ligases (6)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P29/00"><a id="link" href="#" class="style-scope state-modifier">A61P29/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/00"><a id="link" href="#" class="style-scope state-modifier">C07D243/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/06"><a id="link" href="#" class="style-scope state-modifier">C07D243/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/10"><a id="link" href="#" class="style-scope state-modifier">C07D243/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/38"><a id="link" href="#" class="style-scope state-modifier">C07D243/38</a></state-modifier>
                  <span class="description style-scope classification-tree">[b, e]- or [b, f]-condensed with six-membered rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/00"><a id="link" href="#" class="style-scope state-modifier">C07D405/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/02"><a id="link" href="#" class="style-scope state-modifier">C07D405/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/06"><a id="link" href="#" class="style-scope state-modifier">C07D405/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/00"><a id="link" href="#" class="style-scope state-modifier">C07D405/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/14"><a id="link" href="#" class="style-scope state-modifier">C07D405/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/00"><a id="link" href="#" class="style-scope state-modifier">C12N1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/20"><a id="link" href="#" class="style-scope state-modifier">C12N1/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacteria; Culture media therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/205"><a id="link" href="#" class="style-scope state-modifier">C12N1/205</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacterial isolates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/00"><a id="link" href="#" class="style-scope state-modifier">C12N15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/09"><a id="link" href="#" class="style-scope state-modifier">C12N15/09</a></state-modifier>
                  <span class="description style-scope classification-tree">Recombinant DNA-technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/11"><a id="link" href="#" class="style-scope state-modifier">C12N15/11</a></state-modifier>
                  <span class="description style-scope classification-tree">DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/52"><a id="link" href="#" class="style-scope state-modifier">C12N15/52</a></state-modifier>
                  <span class="description style-scope classification-tree">Genes encoding for enzymes or proenzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0004"><a id="link" href="#" class="style-scope state-modifier">C12N9/0004</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/10"><a id="link" href="#" class="style-scope state-modifier">C12N9/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Transferases (2.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/10"><a id="link" href="#" class="style-scope state-modifier">C12N9/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Transferases (2.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/12"><a id="link" href="#" class="style-scope state-modifier">C12N9/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/14"><a id="link" href="#" class="style-scope state-modifier">C12N9/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Hydrolases (3)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/88"><a id="link" href="#" class="style-scope state-modifier">C12N9/88</a></state-modifier>
                  <span class="description style-scope classification-tree">Lyases (4.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/90"><a id="link" href="#" class="style-scope state-modifier">C12N9/90</a></state-modifier>
                  <span class="description style-scope classification-tree">Isomerases (5.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/00"><a id="link" href="#" class="style-scope state-modifier">C12P17/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/10"><a id="link" href="#" class="style-scope state-modifier">C12P17/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Nitrogen as only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A61K38/00"><a id="link" href="#" class="style-scope state-modifier">A61K38/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing peptides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R"><a id="link" href="#" class="style-scope state-modifier">C12R</a></state-modifier>
                  <span class="description style-scope classification-tree">INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R2001/00"><a id="link" href="#" class="style-scope state-modifier">C12R2001/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms ; Processes using microorganisms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R2001/01"><a id="link" href="#" class="style-scope state-modifier">C12R2001/01</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacteria or Actinomycetales ; using bacteria or Actinomycetales</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12R2001/29"><a id="link" href="#" class="style-scope state-modifier">C12R2001/29</a></state-modifier>
                  <span class="description style-scope classification-tree">Micromonospora</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y"><a id="link" href="#" class="style-scope state-modifier">Y</a></state-modifier>
                  <span class="description style-scope classification-tree">GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y02"><a id="link" href="#" class="style-scope state-modifier">Y02</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y02A"><a id="link" href="#" class="style-scope state-modifier">Y02A</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y02A50/00"><a id="link" href="#" class="style-scope state-modifier">Y02A50/00</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="Y02A50/30"><a id="link" href="#" class="style-scope state-modifier">Y02A50/30</a></state-modifier>
                  <span class="description style-scope classification-tree">Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 18 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">JP4913588B2</h2>
                  <p class="tagline style-scope patent-result">Japan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Published granted patent (Second level)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/87/b4/b6/f1b8cba6116e64/JP4913588B2.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;compound&quot;,&quot;seq&quot;,&quot;pharmaceutically acceptable&quot;,&quot;acceptable salt&quot;,&quot;formula&quot;]" data-before="20030121"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/JP4913588B2"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4913588B2/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ブライアン  オー バックマン"><a id="link" href="#" class="style-scope state-modifier">ブライアン  オー バックマン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ジェイムス  ビー ムカルピン"><a id="link" href="#" class="style-scope state-modifier">ジェイムス  ビー ムカルピン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="エマヌエル ザゾプロス"><a id="link" href="#" class="style-scope state-modifier">エマヌエル ザゾプロス</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="クリス  エム ファーネット"><a id="link" href="#" class="style-scope state-modifier">クリス  エム ファーネット</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="マームード ピレー"><a id="link" href="#" class="style-scope state-modifier">マームード ピレー</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    Thallion Pharmaceuticals Inc
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2004</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ561169A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ561169A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2004206046B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2004206046A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2004065591A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/CA2004/000069</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2466340C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002466340A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2483897T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES04703733.8T</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7101872B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US10/762,107</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MXPA05007743A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">MX</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MXPA05007743A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1585814B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP04703733.8A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP4913588B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2006500437A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ541815A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ541815A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2005</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7304054B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/235,398</div>
                <div class="style-scope application-timeline">Filing date: 2005-09-27</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20060079512A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/253,658</div>
                <div class="style-scope application-timeline">Filing date: 2005-10-20</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2006</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7521222B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/511,586</div>
                <div class="style-scope application-timeline">Filing date: 2006-08-28</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2007</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20080131943A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/876,636</div>
                <div class="style-scope application-timeline">Filing date: 2007-10-22</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2009</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20090263886A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US12/400,509</div>
                <div class="style-scope application-timeline">Filing date: 2009-03-09</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application JP2006500437A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2004-01-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Thallion Pharmaceuticals Inc"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Thallion Pharmaceuticals Inc</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2006-06-08</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2006515874A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2006515874A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2012-04-11</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2012-04-11</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP4913588B2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP4913588B2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2024-01-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Expired - Lifetime</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (18)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (17)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=JP&amp;NR=4913588B2&amp;KC=B2&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/JP/4913588/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/JP4913588B2">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES46022446" lang="EN" load-source="google" class="style-scope patent-text">
  <technical-field class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">［関連出願］</u> <br class="style-scope patent-text">
  本発明は、２００３年１月２１日出願の米国仮出願第６０／４４１，１２６号、２００３年８月７日出願の米国仮出願第６０／４９２，９９７号、及び２００３年１１月１０日出願の米国仮出願第６０／５１８，２８６号に対して優先権を主張する。上記仮出願の全ての教示は、参照することにより本明細書に組み込まれる。本発明は、ＥＣＯ−０４６０１と名付けられた新規のファルネシル化ジベンゾジアゼピノン、その薬学的に許容される塩及び誘導体、並びに該化合物を得る方法に関する。該化合物を得る方法には、Micromonospora sp.の新規株、すなわち０４６−ＥＣＯ１１又は［Ｓ０１］０４６の培養による方法や、形質転換した宿主細胞における生合成経路遺伝子の発現を伴う方法がある。本発明は更に、Micromonospora sp.０４６−ＥＣＯ１１株及び（Ｓ０１）０４６株に関し、ＥＣＯ−０４６０１並びにその薬学的に許容される塩及び誘導体の薬剤としての使用、特に癌細胞の増殖、細菌細胞の増殖、哺乳類リポキシゲナーゼの阻害剤としてのその使用、急性炎症や慢性炎症の治療のためのその使用、並びにＥＣＯ−０４６０１又はその薬学的に許容される塩若しくは誘導体を含む医薬組成物に関する。最後に、本発明は、新規のポリヌクレオチド配列及びそれによってコードされるタンパク質に関するが、それらはＥＣＯ−０４６０１の生合成に関連している。
</span> <u class="style-scope patent-text">[Related applications]</u> <br class="style-scope patent-text"> The present invention relates to US Provisional Application No. 60 / 441,126 filed on Jan. 21, 2003, U.S. Provisional Application No. 60 / 492,997 filed on Aug. 7, 2003, and Nov. 10, 2003. Claims priority to US Provisional Application No. 60 / 518,286. The entire teachings of the above provisional application are incorporated herein by reference. The present invention relates to a novel farnesylated dibenzodiazepinone named ECO-04601, pharmaceutically acceptable salts and derivatives thereof, and a method of obtaining the compound. Methods for obtaining the compound include a method of culturing a novel strain of Micromonospora sp., That is, 046-ECO11 or [S01] 046, and a method involving expression of biosynthetic pathway genes in transformed host cells. The invention further relates to Micromonospora sp. 046-ECO11 and (S01) 046 strains, the use of ECO-04601 and pharmaceutically acceptable salts and derivatives thereof as drugs, in particular cancer cell proliferation, bacterial cell proliferation. And its use as an inhibitor of mammalian lipoxygenase, its use for the treatment of acute and chronic inflammation, and a pharmaceutical composition comprising ECO-04601 or a pharmaceutically acceptable salt or derivative thereof. Finally, although the present invention relates to novel polynucleotide sequences and proteins encoded thereby, they are related to the biosynthesis of ECO-04601.</span>
    </p>
  </technical-field>
  <background-art class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
Euactinomycetesは、Actinomycetesとして知られる大きく複雑なグラム陽性細菌群のサブセットである。治療に有用な二次代謝産物として生成される化合物、特に抗生物質が多いことから、人々は過去数十年にわたり、土壌に豊富に存在するこれらの生物に、商業的に、また科学的に重要な興味を抱いてきた。新規の抗生物質を生成することのできる株を徹底的に調査した結果、数百の新種が同定された。
</span>
Euactinomycetes is a subset of a large and complex Gram-positive bacterium group known as Actinomycetes. Due to the large number of compounds, particularly antibiotics, that are produced as secondary metabolites that are useful for treatment, people have become commercially and scientifically important to these organisms that are abundant in soil over the past few decades. I've been very interested. A thorough investigation of strains capable of producing new antibiotics identified hundreds of new species.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
このEuactinomycetesの多く、特にストレプトミセス及び近縁種であるSaccharopolyspora属が鋭意研究されてきた。これら２つの属によって、生物活性代謝産物の多様性が顕著となる。これらの化合物が商業的に重要であることから、これらの生物の遺伝的特徴や生理機能については、多くが知られている。
</span>
Many of these Euactinomycetes, especially Streptomyces and related species, Saccharopolyspora genus, have been intensively studied. With these two genera, the diversity of bioactive metabolites is significant. Since these compounds are commercially important, much is known about the genetic characteristics and physiological functions of these organisms.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
他の代表的なEuactinomycetes属として、人々はMicromonosporaにも商業的な興味を抱いてきた。例えば、米国特許第５，５４１，１８１号（Ohkuma et al.）はジベンゾジアゼピノン化合物を開示している。具体的には、既知のEuactinomycetes株であるMicromonospora sp.Ｍ９９０−６（アクセッション番号第５５３７８）によって生成された５−ファルネシル−４，７，９−トリヒドロキシ−ジベンゾジアゼピン−１１−オン（「ＢＵ−４６６４Ｌ」と命名）を開示している。Ohkuma et al.の特許は、ＢＵ−４６６４Ｌ及びその化学合成されたジ−又はトリ−アルコシキ及びアシロキシ誘導体が、抗炎症活性と抗腫瘍細胞活性とを有していることを報告している。
</span>
As another representative Euactinomycetes genus, people have also had commercial interest in Micromonospora. For example, US Pat. No. 5,541,181 (Ohkuma et al.) Discloses dibenzodiazepinone compounds. Specifically, 5-farnesyl-4,7,9-trihydroxy-dibenzodiazepin-11-one (“BU” produced by Microactormycetes strain Micromonospora sp. M990-6 (Accession No. 55378). -4664L "). The Ohkuma et al. Patent reports that BU-4664L and its chemically synthesized di- or tri-alkoxy and acyloxy derivatives have anti-inflammatory and anti-tumor cell activity.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
多くの生物活性化合物が細菌から同定されたが、依然として、特性を強化された天然由来の新規化合物を得ることが必要とされる。これらの化合物を得る現在の方法には、天然の単離物や既存の化合物の化学的修飾のスクリーニングが含まれるが、これらは多くの費用や時間を要する。現在のスクリーニング方法は該化合物の一般的な生物学的特性に基づいており、分子構造の予備知識を必要とする。既知の活性化合物を化学的に修飾する方法は存在するが、得られる化合物の種類は、実際には今なお限られている。<br class="style-scope patent-text">
したがって、薬理活性化合物を高収量且つ費用効率の高い方法で得ることが、非常に必要とされている。本発明は、試薬（例えば、ポリヌクレオチド、該ポリヌクレオチドを含むベクター、及び該ベクターを含む宿主細胞）だけでなく、強力な新規の治療用化合物を生成することができるMicromonosporaの新規株、及び化学合成ではなく新規の生合成によって新規の化合物を生成する方法を提供することによって、これらの問題が解決される。<br class="style-scope patent-text">
<patcit num="1" class="style-scope patent-text"> <text class="style-scope patent-text">米国特許第５，５４１，１８１号（Ohkuma et al.）</text> </patcit>
</span>Although many bioactive compounds have been identified from bacteria, there is still a need to obtain naturally occurring new compounds with enhanced properties. Current methods of obtaining these compounds include screening for natural isolates and chemical modifications of existing compounds, which are costly and time consuming. Current screening methods are based on the general biological properties of the compounds and require prior knowledge of the molecular structure. Although there are methods for chemically modifying known active compounds, the types of compounds obtained are actually still limited. <br class="style-scope patent-text"> Therefore, there is a great need to obtain pharmacologically active compounds in a high yield and cost effective manner. The present invention provides novel strains of Micromonospora capable of producing not only reagents (eg, polynucleotides, vectors containing the polynucleotides, and host cells containing the vectors), as well as potent new therapeutic compounds, and chemistry These problems are solved by providing a method for producing new compounds by novel biosynthesis rather than synthesis. <br class="style-scope patent-text"> <patcit num="1" class="style-scope patent-text"> <text class="style-scope patent-text"> US Pat. No. 5,541,181 (Ohkuma et al.) </text> </patcit> </span>
    </p>
  </background-art>
  <disclosure class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
第一の実施の形態において、本発明は、下記式で表される化合物（式II）又はその薬学的に許容される塩に関する。
</span>
In the first embodiment, the present invention relates to a compound represented by the following formula (formula II) or a pharmaceutically acceptable salt thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態において、本発明は、下記式で表される化合物又はその薬学的に許容される塩と薬学的に許容されるキャリアとを含む医薬組成物に関する。
</span>
In another embodiment, the present invention relates to a pharmaceutical composition comprising a compound represented by the following formula or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
また別の実施の形態において、本発明は、式Ｉで表される化合物のクラスに関する。
</span>
In yet another embodiment, the invention relates to the class of compounds of formula I.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
（式中、Ｗ１、Ｗ２及びＷ３は、それぞれ独立して下記式
</span>
(W1, W2, and W3 are each independently represented by the following formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
から選択されるか、三環からの側鎖は、Ｗ３、Ｗ２又はＷ１がそれぞれ−ＣＨ＝Ｏ又は−ＣＨ２ＯＨであって、Ｗ３、Ｗ２又はＷ１で終わっていてもよく、<br class="style-scope patent-text">
Ａは、−ＮＨ−、−ＮＣＨ２Ｒ１、−ＮＣ（Ｏ）Ｒ１から選択され、<br class="style-scope patent-text">
Ｒ１は、Ｃ１〜６アルキル、Ｃ２〜６アルケン(alkene)、アリール又はヘテロアリールから選択され、<br class="style-scope patent-text">
Ｒ２、Ｒ３及びＲ４は、それぞれ独立してＨ、Ｒ５、−Ｃ（Ｏ）Ｒ６から選択され、<br class="style-scope patent-text">
Ｒ５は、それぞれ独立してＣ<sub class="style-scope patent-text">１〜６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２〜７</sub>アルカレン(alkalene)、アリール又はヘテロアリールから選択され、<br class="style-scope patent-text">
Ｒ６は、それぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルカレン、アリール又はヘテロアリールから選択されるか、その薬学的に許容される塩である）。
</span>Or the side chain from the tricycle may be terminated with W3, W2 or W1, wherein W3, W2 or W1 is —CH═O or —CH2OH, respectively. <br class="style-scope patent-text"> A is selected from -NH-, -NCH2R1, -NC (O) R1, <br class="style-scope patent-text"> R1 is selected from C1-6 alkyl, C2-6 alkene, aryl or heteroaryl; <br class="style-scope patent-text"> R2, R3 and R4 are each independently selected from H, R5, -C (O) R6; <br class="style-scope patent-text"> R5 are each independently a <sub class="style-scope patent-text">C 1 to 6</sub> <sub class="style-scope patent-text">alkyl, C 2 to 7</sub> Arukaren (alkalene), is selected from aryl or heteroaryl, <br class="style-scope patent-text"> Each R6 is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkane, aryl or heteroaryl, or a pharmaceutically acceptable salt thereof).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ある実施の形態においては、ＡがＮＨである。
</span>
In some embodiments, A is NH.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ａが−ＮＣＨ<sub class="style-scope patent-text">２</sub>Ｒ<sup class="style-scope patent-text">１</sup>である。
</span>In another embodiment, A is —NCH <sub class="style-scope patent-text">2</sub> R <sup class="style-scope patent-text">1</sup> .</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ａが−ＮＣ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>である。
</span>In another embodiment, A is —NC (O) R <sup class="style-scope patent-text">1</sup> .</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ｒ<sup class="style-scope patent-text">２</sup>がＨである。
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> is H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ｒ<sup class="style-scope patent-text">３</sup>がＨである。
</span>In another embodiment, R <sup class="style-scope patent-text">3</sup> is H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ｒ<sup class="style-scope patent-text">４</sup>がＨである。
</span>In another embodiment, R <sup class="style-scope patent-text">4</sup> is H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>、及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨである。
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>、及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであり、Ｗ<sup class="style-scope patent-text">１</sup>が−ＣＨ＝ＣＨ−である。
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H and W <sup class="style-scope patent-text">1</sup> is —CH═CH—.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>、及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであり、Ｗ<sup class="style-scope patent-text">２</sup>が−ＣＨ＝ＣＨ−である。
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H and W <sup class="style-scope patent-text">2</sup> is —CH═CH—.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>、及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであり、Ｗ<sup class="style-scope patent-text">３</sup>が−ＣＨ＝ＣＨ−である。
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H and W <sup class="style-scope patent-text">3</sup> is —CH═CH—.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、ＡがＮＨであり、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>、及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨである。
</span>In another embodiment, A is NH and R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態においては、ＡがＮＨであり、Ｗ<sup class="style-scope patent-text">１</sup>、Ｗ<sup class="style-scope patent-text">２</sup>、及びＷ<sup class="style-scope patent-text">３</sup>がそれぞれ−ＣＨ＝ＣＨ−である。
</span>In another embodiment, A is NH and W <sup class="style-scope patent-text">1</sup> , W <sup class="style-scope patent-text">2</sup> , and W <sup class="style-scope patent-text">3</sup> are each —CH═CH—.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
本発明は更に、下記の群から選択される化合物を含む。
</span>
The present invention further includes a compound selected from the following group.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、本発明は、式Ｉで表される化合物の組成物及びその薬学的に許容されるキャリアに関する。
</span>
&nbsp;&nbsp;In certain embodiments, the present invention relates to a composition of compounds of formula I and pharmaceutically acceptable carriers thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、<br class="style-scope patent-text">
ａ）少なくとも１つの炭素原子源と少なくとも１つの窒素原子源を含む培養地において、好気条件下で培養が行われることを特徴とする、Micromonospora sp.［Ｓ０１］０４６株を培養するステップ、及びｂ）ステップ（ａ）で培養された細菌からファルネシルジベンゾジアゼピノンを単離するステップ含む方法で得られるファルネシルジベンゾジアゼピノンを含む。ある実施の形態において、ファルネシルジベンゾジアゼピノンは式IIで表される化合物である。
</span>The present invention further includes <br class="style-scope patent-text"> a) culturing Micromonospora sp. [S01] 046 strain characterized in that the culture is performed under aerobic conditions in a culture place containing at least one carbon atom source and at least one nitrogen atom source; and b) Farnesyl dibenzodiazepinone obtained by the method comprising the step of isolating farnesyl dibenzodiazepinone from the bacteria cultured in step (a). In certain embodiments, the farnesyl dibenzodiazepinone is a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  基本的に図３、４、５、６、及び７に示すように、ある実施の形態においては、ファルネシルジベンゾジゼアピノンはＮＭＲスペクトルを発生させる。別の実施の形態においては、ファルネシルジベンゾジゼアピノンは図３の<sup class="style-scope patent-text">１</sup>ＨＮＭＲスペクトルを発生させる。<br class="style-scope patent-text">
本発明は更に、少なくとも１つの炭素原子源と少なくとも１つの窒素原子源を含む培地でMicromonospora sp.０４６−ＥＣＯ１１株を培養するステップ、及び化合物を単離し精製するステップを含む、ファルネシルジベンゾジアゼピノン化合物の製造方法を含む。
</span>Basically, as shown in FIGS. 3, 4, 5, 6, and 7, in one embodiment, farnesyl dibenzodiazepinone generates an NMR spectrum. In another embodiment, farnesyl dibenzodizeapinone generates the <sup class="style-scope patent-text">1</sup> H NMR spectrum of FIG. <br class="style-scope patent-text"> The present invention further includes culturing Micromonospora sp. 046-ECO11 strain in a medium containing at least one carbon atom source and at least one nitrogen atom source, and farnesyl dibenzodiazepinone comprising isolating and purifying the compound. A method for producing the compound is included.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、少なくとも１つの炭素原子源と少なくとも１つの窒素原子源を含む培地でMicromonospora sp.［Ｓ０１］０４６株を培養するステップ、及び化合物を単離し精製するステップを含む、ファルネシルジベンゾジアゼピノン化合物の作成方法を含む。<br class="style-scope patent-text">
ある実施の形態においては、培養は好気条件下で行われる。<br class="style-scope patent-text">
別の実施の形態においては、炭素原子源及び窒素原子源が表１６に示される成分から選択される。
</span>The present invention further includes culturing Micromonospora sp. [S01] 046 strain in a medium containing at least one carbon atom source and at least one nitrogen atom source, and farnesyl dibenzodiaze comprising isolating and purifying the compound. Includes methods for making pinone compounds. <br class="style-scope patent-text"> In certain embodiments, the culturing is performed under aerobic conditions. <br class="style-scope patent-text"> In another embodiment, the carbon atom source and the nitrogen atom source are selected from the components shown in Table 16.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施の形態においては、培養は１８〜４０℃の温度で行われる。更なる実施の形態においては、温度範囲は１８〜２９℃である。
</span>
&nbsp;&nbsp;In another embodiment, the culturing is performed at a temperature of 18-40 ° C. In a further embodiment, the temperature range is 18-29 ° C.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施の形態においては、培養はｐＨ６〜９で行われる。
</span>
&nbsp;&nbsp;In another embodiment, the culturing is at pH 6-9.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、ＩＤＡＣ（カナダ国際寄託当局）アクセッション番号第２３１２０３−０１のMicromonospora sp.株を含む。
</span>
&nbsp;&nbsp;The present invention further includes a Micromonospora sp. Strain having IDAC (Canadian International Depository Authority) accession number 231203-01.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、癌細胞の増殖を阻害する方法、すなわち、癌細胞の増殖を阻害するために、癌細胞を式Ｉで表される化合物に接触させるステップを有する方法を含む。<br class="style-scope patent-text">
ある実施の形態において、該化合物はＥＣＯ−０４６０１である。
</span>The present invention further includes a method of inhibiting the growth of cancer cells, i.e., the method comprising contacting the cancer cells with a compound of formula I to inhibit the growth of cancer cells. <br class="style-scope patent-text"> In certain embodiments, the compound is ECO-04601.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、哺乳動物の癌細胞の増殖を阻害する方法、すなわち、哺乳動物における癌細胞の増殖を阻害するために、癌細胞を有する哺乳動物に式Ｉで表される化合物を投与するステップを有する方法を含む。
</span>
&nbsp;&nbsp;The present invention further provides a method for inhibiting the growth of cancer cells in a mammal, ie, administering a compound of formula I to a mammal having cancer cells to inhibit the growth of cancer cells in the mammal. Including a method comprising:
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、該化合物はＥＣＯ−０４６０１である。
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、前癌状態又は癌疾患を治療するために、治療に効果的な量の式Ｉで表される化合物を哺乳動物に投与するステップを有する、哺乳動物における前癌状態又は癌疾患を治療する方法を含む。
</span>
&nbsp;&nbsp;The present invention further comprises the step of administering to the mammal a therapeutically effective amount of a compound of Formula I to treat the precancerous condition or cancerous disease. Including methods of treating.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、該化合物はＥＣＯ−０４６０１である。
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、細菌感染を治療するために、治療に効果的な量の式Ｉで表される化合物を細菌に感染した哺乳動物に投与するステップを有する、哺乳動物における細菌感染を治療する方法を含む。
</span>
&nbsp;&nbsp;The invention further comprises a method of treating a bacterial infection in a mammal comprising administering to the mammal infected with the bacterium a therapeutically effective amount of a compound of formula I to treat the bacterial infection. including.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、該化合物はＥＣＯ−０４６０１である。
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、炎症を抑えるために、治療に効果的な量の式Ｉで表される化合物を、炎症を起こした哺乳動物に投与するステップを有する、哺乳動物における炎症を抑える方法を含む。
</span>
&nbsp;&nbsp;The present invention further includes a method of reducing inflammation in a mammal comprising administering to the inflamed mammal a therapeutically effective amount of a compound of Formula I to reduce inflammation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、該化合物がＥＣＯ−０４６０１である。
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、ファルネシルジベンゾジアゼピノンの生合成経路に関与するポリペプチドをコードする、配列番号１、６４及び７３の１又は２以上を有する単離されたポリヌクレオチドを含む。
</span>
&nbsp;&nbsp;The present invention further includes an isolated polynucleotide having one or more of SEQ ID NOs: 1, 64, and 73 that encode a polypeptide involved in the biosynthesis pathway of farnesyl dibenzodiazepinone.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、ファルネシルジベンゾジアゼピノンの生合成経路に関与するポリペプチドをコードする、配列番号１、６４及び７３を有する単離されたポリヌクレオチドを含む。
</span>
&nbsp;&nbsp;The present invention further includes an isolated polynucleotide having SEQ ID NOs: 1, 64, and 73 that encodes a polypeptide involved in the farnesyl dibenzodiazepinone biosynthetic pathway.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９からなる群から選択されるポリペプチドをコードする、単離されたポリヌクレオチドを含む。
</span>
&nbsp;&nbsp;The present invention further includes SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45. 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89. An isolated polynucleotide encoding the polypeptide is included.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態においては、配列番号１を有する単離されたポリヌクレオチドが、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１及び６３からなる群から選択されるポリペプチドをコードする。<br class="style-scope patent-text">
ある実施の形態においては、配列番号６４を有する単離されたポリヌクレオチドが、配列番号６６、６８、７０及び７２からなる群から選択されるポリペプチドをコードする。<br class="style-scope patent-text">
ある実施の形態においては、配列番号７３を有する単離されたポリヌクレオチドが、配列番号７５、７７、７９、８１、８３、８５、８７及び８９からなる群から選択されるポリペプチドをコードする。
</span>In certain embodiments, the isolated polynucleotide having SEQ ID NO: 1 is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, It encodes a polypeptide selected from the group consisting of 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61 and 63. <br class="style-scope patent-text"> In certain embodiments, the isolated polynucleotide having SEQ ID NO: 64 encodes a polypeptide selected from the group consisting of SEQ ID NOs: 66, 68, 70, and 72. <br class="style-scope patent-text"> In certain embodiments, the isolated polynucleotide having SEQ ID NO: 73 encodes a polypeptide selected from the group consisting of SEQ ID NOs: 75, 77, 79, 81, 83, 85, 87, and 89.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、又は８９で表される単離されたポリペプチドを含む。
</span>
&nbsp;&nbsp;The present invention further includes SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45. 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, or 89 Polypeptides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、ポリペプチドはファルネシルジベンゾジアゼピノンの生合成経路に関与する。
</span>
&nbsp;&nbsp;In certain embodiments, the polypeptide is involved in the biosynthesis pathway of farnesyl dibenzodiazepinone.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、本明細書に記載のポリペプチドを１又は２以上含む発現ベクターを含む。
</span>
&nbsp;&nbsp;The invention further includes an expression vector comprising one or more of the polypeptides described herein.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、該ベクターを１又は２以上含むリコンビナント原核生物を含む。
</span>
&nbsp;&nbsp;The present invention further includes recombinant prokaryotes comprising one or more of the vectors.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、該生物はActinomyceteである。
</span>
&nbsp;&nbsp;In certain embodiments, the organism is Actinomycete.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施の形態においては、ファルネシルジベンゾジアゼピノンを合成するために、該生物が発現ベクターを必要とする。すなわち、本明細書に記載されるように、ポリヌクレオチドで形質転換される前には、該生物にはファルネシルジベンゾジアゼピノンを合成する能力が欠損している。
</span>
&nbsp;&nbsp;In another embodiment, the organism requires an expression vector to synthesize farnesyl dibenzodiazepinone. That is, as described herein, the organism is deficient in the ability to synthesize farnesyl dibenzodiazepinone before being transformed with the polynucleotide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更に、（ａ）ファルネシルジベンゾジアゼピノンを合成することができない原核生物を提供するステップ、（ｂ）本明細書に記載されるように、該原核生物を発現ベクターで形質転換するステップ、及び（ｃ）該原核生物を培養するステップを含み、培養の結果、原核生物においてファルネシルジベンゾジアゼピノンが合成される方法を含む。
</span>
&nbsp;&nbsp;The invention further includes (a) providing a prokaryote that is unable to synthesize farnesyl dibenzodiazepinone, (b) transforming the prokaryote with an expression vector as described herein. And (c) culturing the prokaryote, wherein the method comprises culturing farnesyl dibenzodiazepinone in the prokaryote.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態において、該原核生物がActinomyceteである。
</span>
&nbsp;&nbsp;In certain embodiments, the prokaryote is Actinomycete.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施の形態においては、ベクターが、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、５７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、又は８９で表されるポリペプチドを発現する。
</span>
&nbsp;&nbsp;In another embodiment, the vector is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39. 41, 43, 45, 57, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, or 89 Expresses the represented polypeptide.
</span>
    </p>
    <heading class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">発明の詳細な説明</span>Detailed Description of the Invention</span>
    </heading>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、本明細書で「ＥＣＯ−０４６０１」と称する新規のファルネシルジベンゾジアゼピノンに関する。かかるＥＣＯ−０４６０１は、Actinomycetesの新規の菌株であるMicroponospora sp.０４６−ＥＣＯ１１株及び［Ｓ０１］０４６株から単離された。これらの微生物は、脂肪酸メチルエステル（ＦＡＭＥ）（図１７）、６ＳリボゾームＲＮＡ定量法（図１８）のようなガスクロマトグラフィーを用いて分析され、Micromonospora属に属することが見出だされた。これらの生物は、それぞれ２００３年３月７日、２００３年１２月２３日にカナダ保健省微生物部、カナダ国際寄託当局（ＩＤＡＣ）、 (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)に、それぞれＩＤＡＣアクセッション番号第０７０３０３−０１、ＩＤＡＣアクセッション番号第２３１２０３−０１として寄託された。
</span>
&nbsp;&nbsp;The present invention relates to a novel farnesyl dibenzodiazepinone referred to herein as “ECO-04601”. Such ECO-04601 was isolated from Microponospora sp. 046-ECO11 strain and [S01] 046 strain, which are novel strains of Actinomycetes. These microorganisms were analyzed using gas chromatography such as fatty acid methyl ester (FAME) (FIG. 17), 6S ribosomal RNA quantification (FIG. 18) and found to belong to the genus Micromonospora. These organisms were released on March 7, 2003 and December 23, 2003, respectively, at the Department of Microbiology of the Canadian Ministry of Health, the Canadian International Depository Authority (IDAC), (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2). Deposited as IDAC accession number 070303-01 and IDAC accession number 231203-01.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は更にＥＣＯ−０４６０１の薬学的に許容される塩及び誘導体、並びに該化合物を得る方法に関する。該化合物を得る１つの方法は、Micromonospora sp.０４６−ＥＣＯ１１株又はその突然変異株若しくは変異株を、適当なMicromonospora培養条件下で培養する方法であり、好ましくは以下に記載する発酵のプロトコルを使用する方法である。
</span>
&nbsp;&nbsp;The invention further relates to pharmaceutically acceptable salts and derivatives of ECO-04601 and methods for obtaining the compounds. One method of obtaining the compound is to cultivate Micromonospora sp. 046-ECO11 strain or a mutant or mutant thereof under appropriate Micromonospora culture conditions, preferably using the fermentation protocol described below. It is a method to do.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
また、本発明は、生物の遺伝子情報を選択的に変更することによって、新規のポリケチド化合物、すなわちファルネシルジベンゾジアゼピノンを生成する方法に関する。更に本発明は、単離され、精製されたポリヌクレオチドを提供する。<br class="style-scope patent-text">
該ポリヌクレオチドは、ファルネシルジベンゾジアゼピノンドメイン、すなわちファルネシルジベンゾジアゼピノンを生成する生物のポリペプチド及びそのフラグメント、それらのポリヌクレオチドを含むベクター、並びにこれらのベクターで形質転換された宿主細胞をコードする。これらのポリヌクレオチド及びそのフラグメント、並びに該ポリヌクレオチドを含むベクターを、上述の方法において試薬として使用することができる。本明細書に開示されるポリヌクレオチド配列の部分は、ＤＮＡの増幅のプライマーとして又は他のファルネシルジベンゾジアゼピノンを生成する生物の関連ドメインを同定するためのプローブとしても有用である。
</span>The present invention also relates to a method for producing a novel polyketide compound, namely farnesyl dibenzodiazepinone, by selectively changing the genetic information of an organism. The present invention further provides isolated and purified polynucleotides. <br class="style-scope patent-text"> The polynucleotide encodes a farnesyl dibenzodiazepinone domain, ie, a polypeptide of a living organism that produces farnesyl dibenzodiazepinone and fragments thereof, vectors containing these polynucleotides, and host cells transformed with these vectors. To do. These polynucleotides and fragments thereof, and vectors containing the polynucleotides can be used as reagents in the methods described above. Portions of the polynucleotide sequences disclosed herein are also useful as primers for DNA amplification or as probes for identifying other farnesyl dibenzodiazepinone-related organismal domains.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、ＥＣＯ−０４６０１を含む医薬組成物並びにその薬学的に許容される塩及び誘導体に関する。ＥＣＯ−０４６０１は、特に癌細胞の増殖、細菌細胞の増殖及び哺乳動物のリポキシゲナーゼの阻害剤としての使用するための薬剤として有用である。本発明は、ＥＣＯ−０４６０１の生合成経路に関与する、新規のポリヌクレオチド配列及びそれらにコードされるタンパク質に関する。
</span>
&nbsp;&nbsp;The present invention relates to pharmaceutical compositions comprising ECO-04601 and pharmaceutically acceptable salts and derivatives thereof. ECO-04601 is particularly useful as a drug for use as an inhibitor of cancer cell growth, bacterial cell growth and mammalian lipoxygenase. The present invention relates to novel polynucleotide sequences involved in the biosynthetic pathway of ECO-04601 and proteins encoded by them.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  以下の詳細な説明によって、微生物の増殖及び／又は特定の疾患の経路を阻害するための、ＥＣＯ−０４６０１及び該化合物を含む組成物の作成方法及び使用方法が開示される。
</span>
&nbsp;&nbsp;The following detailed description discloses methods for making and using ECO-04601 and compositions comprising the compounds for inhibiting microbial growth and / or specific disease pathways.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  したがって、本発明のある実施の形態は、本発明のファルネシル化ジベンゾジアゼピノン化合物を含む医薬組成物と薬学的に許容されるキャリア、細菌の増殖を阻害するための該組成物の使用方法、及び癌、慢性炎症並びに急性炎症を含む疾患を治療するための医薬組成物の使用方法に関する。
</span>
&nbsp;&nbsp;Thus, certain embodiments of the invention include a pharmaceutical composition comprising a farnesylated dibenzodiazepinone compound of the invention and a pharmaceutically acceptable carrier, a method of using the composition to inhibit bacterial growth, And a method of using the pharmaceutical composition for treating diseases including cancer, chronic inflammation and acute inflammation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
I．<u class="style-scope patent-text">定義</u> <br class="style-scope patent-text">
  便宜上、本明細書、実施例、及び添付の請求の範囲で用いられる、特定の用語及びフレーズを、以下に示す。
</span>I. For purposes of <u class="style-scope patent-text">definition</u> , certain terms and phrases used in the specification, examples, and appended claims are set forth below.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に用いるように、「ファルネシルジベンゾジアゼピノン」なる用語は、ファルネシル成分を含むジベンゾジアゼピノン化合物の種類に関する。かかる用語には、本発明の例示された化合物であり、本明細書で「ＥＣＯ−０４６０１」と称される１０−ファルネシル−４、６、８、トリヒドロキシ−ジベンゾジアゼピン−１１−オンが含まれるが、これに限定されない。本明細書に用いられるように、「ファルネシルジベンゾジアゼピノン」なる用語は、化学合成において中間生成物として使用可能であるこの種類の化合物を含む。本明細書に用いられるように、「アルキル」なる用語は、直鎖状又は分岐状の炭化水素基に関する。アルキル基の例には、メチル、エチル、ｎ−プロピル、イソプロピル、ｎ−ブチル、ペンチル、へキシル、ヘプチル、シクロペンチル、シクロへキシル、シクロへキシメチル等が含まれるが、これらに限定されない。アルキルは、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルホニル、オキソ、グアニジノ、及びホルミルから選択される置換基で任意に置換されてもよい。
</span>
&nbsp;&nbsp;As used herein, the term “farnesyl dibenzodiazepinone” relates to a class of dibenzodiazepinone compounds that include a farnesyl component. Such terms include the exemplified compounds of the invention, 10-farnesyl-4,6,8, trihydroxy-dibenzodiazepin-11-one, referred to herein as “ECO-04601”. However, it is not limited to this. As used herein, the term “farnesyl dibenzodiazepinone” includes this class of compounds that can be used as intermediate products in chemical synthesis. As used herein, the term “alkyl” refers to a straight or branched hydrocarbon group. Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, pentyl, hexyl, heptyl, cyclopentyl, cyclohexyl, cyclohexylmethyl and the like. Alkyl is acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy, It may be optionally substituted with a substituent selected from sulfinyl, sulfonyl, oxo, guanidino, and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「アルケニル」なる用語は、少なくとも１つの炭素−炭素二重結合を含む直鎖状、分岐状、又は環式の炭化水素基に関する。アルケニル基の例には、ビニル、１−プロペン−２−イル、１−ブテン−４−イル、２−ブテン−４−イル、１−ペンテン−５−イル等が含まれるが、これらに限定されない。アルケニルは、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルホニル、ホルミル、オキソ、及びグアニジノから選択される置換基で任意に置換されてもよい。
</span>
&nbsp;&nbsp;The term “alkenyl” refers to a straight, branched, or cyclic hydrocarbon group containing at least one carbon-carbon double bond. Examples of alkenyl groups include, but are not limited to, vinyl, 1-propen-2-yl, 1-buten-4-yl, 2-buten-4-yl, 1-penten-5-yl and the like. . Alkenyl is acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy, It may be optionally substituted with a substituent selected from sulfinyl, sulfonyl, formyl, oxo, and guanidino.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「シクロアルキル」及び「シクロアルキル環」なる用語は、３から１５の環員を有する単式（一重）カルボキシル環系又は縮合カルボキシル環系における飽和炭素環又は部分的な不飽和炭素環に関する。シクロアルキル基の例には、シクロプロピル、シクロブチル、シクロへキシル、及びシクロヘプチルが含まれるが、これらに限定されない。シクロアルキルは、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルホニル、及びホルミルから選択される置換基で任意に置換されてもよい。
</span>
&nbsp;&nbsp;The terms “cycloalkyl” and “cycloalkyl ring” relate to saturated or partially unsaturated carbocycles in mono (single) carboxyl ring systems or fused carboxyl ring systems having 3 to 15 ring members. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclohexyl, and cycloheptyl. Cycloalkyl is acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy , Optionally substituted with a substituent selected from sulfinyl, sulfonyl, and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「複素環」及び「複素環系」なる語は、３から１５の環員を有する単式（一重）複素環系又は縮合複素環系において、Ｏ、Ｎ、ＮＨ、ＮＲ<sub class="style-scope patent-text">Ｘ</sub>、ＰＯ２、Ｓ、ＳＯ、又はＳＯ２から選択される１から４個のヘテロ原子又はヘテロ基を含む、飽和環又は部分的な不飽和環に関する。複素環又は複素環系の環の例には、モルホリニル、ピペリジニル、及びピロリジニルが含まれるが、これらに限定されない。複素環、複素環系、又は複素環の環は、アシル、アミノ、アシルアミノ、アシルオキシ、オキソ、チオカルボニル、イミノ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルホニル、及びホルミルから選択される置換基で任意に置換されてもよい。
</span>The terms “heterocycle” and “heterocycle system” refer to O, N, NH, NR <sub class="style-scope patent-text">x</sub> , PO 2, S, SO, in mono- (single) heterocycles or fused heterocycles having 3 to 15 ring members. Or a saturated or partially unsaturated ring containing 1 to 4 heteroatoms or heterogroups selected from SO2. Examples of a heterocyclic ring or heterocyclic ring include, but are not limited to, morpholinyl, piperidinyl, and pyrrolidinyl. Heterocycles, heterocycles, or heterocycles are acyl, amino, acylamino, acyloxy, oxo, thiocarbonyl, imino, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl And optionally substituted with a substituent selected from alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy, sulfinyl, sulfonyl, and formyl.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「アミノ酸」なる語は、あらゆる天然アミノ酸に関する。あらゆる天然アミノ酸は、当業者に周知である。
</span>
&nbsp;&nbsp;The term “amino acid” relates to any natural amino acid. All natural amino acids are well known to those skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「ハロ」なる語は、臭素、塩素、フッ素、及びヨウ素等のハロゲン原子に関する。
</span>
&nbsp;&nbsp;The term “halo” relates to halogen atoms such as bromine, chlorine, fluorine and iodine.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「アリール」及び「アリール環」なる語は、５から１５の環員を有する単式（一重）環系又は縮合環系における芳香族基に関する。アリールの例には、フェニル、ナフチル、ビフェニル、テルフェニルが含まれるが、これらに限定されない。アリールは、アシル、アミノ、アシルアミノ、アシルオキシ、アジド、アルキチオ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルホニル、及びホルミルから選択される置換基の１又は２以上で任意に置換されてもよい。
</span>
&nbsp;&nbsp;The terms “aryl” and “aryl ring” relate to aromatic groups in mono- (single) ring systems or fused ring systems having 5 to 15 ring members. Examples of aryl include, but are not limited to, phenyl, naphthyl, biphenyl, terphenyl. Aryl is acyl, amino, acylamino, acyloxy, azide, alkthio, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy , Aryloxy, sulfinyl, sulfonyl, and formyl may be optionally substituted with one or more of the substituents selected.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「ヘテロアリール」及び「ヘテロアリール環」なる語は、単式（一重）環系又は縮合環系において、５から１５の環員を有し、Ｏ、Ｎ、Ｓ、ＳＯ及びＳＯ２等のヘテロ原子を少なくとも１つ含む、芳香基に関する。ヘテロアリール基の例には、ピリジニル、チアゾリル、チアジアゾイル、イソキノリニル、ピラゾリル、オキサゾリル、オキサジアゾイル、トリアゾリル、及びピロリル基が含まれるが、これらに限定されない。ヘテロアリール基は、アシル、アミノ、アシルアミノ、アシルオキシ、カルボアルコキシ、カルボキシ、カルボキシアミド、シアノ、ハロ、ヒドロキシル、ニトロ、チオ、チオカルボニル、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクリル、アリール、ヘテロアリール、アルコキシ、アリールオキシ、スルフィニル、スルホニル、及びホルミルから選択される１又は２以上の置換基で任意に置換されてもよい。
</span>
&nbsp;&nbsp;The terms “heteroaryl” and “heteroaryl ring” have from 5 to 15 ring members in a mono (single) ring system or fused ring system and include heteroatoms such as O, N, S, SO and SO 2. It relates to an aromatic group comprising at least one. Examples of heteroaryl groups include, but are not limited to, pyridinyl, thiazolyl, thiadiazoyl, isoquinolinyl, pyrazolyl, oxazolyl, oxadiazoyl, triazolyl, and pyrrolyl groups. Heteroaryl groups are acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, thiocarbonyl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, It may be optionally substituted with one or more substituents selected from alkoxy, aryloxy, sulfinyl, sulfonyl, and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「アラルキル」及び「ヘテロアラルキル」なる語は、ベンジル等のアルキル基を通してそれぞれ直接結合したアリール基又はヘテロアリール基に関する。アラルキル及びヘテロアラルキルは、アリール基又はヘテロアリール基として任意に置換されてもよい。
</span>
&nbsp;&nbsp;The terms “aralkyl” and “heteroaralkyl” relate to an aryl or heteroaryl group bonded directly through an alkyl group such as benzyl, respectively. Aralkyl and heteroaralkyl may be optionally substituted as aryl groups or heteroaryl groups.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  同様に、「アラルケニル」及び「ヘテロアラルケニル」なる語は、ベンジル等のアルケン基を通してそれぞれ直接結合したアリール基又はヘテロアリール基に関する。アラルキル及びヘテロアラルキルは、アリール基及びヘテロアリール基として任意に置換されてもよい。
</span>
&nbsp;&nbsp;Similarly, the terms “aralkenyl” and “heteroaralkenyl” relate to an aryl or heteroaryl group bonded directly through an alkene group such as benzyl, respectively. Aralkyl and heteroaralkyl may be optionally substituted as aryl and heteroaryl groups.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、１又は２以上の不斉炭素原子を有することができ、ラセミ化合物又は非ラセミ化合物の混合物を形成する光学異性体として存在することができる。本発明の化合物は、単一の異性体又は立体化学異性体の形の混合物として有用である。ジアステレオ異性体、すなわちスーパーインポーズができない立体化学異性体を、クロマトグラフィー、蒸留、結晶化、又は昇華等の従来の手段によって分離することができる。従来の方法でラセミ混合物を分解して、該光学異性体を得ることができる。
</span>
&nbsp;&nbsp;The compounds of the present invention can have one or more asymmetric carbon atoms and can exist as optical isomers forming racemic or non-racemic mixtures. The compounds of the present invention are useful as mixtures in the form of single isomers or stereochemical isomers. Diastereoisomers, ie stereochemical isomers that are not superimposable, can be separated by conventional means such as chromatography, distillation, crystallization, or sublimation. The racemic mixture can be decomposed by a conventional method to obtain the optical isomer.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、単離された又は精製された化合物を含む。「単離された」又は「精製された」化合物は、当業者に周知の従来の生物学的アッセイでテストされた場合に、本発明の化合物を含む混合物が、抗菌作用、細胞分裂停止作用、細胞毒性作用、抗炎症性作用又は酵素阻害作用等の実証可能な（統計的に優位な）生物活性を有するならば、本発明の化合物の少なくとも１０％、２０％、５０％、８０％、又は９０％が混合物中に存在することを示す化合物に関する。
</span>
&nbsp;&nbsp;The present invention includes isolated or purified compounds. An “isolated” or “purified” compound is a compound comprising a compound of the present invention, when tested in a conventional biological assay well known to those skilled in the art, to produce an antibacterial action, a cytostatic action, At least 10%, 20%, 50%, 80%, or at least 10% of a compound of the present invention if it has a demonstrable (statistically superior) biological activity, such as a cytotoxic, anti-inflammatory or enzyme inhibitory effect, or Relates to compounds which indicate that 90% is present in the mixture.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に用いられる「ファルネシルジベンゾジアゼピノンを生成する微生物」及び「ファルネシルジベンゾジアゼピノンの生成者」なる語は、ある生物が自然にファルネシルジベンゾジアゼピノン化合物を生成するか否かに関わらず、該化合物を生成するために必要とされる遺伝子情報を保有する微生物に関する。かかる語は、ファルネシルジベンゾジアゼピノン化合物を生成するための遺伝子情報が、自然環境に存在するように該生物中に見出される生物や、組換え技術によって遺伝子情報が導入されている生物に等しく用いられる。
</span>
&nbsp;&nbsp;As used herein, the terms “microorganism producing farnesyl dibenzodiazepinone” and “producer of farnesyl dibenzodiazepinone” refer to whether an organism naturally produces farnesyl dibenzodiazepinone compounds. Regardless, it relates to a microorganism that possesses the genetic information required to produce the compound. Such terms are equally used for organisms in which the genetic information for producing a farnesyl dibenzodiazepinone compound is found in the organism so that it exists in the natural environment or in which genetic information has been introduced by recombinant technology. It is done.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書で予測される特定の生物には、好ましい属がMicromonospora Actinoplanes及びDactylosporangiumであるMicromonosporaceae科の生物、好ましい属がStreptomyces及びKitasatosporaであるStreptomycetaceae科の生物、好ましい属がAmycolatopsis及びSaccharopolysporaであるPseudonocardiaceae科の生物、及び好ましい属がSaccharothrix及びActinosynnemaであるActinosynnemataceaeが含まれるが、これらに限定されない。しかし、これらの語は、ファルネシルジベンゾジアゼピノン化合物を生成するために必要とされる遺伝子情報を含むあらゆる生物を含むことを意図する。ファルネシルジベンゾジアゼピノン化合物の好ましい生成者には、２００３年３月７日、にカナダ保健省、微生物部、カナダ国際寄託当局（ＩＤＡＣ）、(1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)に、ＩＤＡＣアクセッション番号第０７０３０３−０１として寄託された、微生物菌株０４６−ＥＣＯ１１が含まれる。
</span>
&nbsp;&nbsp;Specific organisms predicted herein include organisms of the family Micromonosporaceae whose preferred genera are Micromonospora Actinoplanes and Dactylosporangium, organisms of the family Streptomycetaceae whose preferred genera are Streptomyces and Kitasatospora, family Pseudonocardiaceae whose preferred genera are Amycolatopsis and Saccharopolyspora And, preferably, Actinosynnemataceae whose preferred genera are Saccharothrix and Actinosynnema. However, these terms are intended to include any organism that contains the genetic information required to produce a farnesyl dibenzodiazepinone compound. Preferred producers of farnesyl dibenzodiazepinone compounds are listed on March 7, 2003 on Health Canada, Department of Microbiology, Canadian International Depository Authority (IDAC), (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2). , Microbial strain 046-ECO11, deposited under IDAC accession number 070303-01.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「遺伝子」なる語は、ポリペプチド鎖の生成に関与するＤＮＡのセグメントを意味する。遺伝子には、コード領域の前後の領域（リーダー及びトレーラー）、並びに適切であればそれぞれをコードするセグメント（エキソン）の間の介在領域（イントロン）が含まれる。
</span>
&nbsp;&nbsp;The term “gene” refers to a segment of DNA involved in the production of a polypeptide chain. A gene includes regions before and after the coding region (leader and trailer) and, if appropriate, intervening regions (introns) between the segments (exons) that encode each.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「遺伝子座」、「遺伝子クラスター」、及び「生合成遺伝子座」なる語は、ファルネシルベンゾジアゼピノン化合物の生合成に関与する遺伝子又はその変異体の群に関する。ＥＣＯ−０４６０１の生成に関する０４６−ＥＣＯ１１株における生合成遺伝子座は、本明細書及び図に「０４６Ｄ」と称される場合が多い。遺伝子座、遺伝子クラスター、及び生合成遺伝子座の遺伝子改変は、ＥＣＯ−０４６０１の変異体を作製するために用いることができる、突然変異生成、不活性化又は核酸の置換等の、当技術分野に周知のあらゆる遺伝子組換え技術に関する。
</span>
&nbsp;&nbsp;The terms “locus”, “gene cluster”, and “biosynthetic locus” relate to a group of genes or variants thereof that are involved in the biosynthesis of farnesyl benzodiazepinone compounds. The biosynthetic locus in the 046-ECO11 strain for production of ECO-04601 is often referred to herein as “046D” in the figures and figures. Genetic modification of loci, gene clusters, and biosynthetic loci can be used in the art to create mutants of ECO-04601, such as mutagenesis, inactivation or nucleic acid replacement. It relates to all known gene recombination techniques.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「配列をコードする」ＤＮＡ又は核酸、又は特定のポリペプチド又はタンパク質を「コードする配列」は、適切な制御配列のコントロール下に置かれた場合に、転写され、ポリペプチド又はタンパク質に翻訳されるＤＮＡ配列である。
</span>
&nbsp;&nbsp;A DNA or nucleic acid that "encodes a sequence" or a "encoding sequence" that encodes a particular polypeptide or protein is transcribed and translated into a polypeptide or protein when placed under the control of appropriate regulatory sequences DNA sequence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
「オリゴヌクレオチド」は、一般的には少なくとも１０ヌクレオチド長、好ましくは１５ヌクレオチド長、より好ましくは少なくとも２０ヌクレオチド長の核酸であって、好ましくは１００ヌクレオチド長より短く、遺伝子、ｍＲＮＡ、ｃＤＮＡ又は他の所望の核酸をコードするゲノムＤＮＡ分子、ｃＤＮＡ分子、若しくはｍＲＮＡ分子とハイブリダイズすることが可能な核酸に関する。
</span>
An “oligonucleotide” is generally a nucleic acid that is at least 10 nucleotides in length, preferably 15 nucleotides in length, more preferably at least 20 nucleotides in length, preferably less than 100 nucleotides in length, and is a gene, mRNA, cDNA or other The present invention relates to a nucleic acid capable of hybridizing with a genomic DNA molecule, cDNA molecule, or mRNA molecule encoding a desired nucleic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  プロモーター配列は、プロモーターで転写を開始し、コード配列をｍＲＮＡに転写するＲＮＡポリメラーゼによって認識された、コード配列に「操作可能な状態で結合している」。
</span>
&nbsp;&nbsp;A promoter sequence is “operably linked” to a coding sequence recognized by RNA polymerase that initiates transcription at the promoter and transcribes the coding sequence into mRNA.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に用いる「レプリコン」なる語は、プラスミド、コスミド、染色体又はウイルス等の、細胞内でポリヌクレオチド複製の自立的な単位として機能する、あらゆる遺伝子的要素を意味する。「発現ベクター」又は「ベクター」は、結びついたフラグメントの複製及び／又は発現を引き起こす等のための、別のポリヌクレオチドフラグメントが結びついたレプリコンである。本明細書において、「プラスミド」は、大文字及び／又は番号の前若しくは後に、小文字の「ｐ」で示される。本明細書に開示される開始プラスミドは、市販されていて制限なく公式に入手可能である。或いは、公開された手順に従って入手可能なプラスミドから該開始プラスミドを構築することができる。更に、本明細書に記載されるプラスミドと同等なプラスミドは、当技術分野に周知であり、当業者には明らかとなろう。
</span>
&nbsp;&nbsp;As used herein, the term “replicon” means any genetic element that functions as an autonomous unit of polynucleotide replication in a cell, such as a plasmid, cosmid, chromosome or virus. An “expression vector” or “vector” is a replicon associated with another polynucleotide fragment, such as to cause replication and / or expression of the associated fragment. In the present specification, “plasmid” is indicated by a small letter “p” before or after capital letters and / or numbers. The starting plasmids disclosed herein are commercially available and formally available without limitation. Alternatively, the starting plasmid can be constructed from plasmids available according to published procedures. In addition, plasmids equivalent to those described herein are well known in the art and will be apparent to those of skill in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「発現する」又は「発現」なる語は、遺伝子配列又はＤＮＡ配列に含まれる情報を明らかにする、又はその原因となることを意味する。例えば、対応する遺伝子配列やＤＮＡ配列の転写や翻訳に関与する細胞の機能を活性化させてタンパク質を生成することを意味する。ＤＮＡ配列は、細胞に発現する又は細胞によって発現し、タンパク質等の「発現生成物」を形成する。発現生成物自体、例えば結果として生じるタンパク質を、細胞によって「発現された」と称してもよい。発現生成物を、細胞内生成物、細胞外生成物又は分泌生成物として特徴付けることができる。
</span>
&nbsp;&nbsp;The term “express” or “expression” means revealing or causing information contained in a gene sequence or DNA sequence. For example, it means that a protein is generated by activating a function of a cell involved in transcription or translation of a corresponding gene sequence or DNA sequence. A DNA sequence is expressed in or by a cell and forms an “expression product” such as a protein. The expression product itself, eg, the resulting protein, may be referred to as “expressed” by the cell. An expression product can be characterized as an intracellular product, an extracellular product or a secreted product.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＤＮＡの「分解」は、ＤＮＡの特定の配列でのみ作用する制限酵素によるＤＮＡの酵素開裂に関する。本明細書に用いられる様々な制限酵素は、市販されており、使用した反応条件、補助因子、及び他の要件は、通常の当業者に周知でる。分析を目的とする場合は、標準的には、約２０μｌの緩衝液中、１μｇのプラスミド又はＤＮＡフラグメントを約２単位の酵素と共に用いる。プラスミドを構築するためにＤＮＡフラグメントを単離する目的であれば、標準的に、より多くの量の緩衝液中、５から５０μｇのＤＮＡを２０から２５０単位の酵素で分解する。特定の酵素に適切な緩衝液や基質の量は、製造業者によって特定されている。通常は３７℃で約１時間の培養時間を用いるが、製造業者の指示に合わせて変えてもよい。分解後に、ゲル電気泳動を行って、所望のフラグメントを単離してもよい。
</span>
&nbsp;&nbsp;“Degradation” of DNA refers to the enzymatic cleavage of DNA by restriction enzymes that act only on specific sequences of DNA. The various restriction enzymes used herein are commercially available and the reaction conditions, cofactors, and other requirements used are well known to those of ordinary skill in the art. For analytical purposes, typically 1 μg of plasmid or DNA fragment is used with about 2 units of enzyme in about 20 μl of buffer. For purposes of isolating DNA fragments to construct plasmids, typically 5 to 50 μg of DNA is digested with 20 to 250 units of enzyme in a larger volume of buffer. The amount of buffer or substrate appropriate for a particular enzyme is specified by the manufacturer. Usually, an incubation time of about 1 hour at 37 ° C. is used, but may be varied according to the manufacturer's instructions. After degradation, gel electrophoresis may be performed to isolate the desired fragment.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に使用される「単離される」なる語は、物質が元の環境（例えば、物質が自然に存在している自然環境）から取り除かれることを意味する。例えば、動物の生体に存在する自然に存在しているポリヌクレオチド又はポリペプチドは単離されていないが、同じポリヌクレオチド又はポリペプチドでも、自然体系に共存している物質の一部又は全部から分離された場合は単離されている。これらのポリヌクレオチドは、ベクターの一部にもなり得るし、且つ／又は組成物の一部にもなり得る。更に、かかるベクター又は組成物が自然環境の一部ではないところで単離されることもある。
</span>
&nbsp;&nbsp;As used herein, the term “isolated” means that the material is removed from its original environment (eg, the natural environment in which the material naturally exists). For example, a naturally occurring polynucleotide or polypeptide present in the animal's body has not been isolated, but the same polynucleotide or polypeptide is separated from some or all of the coexisting substances in the natural system. If so, it is isolated. These polynucleotides can be part of the vector and / or part of the composition. Furthermore, such vectors or compositions may be isolated where they are not part of the natural environment.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
本明細書に使用される「制限フラグメント」なる語は、１又は２以上の制限酵素の作用によって作製されるあらゆる直鎖状のＤＮＡに関する。
</span>
As used herein, the term “restriction fragment” refers to any linear DNA made by the action of one or more restriction enzymes.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
「形質転換」なる用語は、宿主細胞が導入された遺伝子又は配列を発現し、所望の物質を生成するように、外来遺伝子、外来核酸、ＤＮＡ配列又はＲＮＡ配列を宿主細胞に導入することを意味する。所望の物質とは、通常、導入された遺伝子又は配列によってコードされるタンパク質や酵素である。導入された遺伝子又は配列は、「クローン化された」若しくは「外来の」遺伝子又は配列とも称され、開始、停止、プロモーター、シグナル、分泌等の制限配列又は制御配列、又は細胞の遺伝子の機構によって用いられる他の配列が含まれる。これらの遺伝子又は配列は非機能的配列又は既知の機能を有さない配列を含んでいる。導入されたＤＮＡ又はＲＮＡを受け入れて発現する宿主細胞は、「形質転換」され、「形質転換体」又は「クローン」又は「リコンビナント」となる。宿主細胞に導入されたＤＮＡ又はＲＮＡは、該宿主細胞と同属又は同種の細胞、又は異属又は異種の細胞を含むあらゆる起源に由来することができる。
</span>
The term “transformation” means introducing a foreign gene, foreign nucleic acid, DNA sequence or RNA sequence into a host cell so that the host cell expresses the introduced gene or sequence and produces the desired substance. To do. The desired substance is usually a protein or enzyme encoded by the introduced gene or sequence. The introduced gene or sequence is also referred to as a “cloned” or “foreign” gene or sequence, depending on the restriction or control sequence such as initiation, termination, promoter, signal, secretion, etc., or the cellular gene mechanism. Other sequences used are included. These genes or sequences include non-functional sequences or sequences that have no known function. Host cells that accept and express the introduced DNA or RNA are “transformed” and become “transformants” or “clones” or “recombinants”. The DNA or RNA introduced into the host cell can be derived from any source, including cells of the same or same type as the host cell, or of different or different species.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に使用される「リコンビナントポリヌクレオチド」及び「リコンビナントポリペプチド」なる語は、自然に結合している以外に、自然にポリヌクレオチド又はポリペプチドに関連しているか結合している、ポリペプチド又はポリヌクレオチドの全部又は一部と、起源又は操作によって、関連していないポリヌクレオチド又はポリペプチドを意味する。
</span>
&nbsp;&nbsp;As used herein, the terms “recombinant polynucleotide” and “recombinant polypeptide” refer to a polypeptide that is naturally associated with or bound to a polynucleotide or polypeptide in addition to being naturally bound. Alternatively, it refers to a polynucleotide or polypeptide that is not related to all or part of the polynucleotide by origin or manipulation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に使用される「宿主細胞」なる語は、本発明に示されるリコンビナントと真核生物の細胞の両方に関する。ある実施の形態においては、かかる宿主細胞は原核生物である。
</span>
&nbsp;&nbsp;The term “host cell” as used herein relates to both recombinant and eukaryotic cells as indicated in the present invention. In certain embodiments, such host cells are prokaryotic.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に使用される「オープンリーディングフレーム」及び「ＯＲＦ」なる語は、ポリペプチドをコードするポリヌクレオチド配列の領域に関する。該領域は、コードする配列の一部又はコード配列全体を示す場合もある。
</span>
&nbsp;&nbsp;As used herein, the terms “open reading frame” and “ORF” relate to a region of a polynucleotide sequence that encodes a polypeptide. The region may indicate part of the coding sequence or the entire coding sequence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に使用されるように、また当技術分野に周知であるように、「同一性」なる語は、配列の比較によって決定される、２つ以上のポリヌクレオチド配列間の関係をいう。同一性はまた、ポリヌクレオチド配列のストリング間の一致によって決定される、該ポリヌクレオチド配列間の配列関連性の程度も意味する。同一性は容易に計算することができる（例えば、Computation Molecular Biology, Lesk, A. M., eds., Oxford University Press, New York (1988)及びBiocomputing:Informatics and Genome Projects, Smith, D. W., ed., Academic Press, New York (1993)参照。両文献は参照することによって本明細書に含まれる。）２つのポリヌクレオチド配列間の同一性を測定するためには多くの方法があり、かかる用語は当業者には公知である（Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press (1987);及びSequence Analysis Primer, Gribskov., M. and Devereux, J., eds., M. Stockton Press, New York (1991)）。配列間の同一性を測定するために一般的に用いられる方法には、例えば、Carillo, H., and Lipman, D., SIAM J. Applied Math. (1998) 48:1073に開示される方法が含まれる。本明細書に使用されるように、「ほぼ同一な」は、対象となるポリヌクレオチド配列間に非常に高いホモロジー（好ましくは１００％の配列同一性）があることを意味する。しかし、９０％より高い又は９５％の配列同一性を有するポリヌクレオチドを本発明に使用してもよく、したがって遺伝子の突然変異、菌株の多形現象、又は進化による分岐によって起こい得る配列の変異は、許容される。
</span>
&nbsp;&nbsp;As used herein and as is well known in the art, the term “identity” refers to a relationship between two or more polynucleotide sequences, as determined by sequence comparison. Identity also refers to the degree of sequence relatedness between polynucleotide sequences, determined by matching between strings of polynucleotide sequences. Identity can be easily calculated (eg, Computation Molecular Biology, Lesk, AM, eds., Oxford University Press, New York (1988) and Biocomputing: Informatics and Genome Projects, Smith, DW, ed., Academic Press , New York (1993), both of which are hereby incorporated by reference.) There are many ways to determine the identity between two polynucleotide sequences, and such terms are known to those skilled in the art. Is known (Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press (1987); and Sequence Analysis Primer, Gribskov., M. and Devereux, J., eds., M. Stockton Press, New York ( 1991)). Commonly used methods for measuring identity between sequences include, for example, the method disclosed in Carillo, H., and Lipman, D., SIAM J. Applied Math. (1998) 48: 1073. included. As used herein, “approximately the same” means that there is a very high homology (preferably 100% sequence identity) between the polynucleotide sequences of interest. However, polynucleotides having greater than 90% or 95% sequence identity may be used in the present invention, and thus sequence variations that can occur due to genetic mutation, strain polymorphism, or evolutionary branching Is acceptable.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に使用されるように、「治療」なる語は、疾病、疾病の症状、又は疾病の要因を治療する、治す、軽減する、緩和する、変化させる、癒す、改良する、改善する、又はそれらに影響を及ぼすために、患者に対して治療薬を使用又は投与すること、或いは、疾病又は体の異常、疾病の症状、若しくは疾病の要因等の疾患を有する患者から単離した組織又は細胞株に対して治療薬を使用又は投与することに関する。
</span>
&nbsp;&nbsp;As used herein, the term “treatment” treats, cures, alleviates, alleviates, changes, heals, improves, improves a disease, a symptom of the disease, or a factor of the disease, Or the use or administration of a therapeutic agent to a patient to affect them, or a tissue isolated from a patient having a disease, such as a disease or physical abnormality, a disease symptom, or a factor of the disease, or It relates to the use or administration of therapeutic agents to cell lines.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に使用されるように、「医薬組成物」は、薬学的に効果的な量のファルネシルジベンゾジアゼピノンと薬学的に許容されるキャリアとを含む。本明細書に使用されるように、「薬学的に効果的な量」、「治療に効果的な量」、又は単に「効果的な量」は、目的とする薬理学的、治療的、又は予防的結果をもたらすために効果的なファルネシルジベンゾジアゼピノンの量に関する。例えば、疾病又は疾患に関連する、測定可能なパラメータが少なくとも２５％減少した場合、ある臨床治療が効果的であると考えられるならば、その疾病又は疾患の治療に効果的な薬剤の量は、かかるパラメータを少なくとも２５％減少させるために必要な量である。
</span>
&nbsp;&nbsp;As used herein, a “pharmaceutical composition” comprises a pharmaceutically effective amount of farnesyl dibenzodiazepinone and a pharmaceutically acceptable carrier. As used herein, “pharmaceutically effective amount”, “therapeutically effective amount”, or simply “effective amount” is intended to be a pharmacological, therapeutic, or It relates to the amount of farnesyl dibenzodiazepinone effective to produce a preventive result. For example, if a measurable parameter associated with a disease or disorder is reduced by at least 25%, and if a clinical treatment is considered effective, then the amount of drug effective to treat that disease or disorder is An amount necessary to reduce such a parameter by at least 25%.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「薬学的に許容されるキャリア」なる語は、治療薬を投与するためのキャリアに関する。これらのキャリアには生理食塩水、緩衝生理食塩水、ブドウ糖、水、グリセロール、エタノール及びこれらの組合せが含まれるが、これらに限定されない。かかる語には、具体的には細胞培地は含まれない。経口投与される薬剤については、薬学的に許容されるキャリアには、薬学的に許容される不活性の希釈剤、崩壊剤、結合剤、平滑剤、甘味料、着香料、着色料、及び保存料等の賦形剤が含まれるが、これらに限定されない。適当な不活性の希釈剤には、ナトリウムと炭酸カルシウム、ナトリウムとリン酸カルシウム、及びラクトースが含まれ、適当な崩壊剤には、コーンスターチとアルギン酸とが含まれる。結合剤には、デンプンやゼラチンが含まれていてもよく、平滑剤は、存在するのであれば一般的にはステアリン酸マグネシウム、ステアリン酸又はタルクである。必要であれば、消化管での吸収を遅らせるために、錠剤を、グリセリルモノステアレート又はグリセリルジステアレート等の物質でコーティングしてもよい。
</span>
&nbsp;&nbsp;The term “pharmaceutically acceptable carrier” refers to a carrier for administering a therapeutic agent. These carriers include, but are not limited to, saline, buffered saline, glucose, water, glycerol, ethanol, and combinations thereof. Such terms specifically do not include cell culture media. For orally administered drugs, pharmaceutically acceptable carriers include pharmaceutically acceptable inert diluents, disintegrants, binders, smoothing agents, sweeteners, flavoring agents, coloring agents, and preservatives. Excipients such as materials are included, but are not limited thereto. Suitable inert diluents include sodium and calcium carbonate, sodium and calcium phosphate, and lactose, and suitable disintegrants include corn starch and alginic acid. Binders may include starch and gelatin, and the smoothing agent, if present, is typically magnesium stearate, stearic acid or talc. If necessary, tablets may be coated with a substance such as glyceryl monostearate or glyceryl distearate to delay absorption in the gastrointestinal tract.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「薬学的に許容される塩」なる語は、酸付加塩と基付加塩(base addition salts)との両方に関する。薬学的に許容されるのであれば、塩の性質は重要ではない。代表的な酸付加塩には塩酸、臭化水素酸、ヨウ化水素酸、硝酸、炭酸、硫酸、リン酸、ギ酸、酢酸、クエン酸、酒石酸、琥珀酸、シュウ酸、リンゴ酸、グルタミン酸、プロピオン酸、グリコール酸、グルコン酸、マレイン酸、エンボン酸（パモン酸）、メタンスルホン酸、エタンスルホン酸、２−ヒドロキシエタンスルホン酸、パントテン酸、ベンゼンスルホン酸、トルエンスルホン酸、スルファニル酸、メシル酸、シクロヘキシルアミノスルホン酸、ステアリン酸、アルギン酸、β−ヒドロキシ酪酸、マロン酸、ガラクタル酸、ガラクツロン酸等が含まれるが、これらに限定されない。適切な薬学的に許容される基付加塩には、アルミニウム、カルシウム、リチウム、マグネシウム、カリウム、ナトリウム及び亜鉛から作られた金属塩、又はＮ，Ｎ´−ジベンジルエチレンジアミン、クロロプロカイン、コリン、ジエタノールアミン、エチレンアミン、Ｎ−メチルグルカミン、リジン、プロカイン等から作られた有機塩が含まれるが、これらに限定されない。薬学的に許容される塩の更なる例は、Journal of Pharmaceutical Sciences (1977) 66:2に記載されている。これらの塩はすべて、適当な酸又は基で該化合物を処理することによって、従来の手段でファルネシルジベンゾジアゼピノンから調製してもよい。
</span>
&nbsp;&nbsp;The term “pharmaceutically acceptable salts” relates to both acid addition salts and base addition salts. The nature of the salt is not critical provided that it is pharmaceutically acceptable. Typical acid addition salts include hydrochloric acid, hydrobromic acid, hydroiodic acid, nitric acid, carbonic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, citric acid, tartaric acid, succinic acid, oxalic acid, malic acid, glutamic acid, propion Acid, glycolic acid, gluconic acid, maleic acid, embonic acid (pamonic acid), methanesulfonic acid, ethanesulfonic acid, 2-hydroxyethanesulfonic acid, pantothenic acid, benzenesulfonic acid, toluenesulfonic acid, sulfanilic acid, mesylic acid, Examples include, but are not limited to, cyclohexylaminosulfonic acid, stearic acid, alginic acid, β-hydroxybutyric acid, malonic acid, galactaric acid, galacturonic acid, and the like. Suitable pharmaceutically acceptable group addition salts include metal salts made from aluminum, calcium, lithium, magnesium, potassium, sodium and zinc, or N, N'-dibenzylethylenediamine, chloroprocaine, choline, diethanolamine , Organic salts made from ethyleneamine, N-methylglucamine, lysine, procaine, and the like. Further examples of pharmaceutically acceptable salts are described in Journal of Pharmaceutical Sciences (1977) 66: 2. All of these salts may be prepared from farnesyl dibenzodiazepinone by conventional means by treating the compound with a suitable acid or group.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
II．<u class="style-scope patent-text">ファルネシル化ジベンゾジアゼピノン化合物</u> <br class="style-scope patent-text">
ある実施の形態において、本発明は、本明細書で「ＥＣＯ−０４６０１」と称され、下記式で表される化学構造を有する、新規のファルネシルジベンゾジアゼピノンに関する。
</span>II. <u class="style-scope patent-text">Farnesylated dibenzodiazepinone compounds In</u> certain embodiments, the present invention is a novel farnesyl dibenzodia, referred to herein as "ECO-04601", having a chemical structure represented by the formula: Regarding Zepinone.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
      <br class="style-scope patent-text">
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ＥＣＯ−０４６０１は、ジベンゾジアゼピノン環の１０番目の窒素原子（すなわちジアゼピノン環のアミド窒素）に位置する１０のファルネシル置換基を有し、ジベンゾジアゼピノン環の４，６、及び８番目に３つのフェノール性水酸置換基を有する、新規のジベンゾジアゼピノンであると記載される。ＥＣＯ−０４６０１は、質量、ＵＶ、ＮＭＲ分光分析データ等のいずれの１又は２以上の以下に示す物理化学的特性又は分光特性によって特徴付けられる。質量は、エレクトロスプレー質量分析計で４６２．６（図１）と測定され、ＵＶ＝２３０ｎｍ（ショルダー２９０ｎｍ）（図２）と測定された。プロトン（図３）、多次元パルスシーケンスｇＤＱＣＯＳＹ（図４）、ｇＨＳＱＣ（図５）、ｇＨＭＢＣ（図６）及びＮＯＥＳＹ（図７）を含むＭｅＯＨ−ｄ４を使用して、ＮＭＲデータを回収した。
</span>
ECO-04601 has 10 farnesyl substituents located at the 10th nitrogen atom of the dibenzodiazepinone ring (ie, the amide nitrogen of the diazepinone ring), and the fourth, sixth, and eighth positions of the dibenzodiazepinone ring. It is described as a novel dibenzodiazepinone with three phenolic hydroxyl substituents. ECO-04601 is characterized by any one or more of the following physicochemical or spectroscopic properties such as mass, UV, NMR spectroscopy data, etc. The mass was measured with an electrospray mass spectrometer as 462.6 (FIG. 1) and UV = 230 nm (shoulder 290 nm) (FIG. 2). NMR data was collected using MeOH-d4 containing protons (FIG. 3), multidimensional pulse sequences gDQCOSY (FIG. 4), gHSQC (FIG. 5), gHMBC (FIG. 6) and NOESY (FIG. 7).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
別の実施の形態において、本発明は、式１で表される新規の種類のファルネシルジベンゾジアゼピノン化合物に関する
</span>
In another embodiment, the present invention relates to a novel class of farnesyl dibenzodiazepinone compounds represented by Formula 1.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
（式中、Ｗ１、Ｗ２及びＷ３は、それぞれ独立して下記式
</span>
(W1, W2, and W3 are each independently represented by the following formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
      <br class="style-scope patent-text">
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
から選択されるか、三環の側鎖は、Ｗ３、Ｗ２又はＷ１がそれぞれ−ＣＨ＝Ｏ又は−ＣＨ２ＯＨであってＷ３、Ｗ２又はＷ１で終わっていてもよく、<br class="style-scope patent-text">
Ａは、−ＮＨ−、−ＮＣＨ２Ｒ１、−ＮＣ（Ｏ）Ｒ１から選択され、<br class="style-scope patent-text">
Ｒ１は、Ｃ１−６アルキル、Ｃ２−６アルケン、アリール又はヘテロアリールから選択され、<br class="style-scope patent-text">
Ｒ２、Ｒ３及びＲ４は、それぞれ独立してＨ、Ｒ５、−Ｃ（Ｏ）Ｒ６から選択され、<br class="style-scope patent-text">
Ｒ５は、それぞれ独立してＣ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルカレン、アリール又はヘテロアリールから選択され、<br class="style-scope patent-text">
Ｒ６は、それぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルカレン、アリール又はヘテロアリールから選択されるか、それらの薬学的に許容される塩である）。
</span>Or the tricyclic side chain may be terminated with W3, W2 or W1 where W3, W2 or W1 is —CH═O or —CH2OH, respectively; <br class="style-scope patent-text"> A is selected from -NH-, -NCH2R1, -NC (O) R1, <br class="style-scope patent-text"> R1 is selected from C1-6 alkyl, C2-6 alkene, aryl or heteroaryl; <br class="style-scope patent-text"> R2, R3 and R4 are each independently selected from H, R5, -C (O) R6; <br class="style-scope patent-text"> R5 is independently selected <sub class="style-scope patent-text">C 1-6</sub> <sub class="style-scope patent-text">alkyl, C 2-7</sub> Arukaren, aryl or heteroaryl, <br class="style-scope patent-text"> Each R6 is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkane, aryl or heteroaryl, or a pharmaceutically acceptable salt thereof).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他の実施の形態において、本発明は、ＡがＮＨ、ＮＣＨ２Ｒ１及びＮＣ（Ｏ）Ｒ１からなる群から選択され、Ｒ２がＨ、Ｒ３がＨ及びＲ４がＨであることを特徴とする、式１で表される化合物を提供する。別の実施の形態においては、Ｒ２、Ｒ３及びＲ４がそれぞれＨであり、全ての他の群は前述の通りである。更なる実施の形態においては、Ｒ２、Ｒ３及びＲ４がそれぞれＨであり、Ｗ１が−ＣＨ＝ＣＨ−であり、他の全ての群は前述の通りである。更なる実施の形態においては、Ｒ２、Ｒ３及びＲ４がそれぞれＨであり、Ｗ２が−ＣＨ＝ＣＨ−であり、他の全ての群は前述の通りである。更なる実施の形態においては、Ｒ２、Ｒ３及びＲ４がそれぞれＨであり、Ｗ３が−ＣＨ＝ＣＨ−であり、他の全ての群は前述の通りである。更なる実施の形態においては、ＡがＮＨであり、Ｒ２、Ｒ３及びＲ４がそれぞれＨであり、他の全ての群は前述の通りである。更なる実施の形態においては、ＡがＮＨであり、Ｗ１、Ｗ２、及びＷ３がそれぞれ−ＣＨ＝ＣＨ−であり、他の全ての群は前述の通りである。本発明には、前述の化合物のあらゆる薬学的に許容される塩が含まれる。<br class="style-scope patent-text">
以下は本発明の代表的な化合物である。
</span>In another embodiment, the invention provides Formula 1, wherein A is selected from the group consisting of NH, NCH2R1, and NC (O) R1, wherein R2 is H, R3 is H, and R4 is H. The compound represented by these is provided. In another embodiment, R2, R3 and R4 are each H and all other groups are as previously described. In a further embodiment, R2, R3 and R4 are each H, W1 is -CH = CH- and all other groups are as described above. In further embodiments, R2, R3, and R4 are each H, W2 is -CH = CH-, and all other groups are as described above. In a further embodiment, R2, R3 and R4 are each H, W3 is -CH = CH- and all other groups are as described above. In a further embodiment, A is NH, R2, R3 and R4 are each H, and all other groups are as described above. In a further embodiment, A is NH, W1, W2, and W3 are each —CH═CH—, and all other groups are as described above. The present invention includes all pharmaceutically acceptable salts of the aforementioned compounds. <br class="style-scope patent-text"> The following are representative compounds of the present invention.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="9" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態では、式１で表される化合物の１又は２以上を特に含まない。ある実施の形態では、式２で表される化合物を含まない。<br class="style-scope patent-text">
以下の第Ｖ節に検討するように、本発明の化合物を処方して、式１で表される化合物と薬学的に許容されるキャリアとを備える医薬組成物としてもよい。
</span>In certain embodiments, one or more of the compounds represented by Formula 1 are not specifically included. In certain embodiments, the compound represented by Formula 2 is not included. <br class="style-scope patent-text"> As discussed in Section V below, the compound of the present invention may be formulated into a pharmaceutical composition comprising a compound represented by Formula 1 and a pharmaceutically acceptable carrier.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
III．<u class="style-scope patent-text">発酵によるファルネシルジベンゾジアゼピノンの作成方法</u> <br class="style-scope patent-text">
  ある実施の形態において、ＥＣＯ−０４６０１は、Micromonosporaの新規株、すなわちMicromonospora sp.０４６−ＥＣＯ１１株を培養することによって得られる。０４６−ＥＣＯ１１株は、２００３年３月７日にカナダ保健省、微生物部、カナダ国際寄託当局（ＩＤＡＣ）(1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)に、アクセッション番号第０７０３０３−０１として寄託された。菌株の寄託は、特許手続き上の微生物の寄託の国際的承認に関するブダペスト条約に基づいて行われた。寄託株は、取り消すことはできず、制限や条件がない限り、特許が付与される際に公開される。寄託株は単に当業者に便利であるので提供され、米国特許法第１１２条で求められるように、寄託が実施可能要件に必要とされていることを承認するものではない。<br class="style-scope patent-text">
本発明が０４６−ＥＣＯ１１という特定の株の使用に限定されないことは、理解されるであろう。むしろ、以下の第IV節に記載するように、Ｘ線照射、紫外線照射、ナイトロジェンマスタードによる治療、ファージ照射、抗生物質選択等の公知の手段によって、又はリコンビナント遺伝子工学技術の使用することによって０４６−ＥＣＯ１１から得られる、０４６−ＥＣＯ１１の突然変異体又は変異体等の他のＥＣＯ−０４６０１１生成生物の使用を意図するものである。
</span>III. <u class="style-scope patent-text">Method for</u> Making Farnesyl Dibenzodiazepinone <u class="style-scope patent-text">by Fermentation In</u> one embodiment, ECO-04601 is obtained by culturing a new strain of Micromonospora, namely Micromonospora sp. 046-ECO11. The 046-ECO11 strain was issued on March 7, 2003 to the Department of Health, Department of Microbiology, Canadian International Depository Authority (IDAC) (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2) as accession number 070303-01. Deposited. The deposit of strains was made based on the Budapest Treaty concerning the international recognition of the deposit of microorganisms in the patent procedure. The deposited strain cannot be canceled and will be published when the patent is granted unless there are restrictions or conditions. The deposited strain is provided merely as convenient to those skilled in the art and does not acknowledge that the deposit is required for enablement requirements, as required by 35 USC 112. <br class="style-scope patent-text"> It will be understood that the present invention is not limited to the use of the specific strain 046-ECO11. Rather, as described in Section IV below, X-ray irradiation, ultraviolet irradiation, treatment with nitrogen mustard, phage irradiation, antibiotic selection, etc., or by using recombinant genetic engineering techniques. Intended for use of other ECO-046011 producing organisms derived from ECO11, such as mutants or variants of 046-ECO11.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のファルネシルジベンゾジアゼピノン化合物は様々な微生物によって生合成されてもよい。本発明の化合物を生合成する可能性のある微生物には、Actinomycetesとも称されるActinomycetales目の微生物が含まれるが、これに限定されない。Actinomycetes属に属するものの例には、Nocardia、 Geodermatophilus、Actinoplanes、Micromonospora、Nocardioides、Saccharothrix、Amycolatopsis、Kutzneria、Saccharomonopora、Saccharopolyspora、Kitasatospora、Streptomyces、Microbispora、Streptosporangium、及びActinomaduraが含まれるが、これらに限定されない。Actinomycetesの分類法は複雑であり、Goodfellow, Suprageneric Classification of Actinomycetes (1989); Bergey’s Manual of Systematic Bacteriology, Vol. 4 (Williams and Wilkins, Baltimore, pp. 2322-2339);及びEmbley and Stackebrandt, “The molecular phylogeny and systematics of the Actinomycetes,” Annu. Rev. Microbiol. (1994) 48: 257-289を参照する。これらは、本発明の化合物を合成する可能性のある属について、参照することにより本明細書に全体にそれぞれ組み込まれる。
</span>
&nbsp;&nbsp;The farnesyl dibenzodiazepinone compounds of the present invention may be biosynthesized by various microorganisms. Microorganisms that may biosynthesize the compounds of the present invention include, but are not limited to, Actinomycetales microorganisms, also called Actinomycetes. Examples of those belonging to the genus Actinomycetes include Nocardia, Geodermatophilus, Actinoplanes, Micromonospora, Nocardioides, Saccharothrix, Amycolatopsis, Kutzneria, Saccharomonopora, Saccharopolyspora, Kitasatospora, Streptomyces, Microbispora, Streptosporang, and Streptosporanga. The taxonomy of Actinomycetes is complex, Goodfellow, Suprageneric Classification of Actinomycetes (1989); Bergey's Manual of Systematic Bacteriology, Vol. 4 (Williams and Wilkins, Baltimore, pp. 2322-2339); and Embryy and Stackebrandt, “The molecular phylogeny and systematics of the Actinomycetes, ”Annu. Rev. Microbiol. (1994) 48: 257-289. These are each hereby incorporated by reference in their entirety for any genus that may synthesize the compounds of the present invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ファルネシルジベンゾジアゼピノン生成微生物を、Actinomycetes用の既知の栄養源を含む培地で培養する。これらの培地には、炭素同化源、窒素同化源、任意の無機塩、及び他のｐＨが約６から９の既知の成長因子が含まれる。適当な培地には、表１６に示される成長培地が含まれるが、これらに限定されない。微生物は、約１８〜４０℃の培養温度で約３〜４０日間培養される。
</span>
&nbsp;&nbsp;Farnesyl dibenzodiazepinone producing microorganisms are cultured in a medium containing known nutrient sources for Actinomycetes. These media include carbon assimilation sources, nitrogen assimilation sources, optional inorganic salts, and other known growth factors having a pH of about 6-9. Suitable media include, but are not limited to, the growth media shown in Table 16. The microorganism is cultured for about 3 to 40 days at a culture temperature of about 18 to 40 ° C.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ファルネシルジベンゾジアゼピノン生成微生物を播種した培地を、かかる播種した培地を攪拌しながら培養することによって、例えばロータリーシェーカー又はシェーキングウォーターバスで振盪することによって、通気してもよい。培養中、播種した培地に、空気、酸素又は適切な気体混合物を注入することによって、通気を行ってもよい。培養後に、例えば、遠心分離、クロマトグラフィー、吸着、ろ過等の、当業者に周知の及び／又は本明細書に開示される技術を用いて、ファルネシルジベンゾジアゼピノン化合物を抽出し、培養した培地から単離することができる。例えば、培養した培地を、ｎ−ブタノール、酢酸ｎ−ブチル、又は４−メチル−２−ペンタノン等の適当な有機溶剤と混合することができ、例えば溶剤を除去した後に遠心分離を行うことによって、乾燥するまで蒸発させることによって、又は乾燥するまで真空下で蒸発させることによって、有機層を分離することができる。例えば、水、エタノール、エチルアセテート、メタノール又はこれらの混合物で、その結果生じた残基（残留物）を任意に再構成することもでき、へキサン、四塩化炭素、塩化メチレン、又はこれらの混合物等の適当な有機溶剤によって再抽出することもできる。溶剤を除去した後に、クロマトグラフィー等の標準的な技術を用いて該化合物を更に精製してもよい。
</span>
&nbsp;&nbsp;The medium inoculated with the farnesyl dibenzodiazepinone-producing microorganism may be aerated by culturing the inoculated medium with stirring, for example, by shaking in a rotary shaker or a shaking water bath. During culture, aeration may be effected by injecting air, oxygen or a suitable gas mixture into the seeded medium. After culturing, the medium in which the farnesyl dibenzodiazepinone compound is extracted and cultured using techniques well known to those skilled in the art and / or disclosed herein, such as, for example, centrifugation, chromatography, adsorption, filtration, etc. Can be isolated from For example, the cultured medium can be mixed with a suitable organic solvent such as n-butanol, n-butyl acetate, or 4-methyl-2-pentanone, for example by removing the solvent and then performing centrifugation. The organic layer can be separated by evaporating to dryness or by evaporating under vacuum until dry. For example, the resulting residue (residue) can be optionally reconstituted with water, ethanol, ethyl acetate, methanol or mixtures thereof, such as hexane, carbon tetrachloride, methylene chloride, or mixtures thereof. It can also be re-extracted with a suitable organic solvent such as After removal of the solvent, the compound may be further purified using standard techniques such as chromatography.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  微生物によって生合成されたファルネシルジベンゾジアペジノンに、ランダムな及び／又は指示した化学修飾を任意に行い、誘導体又は構造的アナログである化合物を形成してもよい。類似した機能活性を有するこれらの誘導体又は構造的アナログは、本発明の範囲内である。当技術分野で公知の方法及び本明細書に記載された方法を用いて、ファルネシルジベンゾジアペジノン化合物を、任意に修飾してもよい。
</span>
&nbsp;&nbsp;Random and / or directed chemical modifications may be optionally applied to farnesyl dibenzodiapedinone biosynthesized by microorganisms to form compounds that are derivatives or structural analogs. These derivatives or structural analogs with similar functional activity are within the scope of the present invention. The farnesyl dibenzodiapedinone compound may optionally be modified using methods known in the art and described herein.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
IV．<u class="style-scope patent-text">リコンビナント技術を用いたファルネシルジベンゾジアゼピノンの作成方法</u> <br class="style-scope patent-text">
  別の実施の形態において、本発明は、ファルネシルベンゾジアゼピノン(farnesyl benzodiazepinone)の生成に有用なタンパク質をコードする、核酸分子に関する。特に、本発明はリコンビナントＤＮＡベクター及び０４６−ＥＣＯ１１株の生合成遺伝子座の全部又は一部をコードする核酸分子を提供する。該生合成遺伝子座はＥＣＯ−０４６０１の生成に関し、本明細書では「０４６Ｄ」と称される。本発明は更に、ＥＣＯ−０４６０１の化学的変異体を生成するために、突然変異生成、不活性化、又は核酸の置換え等の従来の遺伝子組換え技術を用いる０４６Ｄの遺伝子改変を含む。
</span>IV. <u class="style-scope patent-text">In</u> another embodiment, the present invention relates to a nucleic acid molecule that encodes a protein useful for the production of farnesyl benzodiazepinone. In particular, the present invention provides recombinant DNA vectors and nucleic acid molecules that encode all or part of the biosynthetic locus of strain 046-ECO11. The biosynthetic locus is referred to herein as “046D” for the production of ECO-04601. The invention further includes genetic modification of 046D using conventional genetic recombination techniques such as mutagenesis, inactivation, or nucleic acid replacement to generate a chemical variant of ECO-04601.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  このように、本発明は、１又は２以上の本発明のポリペプチドをコードするリコンビナントＤＮＡベクターを含む形質転換宿主細胞を用いて、ファルネシルベンゾジアゼピノンが生成される条件下で宿主細胞を培養する、ファルネシルベンゾジアゼピノン化合物を作成する方法を提供する。宿主細胞は原核生物である。ある実施の形態においては、宿主細胞はActinomycetesである。別の実施の形態では、宿主細胞はStreptomyces宿主細胞である。
</span>
&nbsp;&nbsp;Thus, the present invention cultivates host cells under conditions that produce farnesyl benzodiazepinone using transformed host cells containing a recombinant DNA vector encoding one or more polypeptides of the present invention. A method of making a farnesyl benzodiazepinone compound is provided. Host cells are prokaryotes. In certain embodiments, the host cell is Actinomycetes. In another embodiment, the host cell is a Streptomyces host cell.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、化学的な手順だけでは容易に合成することができない様々なファルネシルジベンゾジアゼピノン化合物を生成するリコンビナント核酸を提供する。本発明によって、本発明によってファルネシルベンゾジアゼピノンの生合成に関与する酵素の遺伝子工学を通して、生合成遺伝子座０４６Ｄの直接操作が可能となる。生合成遺伝子座０４６Ａを実施例１１に記載する。
</span>
&nbsp;&nbsp;The present invention provides recombinant nucleic acids that produce a variety of farnesyl dibenzodiazepinone compounds that cannot be readily synthesized by chemical procedures alone. The present invention allows direct manipulation of the biosynthetic locus 046D through genetic engineering of enzymes involved in the biosynthesis of farnesyl benzodiazepinone according to the present invention. Biosynthetic locus 046A is described in Example 11.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">リコンビナントＤＮＡベクター</u> <br class="style-scope patent-text">
  本発明のベクターは一般的に、外来性ＤＮＡを挿入された感染性病原体のＤＮＡを含む。ＤＮＡのセグメントをＤＮＡの別のセグメントに挿入する一般的な方法には、制限部位と呼ばれる特定の部位（特定のヌクレオチド群）でＤＮＡを切断する、制限酵素と呼ばれる特定の酵素の使用が含まれる。「カセット」とは、規定された制限部位でベクターに挿入され得る発現生成物をコードする、ＤＮＡをコードする配列又はＤＮＡのセグメントをコードするＤＮＡに関する。カセット制限部位は、適切なリーディングフレームにカセットが確実に挿入するようなっている。一般的に、ファルネシルベンゾジアゼピノンの生成に有用なタンパク質をコードする核酸分子を、ベクターＤＮＡの１又は２以上の制限部位に挿入し、次に形質転換によって、ベクターがActinomycetes等の原核生物に核酸分子を運ぶ（下記参照）。発現ベクター等の、挿入された又は付加されたＤＮＡを有するＤＮＡのセグメント又は配列は、「ＤＮＡコンストラクト」とも称される。通常のタイプのベクターは、一般的に二重鎖ＤＮＡの内蔵分子である「プラスミド」であり、通常細菌に由来しており、付加された（外来）ＤＮＡを容易に受け入れることができ、適当な宿主細胞に容易に導入することができる。プラスミドベクターは、コーディングＤＮＡとプロモーターＤＮＡとを有することが多く、外来ＤＮＡの導入に適する制限部位を１又は２以上有する。コーディングＤＮＡは、特定のタンパク質又は酵素について特定のアミノ酸配列をコードするＤＮＡ配列である。本発明のある実施の形態において、コーディングＤＮＡは、ファルネシルベンゾジアゼピノンの生合成に必要とされる、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７又は８９で表されるポリペプチドをコードする。
</span> <u class="style-scope patent-text">Recombinant DNA Vector</u> The <u class="style-scope patent-text">vector of the</u> present invention generally comprises DNA of an infectious pathogen into which foreign DNA has been inserted. Common methods of inserting a segment of DNA into another segment of DNA include the use of a specific enzyme called a restriction enzyme that cleaves the DNA at a specific site (specific nucleotide group) called a restriction site. . “Cassette” relates to DNA encoding a sequence encoding DNA or a segment of DNA encoding an expression product that can be inserted into a vector at defined restriction sites. The cassette restriction site ensures that the cassette is inserted into the appropriate reading frame. In general, a nucleic acid molecule encoding a protein useful for the production of farnesyl benzodiazepinone is inserted into one or more restriction sites in vector DNA and then transformed into a prokaryote such as Actinomycetes. Carries nucleic acid molecules (see below). A segment or sequence of DNA having inserted or added DNA, such as an expression vector, is also referred to as a “DNA construct”. The usual type of vector is a “plasmid”, which is generally a double-stranded DNA-containing molecule, usually derived from bacteria, can easily accept added (foreign) DNA, and has an appropriate It can be easily introduced into a host cell. A plasmid vector often has a coding DNA and a promoter DNA, and has one or more restriction sites suitable for introducing foreign DNA. Coding DNA is a DNA sequence that codes for a specific amino acid sequence for a specific protein or enzyme. In certain embodiments of the invention, the coding DNA is required for biosynthesis of farnesyl benzodiazepinone, SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23. 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75 , 77, 79, 81, 83, 85, 87 or 89.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  リコンビナントベクターのプロモーターＤＮＡは、コーディングＤＮＡの発現を開始し、制御し、若しくは仲介し、又はコントロールするＤＮＡ配列である。プロモーターＤＮＡ及びコーディングは、同一の又は異なる生物を形成する。リコンビナントクローニングベクターは、クローニング又は発現のための１又は２以上の複製系、耐抗生物質等の宿主で選択を行うための１又は２以上のマーカー、及び１又は２以上の発現カセットを含む場合が多い。当技術分野の技術の範囲で、従来の分子生物学及びＤＮＡ組換え技術を用いて、ベクターのコンストラクトを生成してもよい。これらの技術は、文献に十分に説明されている。例えば、Sambrook, Fritsch &amp; Maniatis, Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York （本明細書では、「Sabrook et al., 1989」と称す）; DNA Cloning: A Practical Approach, Volumes I and II (D. N. Glover ed. 1985); F. M. Ausubel et al. (eds.), Current Protocols in Molecular Biology, John Wiley &amp; Sons, Inc. (1984)参照。Actinomycetes、例えばStreptomycesで機能するプロモーターの例は、米国特許第５，８３０，６９５号及び第５，４６６，５９０号に教示されている。Actinomycetes発現ベクターに有用な転写プロモーターの例は、ｔｉｐＡであり、これは抗生物質チオストレプトンによって誘導されるプロモーターである（Murakami, T., et al., (1989), J. Bacteriol, 171, 1459参照）。
</span>
&nbsp;&nbsp;Recombinant vector promoter DNA is a DNA sequence that initiates, controls, mediates, or controls expression of a coding DNA. Promoter DNA and coding form the same or different organisms. Recombinant cloning vectors may contain one or more replication systems for cloning or expression, one or more markers for selection in a host such as antibiotic resistance, and one or more expression cassettes. Many. Within the skill of the art, vector molecular constructs may be generated using conventional molecular biology and DNA recombination techniques. These techniques are explained fully in the literature. For example, Sambrook, Fritsch &amp; Maniatis, Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (referred to herein as “Sabrook et al., 1989”); See DNA Cloning: A Practical Approach, Volumes I and II (DN Glover ed. 1985); FM Ausubel et al. (Eds.), Current Protocols in Molecular Biology, John Wiley &amp; Sons, Inc. (1984). Examples of promoters that function in Actinomycetes, such as Streptomyces, are taught in US Pat. Nos. 5,830,695 and 5,466,590. An example of a transcriptional promoter useful for Actinomycetes expression vectors is tipA, which is a promoter induced by the antibiotic thiostrepton (Murakami, T., et al., (1989), J. Bacteriol, 171, 1459).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">Actinomycetesの形質転換</u> <br class="style-scope patent-text">
  Actinomycetesを用いた使用に適する形質転換方法には、リゾチームを用いてActinomycetes培養物をスフェロプラストに形成することが含まれる。次に、ベクターを宿主細胞に導入するために、例えば、Thompson 又はKeiser（Thompson, C. J., et al., (1982), J. Bacteriol., 151, 668-677 or Keiser, T. et al. (2000), “Practical Streptomyces Genetics”, The John Innes Foundation, Norwich参照）のいずれかの方法を用いて、リコンビナントＤＮＡベクターとポリエチレングリコールとを含む緩衝液を加える。チオストレプトン耐性遺伝子は、形質転換プラスミドにおいて、選択マーカーとして使用されることが多い（Hopwood, D.A., et al., (1987), “Methods in Enzymology” 153, 116, Aacademic Press, New York参照）が、本発明はこれに限定されない。Actinomycetesの形質転換の他の方法は、米国特許第５，３９３，６６５号に教示されている。
</span> <u class="style-scope patent-text">Transformation of Actinomycetes</u> <br class="style-scope patent-text"> Transformation methods suitable for use with Actinomycetes include forming Actinomycetes cultures into spheroplasts using lysozyme. Next, in order to introduce the vector into a host cell, for example, Thompson or Keiser (Thompson, CJ, et al., (1982), J. Bacteriol., 151, 668-677 or Keiser, T. et al. ( 2000), “Practical Streptomyces Genetics”, The John Innes Foundation, Norwich), a buffer containing a recombinant DNA vector and polyethylene glycol is added. The thiostrepton resistance gene is often used as a selectable marker in transformed plasmids (see Hopwood, DA, et al., (1987), “Methods in Enzymology” 153, 116, Aacademic Press, New York) However, the present invention is not limited to this. Another method of transformation of Actinomycetes is taught in US Pat. No. 5,393,665.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">ファルネシルジベンゾジアゼピノンのアッセイ又は生合成の中間生成物</u> <br class="style-scope patent-text">
  ファルネシルベンゾジアゼピノン生合成経路で１又は２以上のタンパク質をコードし、したがって、特定の欠陥の遺伝的相補作用によってファルネシルベンゾジアゼピノン生合成を回復する１又は２以上の発現ベクターで、ファルネシルジベンゾジアゼピノンの生合成に欠陥のあるActinomycetesを形質転換する。
</span> <u class="style-scope patent-text">Intermediate or farnesyl dibenzodiazepinone assay for farnesyl dibenzodiazepinone Encodes</u> one or more proteins in the farnesyl benzodiazepinone biosynthetic pathway, and thus farnesyl benzodiazepinone biosynthesis by genetic complementation of specific defects Actinomycetes that are defective in biosynthesis of farnesyl dibenzodiazepinone are transformed with one or more expression vectors that restore synthesis.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  リコンビナントActinomycetesの生合成経路におけるファルネシルジベンゾジアゼピノン又は中間生成物の有無（図１３、１４及び１５参照）を、当業者に周知の手順を用いて決定することができる。例えば、リコンビナントActinomycetesの培養に用いられる発酵培地のエチルアセテート抽出物を、実施例２に記載されるように処理し、ファルネシルジベンゾジアゼピノン又は中間生成物を含みフラクションを、市販のKieselgel ６０Ｆ<sub class="style-scope patent-text">２５４</sub>プレートでＴＬＣによって検出する。紫外線下で乾燥プレートを検査することによって、又はエタノール中にバニリン（０．７５％）と濃縮した硫酸（１．５％、ｖ／ｖ）とを含有するスプレーをプレートに噴霧し、続いてプレートを加熱することによって、ファルネシルジベンゾジアゼピノン及び中間生成物の化合物を視覚化する。次に、ＴＬＣによって分離された化合物の正確な性質をガスクロマトグラフィー−質量分析法を用いて測定する。質量分析法は公開された米国特許出願第２００３／００５２２６８号に教示されている。
</span>The presence or absence of farnesyl dibenzodiazepinone or intermediate products in the biosynthetic pathway of recombinant Actinomycetes (see FIGS. 13, 14 and 15) can be determined using procedures well known to those skilled in the art. For example, an ethyl acetate extract of the fermentation medium used for the cultivation of recombinant Actinomycetes is treated as described in Example 2 and the fraction containing farnesyl dibenzodiazepinone or intermediate product is washed with commercially available Kieselgel 60F <sub class="style-scope patent-text">254</sub> plates. Detected by TLC. By inspecting the dry plate under UV light or by spraying the plate with a spray containing vanillin (0.75%) and concentrated sulfuric acid (1.5%, v / v) in ethanol, followed by plate By visualizing the farnesyl dibenzodiazepinone and intermediate product compounds. The exact properties of the compounds separated by TLC are then measured using gas chromatography-mass spectrometry. Mass spectrometry is taught in published US patent application 2003/0052268.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">突然変異誘発</u> <br class="style-scope patent-text">
  本発明によって、本発明のファルネシルベンゾジアゼピノンの生合成に関与する酵素の遺伝子工学により、生合成遺伝子座０４６Ｄを直接的に操作することが可能となる。
</span> <u class="style-scope patent-text">Mutagenesis The</u> present invention allows the biosynthetic locus 046D to be directly manipulated by genetic engineering of enzymes involved in the biosynthesis of the farnesyl benzodiazepinone of the present invention.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  当技術分野では、本発明のＤＮＡ配列のランダムな突然変異、又は標的突然変異を可能とする多くの方法が公知である（例えば、Ausubel et. al. Short Protocols in Molecular Biology (1995) 3<sup class="style-scope patent-text">rd</sup>Ed. John Wiley &amp; Sons, Inc.参照）。更に、従来の方法とＰＣＲに基づく方法とを含む、部位特異的突然変異誘発の多くの市販のキットがある。いずれもStratagene社から入手可能なEXSITE<sup class="style-scope patent-text">TM</sup>PCR-Based Site-directed Mutagenesis Kit (Catalog No. 200502)、QUIKCHANGE<sup class="style-scope patent-text">TM</sup> Site-directed mutagenesis Kit (Catalog No. 200518)、及びCHAMELEON(R) double-stranded Site-directed mutagenesis kit (Catalog No. 200509)が、例として挙げられる。
</span>Many methods are known in the art that allow random or targeted mutations of the DNA sequences of the present invention (see, eg, Ausubel et. Al. Short Protocols in Molecular Biology (1995) 3 <sup class="style-scope patent-text">rd</sup> Ed (See John Wiley &amp; Sons, Inc.). In addition, there are many commercial kits for site-directed mutagenesis, including conventional methods and PCR-based methods. Both Stratagene Inc., available from <sup class="style-scope patent-text">EXSITE TM PCR-Based Site-directed</sup> Mutagenesis Kit (Catalog No. 200502), QUIKCHANGE TM Site-directed mutagenesis Kit (Catalog No. 200518), and CHAMELEON (R) double-stranded Site -directed An example is mutagenesis kit (Catalog No. 200509).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、本発明のヌクレオチドを、当業者に公知の手順に従い、挿入突然変異、又は切断突然変異（Ｎ末端、内部、又はＣ末端）によって作製してもよい。<br class="style-scope patent-text">
当技術分野に公知の従来の部位特異的突然変異誘発方法は、配列のサブクローニングを行って、Ｍ１３バクテリオファージベクター等のベクターに変異させることによる。この結果、１本鎖ＤＮＡテンプレートの単離が可能となる。これらの方法においては、突然変異誘発プライマー（すなわち、突然変異を起こす部位をアニーリングできるが、突然変異を起こす部位に１又は２以上のマッチしないヌクレオチドを有することができるプライマー）を、一重鎖テンプレートにアニ−リングして、次に突然変異誘発プライマーの３´末端から始まるテンプレートの補体を重合する。この結果生じる二本鎖を宿主細菌に形質転換し、目的とする突然変異について、プラークをスクリーニングする。
</span>The nucleotides of the present invention may also be made by insertion mutation or truncation mutation (N-terminal, internal, or C-terminal) according to procedures known to those skilled in the art. <br class="style-scope patent-text"> Conventional site-directed mutagenesis methods known in the art are by subcloning the sequence and mutating it to a vector such as the M13 bacteriophage vector. As a result, the single-stranded DNA template can be isolated. In these methods, a mutagenic primer (ie, a primer that can anneal the site of mutation, but can have one or more unmatched nucleotides at the site of mutation) is added to the single-stranded template. Annealing and then polymerizing the template complement starting from the 3 'end of the mutagenic primer. The resulting duplex is transformed into host bacteria and plaques are screened for the mutation of interest.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  最近は、部位特異的突然変異誘発にＰＣＲ法が使用される。この方法は、一重鎖テンプレートを必要としないという利点を有している。更に、サブクローニングを必要としない方法が開発されている。ＰＣＲ基づく部位特異的遺伝子突然変異誘発が行われる場合には、検討しなくてはならない問題がいくつかある。第一に、これらの方法においては、ポリメラ−ゼによって導入される好ましくない突然変異が増大するのを防ぐために、ＰＣＲサイクルの回数を減らすことが望ましい。第二に、反応中に残留する非突然変異親分子の数を減らすために、選択を行わなくてはならない。第三に、ＰＣＲプライマーセットを使用可能にするためには、伸長ＰＣＲ法(an extended-length PCR method)が好ましい。第四に、末端伸長活性は熱安定性ポリメラ−ゼのテンプレートに依存しないので、ＰＣＲ作製突然変異生成物の平滑末端ライゲーションの前に、エンドポリッシングステップを手続に組み込むことが必要とされる場合が多い。
</span>
&nbsp;&nbsp;Recently, PCR has been used for site-directed mutagenesis. This method has the advantage of not requiring a single-stranded template. In addition, methods have been developed that do not require subcloning. There are several issues that must be considered when PCR-based site-directed gene mutagenesis is performed. First, in these methods, it is desirable to reduce the number of PCR cycles in order to prevent an increase in undesirable mutations introduced by polymerase. Second, selection must be made to reduce the number of non-mutated parent molecules remaining in the reaction. Third, in order to be able to use the PCR primer set, an extended-length PCR method is preferable. Fourth, since end extension activity does not depend on a thermostable polymerase template, it may be necessary to incorporate an end polishing step into the procedure prior to blunt end ligation of the PCR-generated mutagenesis product. Many.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  後述のプロトコルは、下記のステップを通してこれらの問題に対応する。第一に、使用されるテンプレートの濃度は、従来のＰＣＲ反応に使用される濃度の約１０００倍であるので、生成量を劇的に減少させることなく、サイクル数を２５〜３０から５〜１０に減らすことができる。第二に、最も一般的なＥ．ｃｏｌｉＤａｍ株がそのＤＮＡを配列５−ＧＡＴＣ−３でメチル化するので、制限エンドヌクレア−ゼＤｐｎＩ（認知ターゲット配列：Ａ残基がメチル化された５−Ｇｍ６ＡＴＣ−３）を使用して親ＤＮＡを選択する。第三に、長い（すなわち全プラスミドの長さ）ＰＣＲ生成物の割合を増加するために、ＰＣＲｍｉｘでTaq Extenderを使用する。最後に、Ｔ４ＤＮＡリガーゼを用いた分子内でのリゲーションの前に、ＰｆｕＤＮＡポリメラ−ゼを使用して、ＰＣＲ生成物の末端をポリッシュする。
</span>
&nbsp;&nbsp;The protocol described below addresses these issues through the following steps. First, the concentration of template used is about 1000 times that used in conventional PCR reactions, so the number of cycles is reduced from 25-30 to 5-10 without dramatically reducing production. Can be reduced. Second, the most common E.I. Since the E.coliDam strain methylates its DNA with the sequence 5-GATC-3, the restriction endonuclease DpnI (cognitive target sequence: 5-Gm6ATC-3 with A residue methylated) is used to select the parent DNA To do. Third, use Taq Extender with PCRmix to increase the proportion of long (ie, total plasmid length) PCR products. Finally, the end of the PCR product is polished using Pfu DNA polymerase prior to intramolecular ligation with T4 DNA ligase.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  突然変異ポリヌクレオチドの単離の例を、下記に詳細に記載するが、これに限定されない。
</span>
&nbsp;&nbsp;Examples of isolation of mutant polynucleotides are described in detail below, but are not limited thereto.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １×突然変異誘発緩衝液（トリス塩酸２０ｍＭ、ｐＨ７．５；ＭｇＣｌ２  ８ｍＭ；ＢＳＡ４０ｇ／ｍｌ）、各プライマー１２〜２０ｐＭ（当業者であれば、必要に応じて、オリゴヌクレオチドプライマーのアニ−リングの特徴に影響を与える、塩基組成、プライマーの長さ及び目的とする緩衝液の塩濃度等の因子を考慮に入れて、突然変異誘発プライマーをデザインすることができるであろう。プライマーは目的とする変異を含んでいなくてはならず、プライマー（同一又は他の）は後のリゲーションを容易にするために、５´リン酸塩を含んでいなくてはならない）、各ｄＮＴＰ２５０Ｍ、ＴａｇＤＮＡポリメラ−ゼ２．５U、及びTaq Extender２．５U（Stratageneより入手可能：Nelson et al. (1994)  Strategies 7: 27、及び米国特許第５，５５６，７７２号参照） を含むＰＣＲカクテルに、プラスミドテンプレートＤＮＡ（約０．５ｐＭ）を加える。プライマーは、Matteucci et al., 1981, J. Am. Chem. Soc. 103:3185-3191のトリエステル法を使用して調整することができる。かかる方法は、参照することにより本明細書に組み込まれる。或いは、例えば、シアノエチルホスホロアミダイト(cyanoethyl phosphoramidite)化学を用いたBiosearch 8700 DNA Synthesizer での自動合成が好ましい場合もある。
</span>
&nbsp;&nbsp;1 × mutagenesis buffer (Tris-HCl 20 mM, pH 7.5; MgCl 2 8 mM; BSA 40 g / ml), 12-20 pM of each primer (the person skilled in the art will characterize oligonucleotide primer annealing as required The mutagenic primer could be designed taking into account factors such as base composition, primer length and desired buffer salt concentration that affect the And the primer (same or other) must contain 5 'phosphate to facilitate later ligation), each dNTP250M, TagDNA polymerase Ze 2.5U and Taq Extender 2.5U (available from Stratagene: Nelson et al. (1994) Strategies 7: 27, and US Pat. No. 5,556,772) A PCR cocktail containing references), added plasmid template DNA (approximately 0.5 pM). Primers can be prepared using the triester method of Matteucci et al., 1981, J. Am. Chem. Soc. 103: 3185-3191. Such methods are incorporated herein by reference. Alternatively, automated synthesis with a Biosearch 8700 DNA Synthesizer using, for example, cyanoethyl phosphoramidite chemistry may be preferred.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＰＣＲサイクルは次のように実施する。９４℃で４分、５０℃で２分、及び７２℃で２分の１サイクル、続いて、９４℃で１分、５４℃で２分、７２℃で１分の５〜１０サイクルを行う。親テンプレートＤＮＡ、及び突然変異誘発プライマーを含む、ＰＣＲで作製された直鎖状のＤＮＡを、Ｄｐｎｌ（１０Ｕ）及びＰｆｕＤＮＡポリメラ−ゼ（２．５U）で処理する。この結果、インビボでメチル化した親テンプレート及びハイブリッドＤＮＡがＤｐｎｌ分解され、ＰｆｕＤＮＡポリメラ−ゼによって、直鎖状のＰＣＲ生成物上で、テンプレートに関しないＴａｇＤＮＡポリメラ−ゼ延長塩基が除去される。かかる反応は３７℃で３０分培養され、更に３０分間で７２℃に移行する。０．５ｍＭのＡＴＰを含む突然変異誘発緩衝剤（１１５ｕｌ×１）を、Ｄｐｎｌ分解ＰｆｕＤＮＡポリメラ−ゼ研磨ＰＣＲ生成物に加える。溶液を混合し、１０ｕｌを取り除き新しい微量遠心管に移し、Ｔ４ＤＮＡリガーゼ（２〜４Ｕ）を加える。リゲーションを３７℃で約６０分より長く培養する。最後に、標準方法に従って、処理済の溶液をコンピテントＥ．ｃｏｌｉに形質転換する。
</span>
&nbsp;&nbsp;The PCR cycle is performed as follows. 94 ° C. for 4 minutes, 50 ° C. for 2 minutes, and 72 ° C. for a half cycle, followed by 94 ° C. for 1 minute, 54 ° C. for 2 minutes, 72 ° C. for 1 minute 10 cycles. PCR generated linear DNA containing parental template DNA and mutagenic primers is treated with Dpnl (10 U) and Pfu DNA polymerase (2.5 U). This results in Dpnl degradation of the in vivo methylated parent template and hybrid DNA, and Pfu DNA polymerase removes the non-template TagDNA polymerase extended base on the linear PCR product. Such a reaction is incubated at 37 ° C. for 30 minutes, and further transferred to 72 ° C. in 30 minutes. Mutagenesis buffer (115 ul × 1) containing 0.5 mM ATP is added to the Dpnl-degraded Pfu DNA polymerase polished PCR product. Mix the solution, remove 10 ul and transfer to a new microcentrifuge tube and add T4 DNA ligase (2-4 U). Incubate the ligation at 37 ° C for more than about 60 minutes. Finally, the treated solution is treated with competent E. coli according to standard methods. transform into E. coli.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  当該技術分野には、ランダムな突然変異誘発方法が存在するが、この結果、１又は２以上のランダムな状態にある突然変異のパネルが生じる。このような突然変異体のパネルは、次に、野生型ポリメラ−ゼと比較して、減少したウラシル検出能を示す突然変異体を（例えば、ｄＵＴＰ２００Ｍ存在下、所定のＤＮＡポリメラーゼに最適な温度で、１０ｎＭのｄＮＴＰのポリマー型への取込みを３０分間測定することによって）スクリーニングしてもよい。ランダムな突然変異誘発方法の例は、いわゆる「変異性ＰＣＲ法」である。その名が示すように、かかる方法は、ＤＮＡポリメラーゼが高フィデリティーの取込みを支持しない条件下で、所定の配列を増幅する。異なるＤＮＡポリメラーゼの変異性取込みを促進する条件は変化するが、当業者であれば、所定の酵素のための条件を決定できるであろう。増幅のフィデリティーにおける多くのＤＮＡポリメラーゼの基本変数は、例えば、緩衝液中の二価金属イオンの種類と濃度である。ポリメラーゼの誤差率に影響を与えるために、マンガンイオン及び／又はマグネシウムイオン若しくはマンガンイオン濃度の変動を使用してもよい。
</span>
&nbsp;&nbsp;There are random mutagenesis methods in the art, which results in a panel of mutations in one or more random states. A panel of such mutants then produces mutants that exhibit reduced uracil detectability compared to wild-type polymerase (eg, in the presence of dUTP200M at the optimal temperature for a given DNA polymerase). Screening may be done by measuring the incorporation of 10 nM dNTP into the polymer form for 30 minutes. An example of a random mutagenesis method is the so-called “variable PCR method”. As the name implies, such methods amplify a given sequence under conditions where the DNA polymerase does not support high fidelity incorporation. Conditions that promote the variability uptake of different DNA polymerases will vary, but one skilled in the art will be able to determine conditions for a given enzyme. The basic variables of many DNA polymerases in amplification fidelity are, for example, the type and concentration of divalent metal ions in the buffer. Variations in manganese ions and / or magnesium ions or manganese ion concentrations may be used to affect the error rate of the polymerase.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  突然変異誘発によって作製される所望の突然変異ポリペプチドの遺伝子を、突然変異の部位と数を同定するためにシーケンスしてもよい。１又は２以上の突然変異を有するこれらの突然変異体について、特定の突然変異体が有する他の変異から単離する際に、同定された突然変異を野生型遺伝子に部位特異的突然変異誘発で導入することによって、所定の突然変異の影響を評価してもよい。このように生成された一重突然変異体のスクリーニングアッセイによって、突然変異体単独の影響を測定することができる。
</span>
&nbsp;&nbsp;The gene for the desired mutant polypeptide produced by mutagenesis may be sequenced to identify the site and number of mutations. For these mutants with one or more mutations, the site-specific mutagenesis of the identified mutation into the wild-type gene when isolated from other mutations of the particular mutant. By introducing, the influence of a predetermined mutation may be evaluated. The effect of the mutant alone can be measured by a single mutant screening assay thus generated.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
Ｖ．<u class="style-scope patent-text">ＥＣＯ−０４６０１生成のための遺伝子及びタンパク質</u> <br class="style-scope patent-text">
  下記により詳細に記載するように、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９の１つで表される単離し、精製し、又は濃縮した、核酸を使用して、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドのうち１つをそれぞれ調製してもよいし、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドのうち１つの、少なくとも５０、７５、１００、２００、３００、５００又はそれ以上の連続したアミノ酸を含むフラグメントを調製してもよい。
</span>V. <u class="style-scope patent-text">Genes and proteins for production of ECO-04601</u> SEQ ID NOs: 3, 5, 7, 9, 11, <u class="style-scope patent-text">13, 15, 17, 19, 21, 23, 25, 27, 29, 31</u> as described in more detail below 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83 , 85, 87, and 89, using isolated, purified, or enriched nucleic acids, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and One of the polypeptides represented by 8 may be prepared respectively, or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, A fragment comprising at least 50, 75, 100, 200, 300, 500 or more consecutive amino acids of one of the polypeptides represented by 80, 82, 84, 86, and 88 may be prepared.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  したがって、本発明の別の実施の形態は、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、４６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６及び８８で表されるポリペプチドのうち１つをコードする、単離し、精製し、又は濃縮した核酸、若しくは、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの１つの、少なくとも５０、７５、１００、１５０、２００、３００以上の連続したアミノ酸を含むフラグメントである。遺伝コードの重複性や縮重の結果、これらの核酸のコード配列は、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される核酸の１つのコード配列の１つ又はそのフラグメントと一致してもよく、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの１つをコードするコード配列、又は配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの１つの、少なくとも５０、７５、１００、１５０、２００、３００の連続したアミノ酸を含むフラグメントと異なっていてもよい。遺伝コードは、当業者に公知であり、例えば、Stryer, Biochemistry 3<sup class="style-scope patent-text">rd</sup> edition, W. H. Freeman &amp; Co., New Yorkから入手することができる。
</span>Accordingly, another embodiment of the present invention provides SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 46, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86 and An isolated, purified or enriched nucleic acid encoding one of the polypeptides represented by 88, or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 One polypeptide is a fragment comprising at least 50,75,100,150,200,300 or more consecutive amino acids. As a result of the redundancy and degeneracy of the genetic code, the coding sequences of these nucleic acids are SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31. 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83 85, 87, and 89, which may coincide with one of the coding sequences of one of the nucleic acids or fragments thereof, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, Represented by 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 A coding sequence that encodes one of the polypeptides or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36 , 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86 And one of the polypeptides represented by 88 may be different from a fragment comprising at least 50, 75, 100, 150, 200, 300 consecutive amino acids. The genetic code, are known to those skilled in the art, for example, can be obtained <sup class="style-scope patent-text">Stryer, Biochemistry 3 rd edition, WH</sup> Freeman &amp; Co., from New York.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの１つをコードする、単離し、精製し、又は濃縮した核酸には、（１）配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７及び８９で表されるコード配列のうち１つのコード配列のみ、（２）配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９のコード配列、並びにリーダー配列又はプロタンパク質等の他のコード配列、及び（３）配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表されるコード配列、並びにコード配列の５´及び／又は３´等の非コード配列が含まれるが、これらに限定されない。したがって、本明細書に使用されるように、「ポリペプチドをコードするポリヌクレオチド」なる語は、ポリペプチドのコード配列だけを含むポリヌクレオチドと、他のコード配列及び／又は非コード配列を含むポリヌクレオチドとを含む。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, One of the polypeptides represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Nucleic acids that are encoded, isolated, purified or enriched include (1) SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83 , 85, 87 and 89, only one coding sequence is represented by (2) Numbers 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89, as well as leader sequences or proproteins, etc. And (3) SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Coding sequence and non-coding such as 5 ′ and / or 3 ′ of the coding sequence Although includes columns, without limitation. Thus, as used herein, the term “polynucleotide encoding a polypeptide” refers to a polynucleotide that includes only the coding sequence of a polypeptide and a polynucleotide that includes other coding and / or non-coding sequences. Nucleotides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される配列に基づくポリヌクレオチドに関するが、ポリヌクレオチドが、例えば、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表されるポリヌクレオチドによってコードされる、アミノ酸配列を変えない、「サイレントな」変化を起こしている。また、本発明は、ヌクレオチドが変化した結果、アミノ酸で、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの置換、付加、欠失、融合又は切断が生じている、ポリヌクレオチドに関する。このようなヌクレオチドの変化は、部位特異的突然変異、ランダムな化学的突然変異誘発法、エキソヌクレアーゼIII欠損、及び他のＤＮＡ組換え技術のような技術を用いて導入されてもよい。
</span>
&nbsp;&nbsp;The present invention relates to SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, Poly, based on the sequences represented by 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 For nucleotides, the polynucleotide is, for example, SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 The amino acid sequence encoded by the polynucleotide to be Not to change, it has caused a change in "silent". In addition, the present invention relates to amino acids as a result of nucleotide changes, and SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34. 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84 , 86, and 88, wherein the substitution, addition, deletion, fusion or cleavage of the polypeptide occurs. Such nucleotide changes may be introduced using techniques such as site-directed mutagenesis, random chemical mutagenesis, exonuclease III deficiency, and other DNA recombination techniques.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される、単離し、精製し、又は濃縮した核酸、その相補配列、又は配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される配列のうちの１つの、少なくとも１００、１５０、２００、３００、４００又はそれ以上の連続した塩基を含むフラグメント、又はその相補配列を、プローブとして使用し、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドをそれぞれコードするＤＮＡを特に同定し、単離してもよい。このような手順において、サンプルの微生物又はファルネシルジベンゾジアゼピノンを生成することができる微生物を含むサンプルから、ゲノムＤＮＡライブラリを構築する。次に、プローブがその相補的な配列に特異的にハイブリダイズできる条件下で、コード配列又はコード配列のフラグメントを有し、配列２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドのうちの１つ又はそのフラグメントをコードするプローブと、ゲノムＤＮＡライブラリとを接触させる。好ましい実施例においては、プローブは約１０から約３０ヌクレオチド長のオリゴヌクレオチドで、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される核酸に基づいて設計される。次に、プローブにハイブリダイズするゲノムＤＮＡクローンを、検出し、単離する。目的のＤＮＡクローンを調製し、同定する手順は、Ausubel et al., Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997；及びSambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989 に開示されている。別の実施の形態においては、プローブは配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９に由来する、制限フラグメント又はＰＣＲ増幅核酸である。
</span>
&nbsp;&nbsp;SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, Isolated, purified, or represented by 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89, or Concentrated nucleic acid, its complementary sequence, or SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 At least 100, 150, 200, 300, 400, or A fragment containing more than one consecutive base or a complementary sequence thereof is used as a probe, and SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28 , 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78 , 80, 82, 84, 86, and 88, respectively, may be specifically identified and isolated. In such a procedure, a genomic DNA library is constructed from a sample microorganism or a sample containing a microorganism capable of producing farnesyl dibenzodiazepinone. Next, under conditions that allow the probe to specifically hybridize to its complementary sequence, it has a coding sequence or fragment of the coding sequence and the sequences 2, 4, 6, 8, 10, 12, 14, 16, 18 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69 , 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88, a probe encoding one of the polypeptides or a fragment thereof is contacted with the genomic DNA library. In a preferred embodiment, the probe is an oligonucleotide of about 10 to about 30 nucleotides in length and is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, Designed based on nucleic acids represented by 83, 85, 87, and 89. Next, a genomic DNA clone that hybridizes to the probe is detected and isolated. Procedures for preparing and identifying DNA clones of interest are described in Ausubel et al., Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997; and Sambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989. In another embodiment, the probe is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Restriction fragments or PCR amplified nucleic acids.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される単離し、精製し、又は濃縮した核酸、その相補配列、若しくは配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される１つの配列の、少なくとも１０、１５、２０、２５、３０、３５、４０、５０、７５、１００、１５０、２００、３００、４００、又は５００の連続した塩基を含むフラグメント又はその相補配列を、プローブとして使用して、関連する核酸を同定して、単離してもよい。ある実施の形態では、関連する核酸が、潜在的なファルネシルジベンゾジアゼピノン生産者のゲノムＤＮＡ（又はｃＤＮＡ）であってもよい。このような手順において、プローブが関連する配列を特異的にハイブリダイズできる条件下で、潜在的なファルネシルジベンゾジアゼピノン生産者に由来する核酸を含む核酸のサンプルを、プローブに接触させる。核酸のサンプルは、潜在的なファルネシルジベンゾジアゼピノン生産者のゲノムＤＮＡ（又はｃＤＮＡ）ライブラリでよい。プローブの核酸へのハイブリダイゼーションは、上述の方法のいずれかを用いて検出される。
</span>
&nbsp;&nbsp;SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Nucleic acid, its complementary sequence, or SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 At least 10, 15, 20, 25, 30, 35, 40, 50 of one sequence 75,100,150,200,300,400, or fragments or a complementary sequence thereof comprising 500 contiguous bases, and used as a probe, to identify the related nucleic acid may be isolated. In certain embodiments, the relevant nucleic acid may be the genomic DNA (or cDNA) of a potential farnesyl dibenzodiazepinone producer. In such a procedure, a sample of nucleic acid containing nucleic acid from a potential farnesyl dibenzodiazepinone producer is contacted with the probe under conditions that allow the probe to specifically hybridize to the relevant sequence. The nucleic acid sample may be a genomic DNA (or cDNA) library of potential farnesyl dibenzodiazepinone producers. Hybridization of the probe to the nucleic acid is detected using any of the methods described above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ハイブリダイゼーションは、低、中、又は高ストリンジェンシーの条件下で行われる。核酸ハイブリダイゼーションの例としては、固定され、変性した核酸を含むポリマー膜を、始めに、０．９ＭのＮａＣｌ、５０ｍＭのＮａＨ<sub class="style-scope patent-text">２</sub>ＰＯ<sub class="style-scope patent-text">４</sub>、ｐＨ７．０、５０ｍＭのＮａ<sub class="style-scope patent-text">２</sub>ＥＤＴＡ、０．５％ＳＤＳ、１０×デンハート、及び０．５ｍｇ／ｍｌのポリリボアデニル酸からなる溶液で、３０分間４５℃でプレハイブリダイズする。次に、約２×１０<sup class="style-scope patent-text">７</sup>ｃｐｍ（特異的活性４〜９×１０<sup class="style-scope patent-text">８</sup>ｃｐｍ／ｕｇ）の<sup class="style-scope patent-text">３２</sup>Ｐ末端標識オリゴヌクレオチドプローブを、該溶液に添加する。培養の１２〜１６時間後に、０．５％ＳＤＳを含む１×ＳＥＴ（１５０ｍＭのＮａＣｌ、２０ｍＭのトリス塩酸、ｐＨ７．８、１ｍＭのＮａ<sub class="style-scope patent-text">２</sub>ＥＤＴＡ）で、３０分間室温でかかる膜を洗浄し、続いて新しい１×ＳＥＴで、Ｔｍ−１０℃でオリゴヌクレオチドプローブを洗浄する。ここで、Ｔｍは、融解温度である。次に、ハイブリダイゼーションシグナルを検出するために、オートラジオグラフィックフィルムにかかる膜を曝露する。
</span>Hybridization is performed under conditions of low, medium or high stringency. As an example of nucleic acid hybridization, a polymer membrane containing immobilized and denatured nucleic acid is first prepared with 0.9 M NaCl, 50 mM NaH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> , pH 7.0, 50 mM Na <sub class="style-scope patent-text">2</sub> EDTA, 0.5% Prehybridize with a solution of SDS, 10 × Denhart, and 0.5 mg / ml polyriboadenylic acid at 45 ° C. for 30 minutes. Next, approximately 2 × 10 <sup class="style-scope patent-text">7</sup> cpm (specific activity 4-9 × 10 <sup class="style-scope patent-text">8</sup> cpm / ug) of <sup class="style-scope patent-text">32</sup> P end-labeled oligonucleotide probe is added to the solution. After 12-16 hours of culture, the membrane is washed with 1 × SET (150 mM NaCl, 20 mM Tris-HCl, pH 7.8, 1 mM Na <sub class="style-scope patent-text">2</sub> EDTA) containing 0.5% SDS for 30 minutes at room temperature, Subsequently, the oligonucleotide probe is washed with fresh 1 × SET at Tm−10 ° C. Here, Tm is a melting temperature. Next, the membrane over the autoradiographic film is exposed to detect the hybridization signal.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ゲノムＤＮＡ又はｃＤＮＡ等の、検出可能なプローブにハイブリダイズする核酸を同定するために使用される、ハイブリダイゼーション条件のストリンジェンシーを変えることによって、プローブに対して異なるレベルのホモロジーを有する核酸を同定し、単離することができる。プローブの融解温度より低温の様々な温度でハイブリダイゼーションを行うことによって、ストリンジェンシーを変化させてもよい。プローブの融解温度は、次の式を用いて計算することができる。
</span>
&nbsp;&nbsp;Identifying nucleic acids with different levels of homology to the probe by altering the stringency of the hybridization conditions used to identify the nucleic acid that hybridizes to the detectable probe, such as genomic DNA or cDNA. Can be isolated. Stringency may be changed by performing hybridization at various temperatures below the melting temperature of the probe. The melting temperature of the probe can be calculated using the following formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １４から７０ヌクレオチド長のオリゴヌクレオチドのプローブの融解温度（Ｔｍ）の摂氏温度は、次の式を用いて計算することができる。<br class="style-scope patent-text">
Ｔｍ＝８１．５＋１６．６（ｌｏｇ［Ｎａ＋］＋０．４１（フラクションＧ＋Ｃ）−（６００／Ｎ）。ここで、Ｎはオリゴヌクレオチドの長さである。
</span>The Celsius temperature of the melting temperature (Tm) of an oligonucleotide probe of 14 to 70 nucleotides in length can be calculated using the following formula: <br class="style-scope patent-text"> Tm = 81.5 + 16.6 (log [Na +] + 0.41 (fraction G + C) − (600 / N), where N is the length of the oligonucleotide).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ホルムアミドを含む溶液中でハイブリダイゼーションが行われる場合は、融解温度は次の方程式を用いて計算することができる。<br class="style-scope patent-text">
Ｔｍ＝８１．５＋１６．６（ｌｏｇ［Ｎａ＋］＋０．４１（フラクションＧ＋Ｃ）−（０．６３％ホルムアミド）−（６００／Ｎ）。ここで、Ｎはプローブの長さである。<br class="style-scope patent-text">
６×ＳＳＣ、５×デンハート試薬、０．５％ＳＤＳ、変性した断片化サケ精子ＤＮＡ０．１ｍｇ／ｍｌ又は６×ＳＳＣ、５×デンハート試薬、０．５％ＳＤＳ、変性した断片化サケ精子ＤＮＡ０．１ｍｇ／ｍｌ、５０％ホルムアミド中で、プレハイブリダイゼーションを行ってもよい。ＳＳＣ及びデンハート溶液の組成は、Sambrook et al., supraに記載されている。
</span>When hybridization is performed in a solution containing formamide, the melting temperature can be calculated using the following equation: <br class="style-scope patent-text"> Tm = 81.5 + 16.6 (log [Na +] + 0.41 (fraction G + C)-(0.63% formamide)-(600 / N), where N is the length of the probe). <br class="style-scope patent-text"> 6 × SSC, 5 × Denhart reagent, 0.5% SDS, denatured fragmented salmon sperm DNA 0.1 mg / ml or 6 × SSC, 5 × Denhart reagent, 0.5% SDS, denatured fragmented salmon sperm DNA Prehybridization may be performed in 1 mg / ml, 50% formamide. The composition of SSC and Denhardt's solution is described in Sambrook et al., Supra.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上述のハイブリダイゼーション溶液に検出可能なプローブを添加して、ハイブリダイゼーションを行う。該プローブが二重鎖ＤＮＡを含む場合は、ハイブリダイゼーション溶液に添加する前に高温で培養し、急激に冷却することによって、変性が行われる。同様に一重鎖プローブを変性して、二次構造の形成又はオリゴマー形成を除く又は減少させることも望ましいであろう。フィルターをハイブリダイゼーション溶液と十分な時間接触させることによって、それらに相補的又は相同的な配列を含むｃＤＮＡ又はゲノムＤＮＡにプローブがハイブリダイズすることが可能となる。２００ヌクレオチド長より長いプローブについては、融解温度より１５〜２５℃低温でハイブリダイゼーションを行う。オリゴヌクレオチドプローブ等の短いプローブについては、融解温度より５〜１０℃低温でハイブリダイゼーションを行ってもよい。好ましくは、短いプローブについては、６×ＳＳＣでハイブリダイゼーションを行ってもよい。好ましくは、長いプローブについては、５０％ホルムアミドを含む溶液でハイブリダイゼーションを行う。前述のハイブリダイゼーションは全て、高ストリンジェンシーの条件下で実施されるハイブリダイゼーションの例であるとみなす。
</span>
&nbsp;&nbsp;Hybridization is performed by adding a detectable probe to the hybridization solution described above. When the probe contains double-stranded DNA, denaturation is performed by culturing at a high temperature before adding it to the hybridization solution and rapidly cooling. Similarly, it may be desirable to denature single-stranded probes to eliminate or reduce secondary structure formation or oligomer formation. By contacting the filter with the hybridization solution for a sufficient time, the probe can hybridize to cDNA or genomic DNA containing sequences complementary or homologous thereto. For probes longer than 200 nucleotides, hybridization is performed at 15-25 ° C. below the melting temperature. For short probes such as oligonucleotide probes, hybridization may be performed at a temperature 5 to 10 ° C lower than the melting temperature. Preferably, for short probes, hybridization may be performed with 6 × SSC. Preferably, long probes are hybridized with a solution containing 50% formamide. All of the aforementioned hybridizations are considered examples of hybridization performed under conditions of high stringency.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
ハイブリダイゼーションに続き、所望のストリンジェンシーに応じて、フィルターを少なくとも１５分間２×ＳＳＣ、０．１％ＳＤＳ中、室温以上の温度で洗浄する。その後０．１×ＳＳＣ、０．５％ＳＤＳを用いて、室温で（再度）３０分から１時間フィルターを洗浄する。従来のオートラジオグラフィー及び非放射性検出方法によって、プローブにハイブリダイズした核酸を同定する。
</span>
Following hybridization, the filter is washed in 2 × SSC, 0.1% SDS at room temperature or higher for at least 15 minutes, depending on the desired stringency. The filter is then washed with 0.1 × SSC, 0.5% SDS at room temperature (again) for 30 minutes to 1 hour. Nucleic acids hybridized to the probe are identified by conventional autoradiography and non-radioactive detection methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上述の手順を改良して、プローブの配列に対するホモロジーのレベルが低下した核酸を同定してもよい。例えば、検出可能なプローブに対するホモロジーが低下した核酸を得るために、ストリンジェントがより低い条件を用いてもよい。例えば、Ｎａ＋濃度が約１Ｍであるハイブリダイゼーション緩衝液のハイブリダイゼーション温度を６８℃から４２℃へと５℃ずつ低下させてもよい。ハイブリダイゼーション後、２×ＳＳＣ、０．５％ＳＤＳを用いて、ハイブリダイゼーション温度でフィルターを洗浄してもよい。これらの条件は５０℃より高温の「中ストリンジェンシー」条件、５０℃より低温の「低ストリンジェンシー」条件であると考えられる。「中ストリンジェンシー」ハイブリダイゼーション条件の具体例は、上述のハイブリダイゼーションが５５℃で行われる場合である。「低ストリンジェンシー」ハイブリダイゼーション条件の具体例は、上述のブリダイゼーションが４５℃で行われる場合である。
</span>
&nbsp;&nbsp;The above procedure may be modified to identify nucleic acids with reduced levels of homology to the probe sequence. For example, conditions with lower stringency may be used to obtain nucleic acids with reduced homology to detectable probes. For example, the hybridization temperature of a hybridization buffer having a Na + concentration of about 1M may be decreased by 5 ° C. from 68 ° C. to 42 ° C. After hybridization, the filter may be washed at the hybridization temperature using 2 × SSC, 0.5% SDS. These conditions are considered “medium stringency” conditions above 50 ° C. and “low stringency” conditions below 50 ° C. A specific example of “medium stringency” hybridization conditions is when the above-described hybridization is performed at 55 ° C. A specific example of “low stringency” hybridization conditions is when the above-described hybridization is performed at 45 ° C.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  或いは、ホルムアミドを含む６×ＳＳＣ等の緩衝液中、４２℃でハイブリダイゼーションを行ってもよい。この場合、プローブに対するホモロジーのレベルが低下したクローンを同定するために、ハイブリダイゼーション緩衝液中のホルムアミドの濃度を、５０％から０％に５％ずつ低下させてもよい。ハイブリダイゼーション後に、６×ＳＳＣ、０．５％ＳＤＳを使用し、５０℃でフィルターを洗浄してもよい。これらの条件は、ホルムアミドが２５％より高い場合は「中ストリンジェンシー」条件、２５％より低い場合は「低ストリンジェンシー」条件である。「中ストリンジェンシー」のハイブリダイゼーション条件の具体例は、上記のハイブリダイゼーションが３０％ホルムアミドで実施される場合である。「低ストリンジェンシー」ハイブリダイゼーション条件の具体例は、上記のハイブリダイゼーションが１０％ホルムアミドで実施される場合である。プローブにハイブリダイズした核酸を、従来のオートラジオグラフィー及び非放射性検出方法によって同定する。
</span>
&nbsp;&nbsp;Alternatively, hybridization may be performed at 42 ° C. in a buffer such as 6 × SSC containing formamide. In this case, in order to identify clones with reduced levels of homology to the probe, the formamide concentration in the hybridization buffer may be reduced by 5% from 50% to 0%. After hybridization, the filter may be washed at 50 ° C. using 6 × SSC, 0.5% SDS. These conditions are “medium stringency” conditions when formamide is greater than 25% and “low stringency” conditions when formamide is less than 25%. A specific example of “medium stringency” hybridization conditions is when the above hybridization is carried out with 30% formamide. A specific example of “low stringency” hybridization conditions is when the above hybridization is carried out with 10% formamide. Nucleic acids hybridized to the probe are identified by conventional autoradiography and non-radioactive detection methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前述の方法を用いて、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される配列からなる群から選択される核酸配列に、少なくとも９７％、少なくとも９５％、少なくとも９０％、少なくとも８５％、少なくとも８０％、又は少なくとも７０％の配列同一性を有する核酸を単離してよい。単離された核酸配列は、本明細書に記載されたコード配列のうちの１つの配列の自然発生的な対立遺伝子変異体であるコード配列を有していてもよい。このような対立遺伝子変異体は、配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、６３、６６、６８、７０、７２、７５、７７、７９、８１、８３、８５、８７、及び８９で表される核酸又はこれらの相補配列と比較して、１又は２以上の核酸が置換、欠失、付加されていてもよい。
</span>
&nbsp;&nbsp;Using the method described above, SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Nucleic acids having at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% sequence identity to a nucleic acid sequence selected from the group consisting of: An isolated nucleic acid sequence may have a coding sequence that is a naturally occurring allelic variant of one of the coding sequences described herein. Such allelic variants are SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41. 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 One or more nucleic acids may be substituted, deleted, or added as compared to the nucleic acid or the complementary sequence thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表される配列の１つを有するポリペプチド、又は少なくともその５０、７５、１００、１５０、２００、３００の連続したアミノ酸を有するフラグメントに対して、少なくとも９９％、少なくとも９５％、少なくとも９０％、少なくとも８５％、少なくとも８０％、又は少なくとも７０％の同一性を有するポリペプチドをコードする核酸を単離するために、上述の手順を使用してもよい。
</span>
&nbsp;&nbsp;Also, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, One of the sequences represented by 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 At least 99%, at least 95%, at least 90%, at least 85%, at least 80%, for polypeptides having at least 50, 75, 100, 150, 200, 300 contiguous amino acids, Alternatively, the above procedure may be used to isolate nucleic acids encoding polypeptides having at least 70% identity.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施の形態は、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表される配列の１つ、又は少なくともその５０、７５、１００、１５０、２００、３００の連続したアミノ酸を有するフラグメントを含む、単離された、又は精製されたポリペプチドである。本明細書に記載するように、コードされたポリペプチドを適当な宿主細胞に発現させることができる配列に、コード配列が操作可能な状態で結合するように、ポリペプチドをコードする核酸をベクターに挿入することによって、これらのポリペプチドを得てもよい。例えば、これらの発現ベクターはプロモーター、翻訳開始用のリボソーム結合部位、及び転写終結区を含んでいてもよい。該ベクターはまた、発現レベルを調整するための適当な配列、複製開始点、及び選択可能なマーカーを含んでいてもよい。
</span>
&nbsp;&nbsp;Another embodiment of the present invention is SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 An isolated or purified polypeptide comprising one of the sequences represented by: or a fragment having at least 50, 75, 100, 150, 200, 300 consecutive amino acids thereof. As described herein, a nucleic acid encoding a polypeptide is inserted into a vector so that the encoded sequence is operably linked to a sequence that can be expressed in a suitable host cell. These polypeptides may be obtained by insertion. For example, these expression vectors may contain a promoter, a ribosome binding site for initiating translation, and a transcription termination region. The vector may also contain appropriate sequences for adjusting the expression level, origin of replication, and selectable markers.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ポリペプチド又はそのフラグメントを細菌で発現するために適したプロモーターには、E．coli ｌａｃ又はｔｒｐプロモーター、ｌａｃｌプロモーター、ｌａｃＺプロモーター、Ｔ３プロモーター、Ｔ７プロモーター、ｇｐｔプロモーター、ラムダＰ<sub class="style-scope patent-text">Ｒ</sub>プロモーター、及びラムダＰ<sub class="style-scope patent-text">Ｌ</sub>プロモーターや、３−ホスホグリセリン酸キナーゼ（ＰＧＫ）及び酸性ホスファタ−ゼプロモーター等の糖分解酵素をコードするオペロンのプロモーターが含まれる。真菌のプロモーターには、αファクタープロモーターが含まれる。真核生物のプロモーターには、ＣＭＶ immediate early プロモーター、ＨＳＶチミジンキナーゼプロモーター、熱ショックプロモーター、early and late ＳＶ４０プロモーター、レトロウイルスのＬＴＲ、及びマウスメタロチオネイン−Ｉプロモーターが含まれる。原核生物若しくは真核生物の細胞又はそれらのウイルスにおいて遺伝子の発現をコントロールすることが知られている他のプロモーターを用いてもよい。
</span>Suitable promoters for expressing the polypeptide or fragment thereof in bacteria include E. coli. coli lac or trp promoter, lacl promoter, lacZ promoter, T3 promoter, T7 promoter, gpt promoter, the lambda <sub class="style-scope patent-text">P R</sub> promoter, and and lambda <sub class="style-scope patent-text">P L</sub> promoter, 3-phosphoglycerate kinase (PGK) and the acid phosphatase - such lactamase promoter An operon promoter encoding a glycolytic enzyme is included. Fungal promoters include the alpha factor promoter. Eukaryotic promoters include CMV immediate early promoter, HSV thymidine kinase promoter, heat shock promoter, early and late SV40 promoter, retroviral LTR, and mouse metallothionein-I promoter. Other promoters known to control gene expression in prokaryotic or eukaryotic cells or their viruses may be used.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  哺乳動物の発現ベクターは、複製開始点、全ての必要なリボソーム結合部位、ポリアデニル化部位、スプライスドナー、及びアクセプター部位、転写終止配列及び５´フランキング非転写配列も備えていてもよい。ある実施の形態では、ＳＶ４０スプライス部位とポリアデニル化部位由来のＤＮＡ配列を使用して、必要とされている非転写遺伝要素を得てもよい。
</span>
&nbsp;&nbsp;Mammalian expression vectors may also comprise an origin of replication, all necessary ribosome binding sites, polyadenylation sites, splice donors and acceptor sites, transcription termination sequences and 5 ′ flanking non-transcribed sequences. In certain embodiments, DNA sequences derived from SV40 splice sites and polyadenylation sites may be used to obtain the required non-transcribed genetic elements.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  真核生物の細胞でポリペプチド又はそのフラグメントを発現するためのベクターは、発現レベルを向上させるためのエンハンサーを含んでいてもよい。エンハンサーはＤＮＡのシス活性要素であり、通常約１０ｂｐから３００ｂｐの長さで、プロモーターに作用し、その転写を促進する。複製開始点１００ｂｐから２７０ｂｐの後ろ側ＳＶ４０エンハンサー、サイトメガロウイルス初期プロモーターエンハンサー、複製開始点の後ろ側のポリオーマエンハンサー、及びアデノウイルスエンハンサーが、例に含まれる。
</span>
&nbsp;&nbsp;A vector for expressing a polypeptide or fragment thereof in a eukaryotic cell may contain an enhancer for improving the expression level. Enhancers are cis-acting elements of DNA, usually about 10 bp to 300 bp long, act on promoters and promote their transcription. Examples include the SV40 enhancer behind the origin of replication 100 bp to 270 bp, the cytomegalovirus early promoter enhancer, the polyoma enhancer behind the origin of replication, and the adenovirus enhancer.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  更に、発現ベクターが、好ましくは１又は２以上の選択可能なマーカー遺伝子を含むため、該ベクターを含む宿主細胞の選択が可能となる。使用される選択可能なマーカーの例としては、ジヒドロ葉酸リダクターゼをコードする遺伝子、真核細胞培養物にネオマイシン耐性を与える遺伝子、E．coli 及びS.cerevisiae ＴＲＰ１遺伝子にテトラサイクリン耐性又はアンピシリン耐性を与える遺伝子が挙げられる。
</span>
&nbsp;&nbsp;Furthermore, since the expression vector preferably contains one or more selectable marker genes, it is possible to select a host cell containing the vector. Examples of selectable markers used include a gene encoding dihydrofolate reductase, a gene that confers neomycin resistance to eukaryotic cell cultures, E. coli. Examples include genes that give tetracycline resistance or ampicillin resistance to the E. coli and S. cerevisiae TRP1 genes.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
様々な手順により、適当なＤＮＡ配列をベクターに挿入してよい。一般には、ＤＮＡ配列を挿入断片の分解後のベクターや適当な制限エンドヌクレアーゼを有するベクターの所望の位置に連結する。或いは、ＰＣＲによって、適当な制限酵素部位を操作してＤＮＡに挿入する。様々なクローン技術が、Ausbel et al. Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997 and Sambrook et al., Molecualr Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbour Laboratory Press, 1989に開示されている。これらの手順や他の手順は、当業者の範囲内であるとみなされる。
</span>
The appropriate DNA sequence may be inserted into the vector by a variety of procedures. In general, the DNA sequence is ligated to a desired position in the vector after degradation of the inserted fragment or a vector having an appropriate restriction endonuclease. Alternatively, an appropriate restriction enzyme site is manipulated and inserted into DNA by PCR. Various cloning techniques are disclosed in Ausbel et al. Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997 and Sambrook et al., Molecualr Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989. ing. These and other procedures are considered to be within the scope of those skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ベクターは、例えばプラスミド、ウイルス粒子、又はファージの形であってよい。他のベクターには、染色体や非染色体や合成ＤＮＡ配列の誘導体、ウイルス、細菌プラスミド、ファージＤＮＡ、バキュロウイルス、酵母プラスミド、プラスミドとファージＤＮＡとの組合せに由来するベクター、ワクシニア、アデノウイルス、鶏痘ウイルス、及び仮性狂犬病等のウイルスＤＮＡ等が含まれる。原核生物又は真核生物の宿主に用いる様々なクローニングや発現ベクターは、Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, N.Y, (1989) に開示されている。
</span>
&nbsp;&nbsp;The vector may be, for example, in the form of a plasmid, viral particle, or phage. Other vectors include chromosomal, non-chromosomal and synthetic DNA sequence derivatives, viruses, bacterial plasmids, phage DNA, baculovirus, yeast plasmids, vectors derived from combinations of plasmids and phage DNA, vaccinia, adenovirus, fowlpox. Viruses and viral DNA such as pseudorabies are included. Various cloning and expression vectors for use in prokaryotic or eukaryotic hosts are disclosed in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, NY (1989).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  使用される特定の細菌ベクターには、ｐＢＲ３２２（ＡＴＣＣ３７０１７）、ｐＫＫ２２３−３(Pharmacia Fine Chemicals, Uppsala, Sweden)、ｐＧＥＭ１(Promega Biotec, Madison, WI, USA)、ｐＱＥ７０、ｐＱＥ６０、ｐＱＥ−９(Qiagen)、ｐＤ１０、ｐｈｉＸ１７４、pBluescript<sup class="style-scope patent-text">TM </sup>IIＫＳ、ｐＮＨ８Ａ、ｐＮＨ１６ａ、ｐＮＨ１８Ａ、ｐＮＨ４６Ａ (Stratagene)、ｐｔｒｃ９９ａ、ｐＫＫ２２３−３、ｐＫＫ２３３−３、ｐＤＲ５４０、ｐＲＩＴ５(Pharmacia)、ｐＫＫ２３２−８及びｐＣＭ７等の、周知のクローニングベクターの遺伝要因を含む市販のプラスミドが含まれる。特定の真核生物のベクターには、ｐＳＶ２ＣＡＴ、ｐＯＧ４４、ｐＸＴ１、ｐＳＧ(Stratagene)、ｐＳＶＫ３、ｐＢＰＶ、ｐＭＳＧ及びｐＳＶＬ(Pharmacia)が含まれる。しかし、宿主細胞で再製可能且つ安定していれば、他のベクターを使用してもよい。
</span>Specific bacterial vectors used include pBR322 (ATCC 37017), pKK223-3 (Pharmacia Fine Chemicals, Uppsala, Sweden), pGEM1 (Promega Biotec, Madison, Wis., USA), pQE70, pQE60, pQE-9 (Qiagen) , PD10, phiX174, pBluescript <sup class="style-scope patent-text">™</sup> IIKS, pNH8A, pNH16a, pNH18A, pNH46A (Stratagene), ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 (Pharmacia), pKK232-8 and pCM7 Commercially available plasmids containing genetic factors are included. Specific eukaryotic vectors include pSV2CAT, pOG44, pXT1, pSG (Stratagene), pSVK3, pBPV, pMSG and pSVL (Pharmacia). However, other vectors may be used as long as they are reproducible and stable in the host cell.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  宿主細胞は、原核生物の細胞又は真核生物の細胞を含む、当業者に公知であるいずれの宿主細胞であってよい。適当な宿主の代表例には、E.coli、Streptomyces lividans、Streptomyces griseofuscus、Streptomyces ambofaciens、Bacillus subtilis、Salmonella typhimurium及びPseudomonas属、Streptomyces属、Bacillus属、Staphylococcus属の様々な種等の細菌細胞、酵母等の真菌細胞、Drosophila S2及びSpodoptera Sf9等の昆虫細胞、並びにＣＨＯ、ＣＯＳ又はBowes melanoma及びアデノウイルス等の動物細胞が含まれる。適切な宿主を選択することは、当業者の能力の範囲内である。
</span>
&nbsp;&nbsp;The host cell can be any host cell known to those of skill in the art, including prokaryotic cells or eukaryotic cells. Representative examples of suitable hosts include bacterial cells such as E. coli, Streptomyces lividans, Streptomyces griseofuscus, Streptomyces ambofaciens, Bacillus subtilis, Salmonella typhimurium and Pseudomonas, various species of Streptomyces, Bacillus, Staphylococcus, etc. Fungal cells, insect cells such as Drosophila S2 and Spodoptera Sf9, and animal cells such as CHO, COS or Bowes melanoma and adenovirus. Selecting an appropriate host is within the abilities of those skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  エレクトロポレーション形質転換、トランスフェクション、形質導入、ウイルス感染、遺伝子銃、又はＴｉ−媒介遺伝子導入を含む、様々な技術のいずれかを用いて、ベクターを宿主細胞に導入してもよい。適当であれば、プロモーターの活性化、形質転換株の選択、又は本発明の遺伝子の増幅に適するように改良された従来の栄養培地で、組み換えられた宿主細胞を培養することができる。適当な宿主株を形質転換し、宿主株が適切な細胞密度まで成長した後、選択されたプロモーターが適当な手段（例えば、温度の変換又は化学作用による誘発）によって誘発され、細胞を更に１周期培養して、細胞が所望のポリペプチド又はそのフラグメントを生成できるようにしてもよい。
</span>
&nbsp;&nbsp;The vector may be introduced into the host cell using any of a variety of techniques, including electroporation transformation, transfection, transduction, viral infection, gene gun, or Ti-mediated gene transfer. Where appropriate, recombinant host cells can be cultured in conventional nutrient media modified to be suitable for promoter activation, selection of transformants, or amplification of the genes of the present invention. After transformation of the appropriate host strain and growth of the host strain to the appropriate cell density, the selected promoter is induced by suitable means (eg, temperature conversion or chemical induction), and the cells are further cycled. Culturing may be performed to allow the cells to produce the desired polypeptide or fragment thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  通常、細胞は遠心分離によって回収され、物理的又は化学的手段によって破壊される。その結果生じた粗抽出物は、その後の精製のために保持される。凍結融解サイクル、超音波処理、機械的破壊又は細胞溶解剤の使用を含むあらゆる従来の方法によって、タンパク質を発現させるために用いられる微生物細胞を破壊することができる。これらの方法は、当業者に周知である。発現したポリペプチド又はそのフラグメントを、硫酸アンモニウム沈澱法又はエタノール沈澱法、酸抽出法、アニオン若しくはカチオン交換クロマトグラフィー、ホスホセルロースクロマトグラフィー、疎水性相互作用クロマトグラフィー、アフィニティークロマトグラフィー、ヒドロキシルアパタイトクロマトグラフィー、及びレクチンクロマトグラフィーを含む方法で、リコンビナント細胞培養物から回復し、精製することができる。必要であれば、ポリペプチドの構成を完成させる際に、タンパク質リフォールディングステップを用いることができる。必要に応じて、最終精製ステップに高性能液体クロマトグラフィー（ＨＰＬＣ）を用いることができる。
</span>
&nbsp;&nbsp;Usually, the cells are collected by centrifugation and destroyed by physical or chemical means. The resulting crude extract is retained for subsequent purification. Microbial cells used to express the protein can be disrupted by any conventional method including freeze-thaw cycles, sonication, mechanical disruption or the use of cytolytic agents. These methods are well known to those skilled in the art. Expressing the polypeptide or fragment thereof by ammonium sulfate precipitation or ethanol precipitation, acid extraction, anion or cation exchange chromatography, phosphocellulose chromatography, hydrophobic interaction chromatography, affinity chromatography, hydroxylapatite chromatography, and It can be recovered from recombinant cell culture and purified by methods involving lectin chromatography. If necessary, a protein refolding step can be used in completing the construction of the polypeptide. If necessary, high performance liquid chromatography (HPLC) can be used for final purification steps.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  様々な哺乳動物の細胞培養系を使用して、リコンビナントタンパク質を発現させることもできる。哺乳動物の発現系の例には、サル腎臓繊維芽細胞ＣＯＳ−７株（Gluzman, Cell, 23:175(1981)に記載）、及びＣ１２７、３Ｔ３、ＣＨＯ、ＨｅＬａ及びＢＨＫ細胞株等のコンパチブルベクター(compatible vector)からタンパク質を発現することができる他の細胞株が含まれる。従来の方法で宿主細胞におけるコンストラクトを使用して、リコンビナント配列によってコードされる遺伝子生成物を生成してもよい。本発明のポリペプチドは、開始メチオニンアミノ酸残基を含んでいてもよく、含んでいなくてもよい。
</span>
&nbsp;&nbsp;Various mammalian cell culture systems can also be employed to express recombinant protein. Examples of mammalian expression systems include monkey kidney fibroblast COS-7 strain (described in Gluzman, Cell, 23: 175 (1981)) and compatible vectors such as C127, 3T3, CHO, HeLa and BHK cell lines. Other cell lines capable of expressing the protein from (compatible vectors) are included. The construct in the host cell may be used in a conventional manner to produce the gene product encoded by the recombinant sequence. The polypeptides of the present invention may or may not contain an initiating methionine amino acid residue.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  或いは、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチド又は少なくともその５０、７５、１００、１５０、２００、又は３００の連続したアミノ酸を含むフラグメントを、従来のペプチドシンセサイザーによって合成で生成することができる。別の実施の形態においては、対応する全長ポリペプチドをペプチド合成で生成するために、フラグメント又はポリヌクレオチドの部分を使用してもよい。したがって、全長ポリペプチドを生成するための中間生成物として、フラグメントを用いる。
</span>
&nbsp;&nbsp;Alternatively, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Its fragment containing 50, 75, 100, 150, 200, or 300 consecutive amino acids can be generated synthetically by a conventional peptide synthesizer. In another embodiment, fragments or portions of polynucleotides may be used to generate the corresponding full-length polypeptide by peptide synthesis. Therefore, the fragment is used as an intermediate product to produce a full-length polypeptide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  無細胞翻訳系を使用し、ポリペプチド又はそのフラグメントをコードする核酸に操作可能な状態で結合するプロモーターを含むＤＮＡコンストラクトから転写されたｍＲＮＡを用いて、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドのうち１つ、又は少なくともその５０、７５、１００、１５０、２００、若しくは３００の連続したアミノ酸を含むフラグメントを生成することができる。ある実施の形態においては、インビトロで転写反応が行われる前に、該ＤＮＡコンストラクトが線状化される。次に、転写されたｍＲＮＡは、ウサギ網状赤血球抽出物等の適当な無細胞の翻訳抽出物と共に培養され、所望のポリペプチド又はそのフラグメントを生成する。
</span>
&nbsp;&nbsp;Using mRNA transcribed from a DNA construct comprising a promoter operably linked to a nucleic acid encoding a polypeptide or fragment thereof using a cell-free translation system, SEQ ID NOs: 2, 4, 6, 8, 10 , 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88, or at least 50, 75, 100, 150 thereof. Fragments containing 200, 300, or 300 consecutive amino acids can be generated. In certain embodiments, the DNA construct is linearized before the transcription reaction is performed in vitro. The transcribed mRNA is then cultured with a suitable cell-free translation extract, such as a rabbit reticulocyte extract, to produce the desired polypeptide or fragment thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、本発明は、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの変異体、又は少なくともその５０、７５、１００、１５０、２００、若しくは３００の連続したそのアミノ酸を含むフラグメントに関する。「変異体(variant)」なる語は、これらのポリペプチドの誘導体又はアナログを含む。特に、変異体は、置換、付加、欠失、融合、及び切断の１又２以上によって、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドとは、アミノ酸配列が異なっている。かかる置換、付加、欠失、融合、及び切断には、あらゆる組合せがあってよい。
</span>
&nbsp;&nbsp;The present invention also includes SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 It relates to a variant of a polypeptide, or a fragment comprising at least 50, 75, 100, 150, 200, or 300 consecutive amino acids thereof. The term “variant” includes derivatives or analogs of these polypeptides. In particular, variants may be represented by SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, by one or more of substitutions, additions, deletions, fusions, and truncations. 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, The polypeptide represented by 76, 78, 80, 82, 84, 86, and 88 differs in amino acid sequence. There may be any combination of such substitutions, additions, deletions, fusions and truncations.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  変異体は自然発生するか、インビトロで作製される。特に、これらの変異体は、部位特異的突然変異誘発、ランダムな化学的突然変異誘発、エキソヌクレアーゼIII欠失法、及び標準的なクローニング技術等の遺伝子工学技術を用いて作製される。或いは、化学合成または一時変異(modification)の方法を用いて、これらの変異体、フラグメント、アナログ又は誘導体が作製される。
</span>
&nbsp;&nbsp;Variants occur naturally or are generated in vitro. In particular, these variants are made using genetic engineering techniques such as site-directed mutagenesis, random chemical mutagenesis, exonuclease III deletion methods, and standard cloning techniques. Alternatively, these mutants, fragments, analogs or derivatives are made using methods of chemical synthesis or modification.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  変異体を作製する他の方法も、当業者には公知である。これらには、天然の単離物(natural isolates)から得られた核酸配列を一時変異させ、産業上又は研究用の利用においてこれらの価値を高める特徴を有するポリペプチドをコードする核酸を作製する手順が含まれる。天然の単離物から得られた配列に対して１又は２以上のヌクレオチドの違いを有する多くの変異体の配列を、これらの手順で作製し、特徴付ける。好ましくは、これらのヌクレオチドの違いによって、天然の単離物から核酸によってコードされるポリペプチドに対して、アミノ酸の変化が生じる。
</span>
&nbsp;&nbsp;Other methods of making variants are known to those skilled in the art. These include procedures for making nucleic acids encoding polypeptides having characteristics that enhance their value in industrial or research applications by temporarily mutating nucleic acid sequences obtained from natural isolates. Is included. Many variant sequences with one or more nucleotide differences relative to sequences obtained from natural isolates are generated and characterized by these procedures. Preferably, these nucleotide differences result in amino acid changes from the natural isolate to the polypeptide encoded by the nucleic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの変異体は、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの１又は２以上のアミノ酸残基が、保存された又は保存されていないアミノ酸残基（好ましくは保存されたアミノ酸残基）で置換されている変異体である。その置換されたアミノ酸残基は遺伝子コードにコードされてもよく、コードされなくてもよい。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, Variants of the polypeptides represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48 , 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Two or more amino acid residues are conserved or non-conserved amino acid residues (preferably It is properly a mutant substituted with stored amino acid residues). The substituted amino acid residue may or may not be encoded by the genetic code.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  保存された置換とは、ポリペプチドの特定のアミノ酸を、同様の特徴を有する別のアミノ酸によって置換したものである。保存された置換として典型的に見られるものは、別の脂肪族アミノ酸によるＡｌａ、Ｖａｌ、Ｌｅｕ、及びｌｌｅ等の脂肪族アミノ酸の置換、ＴｈｒによるＳｅｒの置換若しくはＳｅｒによるＴｈｒの置換、他の酸性残基によるＡｓｐ又はＧｌｕ等の酸性残基の置換、アミド基を有する他の残基によるＡｓｎ又はＧｌｎ等のアミド基を有する残基の置換、他の塩基の残基によるＬｙｓ又はＡｒｇ等の塩基の残基の交換、及び他の芳香族残基によるＰｈｅ又はＴｙｒ等の芳香族残基の置換である。
</span>
&nbsp;&nbsp;A conserved substitution is one in which a particular amino acid of a polypeptide is replaced with another amino acid having similar characteristics. Typical conserved substitutions include substitution of aliphatic amino acids such as Ala, Val, Leu, and lle with another aliphatic amino acid, substitution of Ser with Thr or substitution of Thr with Ser, other acidic Substitution of acidic residues such as Asp or Glu by residues, substitution of residues having amide groups such as Asn or Gln by other residues having an amide group, bases such as Lys or Arg by residues of other bases And replacement of aromatic residues such as Phe or Tyr with other aromatic residues.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他の変異体は、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８のポリペプチドで表される１又２以上のアミノ酸残基が、置換基を含む変異体である。更に他の変異体は、ポリペプチドの半減期を増大する化合物（例えば、ポリエチレングリコール）等の他の化合物とポリペプチドとが関連している変異体である。更なる変異体は、付加されたアミノ酸が、リーダー配列、分泌配列、プロタンパク質配列、又はポリペプチドの精製、濃縮、又は安定化を促進する配列等の、ポリペプチドに融合している変異体である。
</span>
&nbsp;&nbsp;Other variants are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, With 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 polypeptides One or more amino acid residues represented is a variant containing a substituent. Still other variants are those in which the polypeptide is associated with another compound, such as a compound that increases the half-life of the polypeptide (eg, polyethylene glycol). Additional variants are those in which the added amino acid is fused to the polypeptide, such as a leader sequence, secretory sequence, proprotein sequence, or a sequence that facilitates purification, enrichment, or stabilization of the polypeptide. is there.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ある実施の形態においては、フラグメント、誘導体、及びアナログが、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドとしての、同一の生物学的機能又は活性を保持している。他の実施の形態において、該フラグメント、誘導体、又はアナログには、融合した異種配列が含まれる。この異種配列は、該フラグメント、誘導体、又はアナログから、一部又は全部を酵素で切断可能なポリペプチドの精製、濃縮、検出、安定化、又は分泌を促進する。
</span>
&nbsp;&nbsp;In certain embodiments, the fragments, derivatives, and analogs are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34. 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84 , 86, and 88, which retain the same biological function or activity. In other embodiments, the fragment, derivative, or analog includes a fused heterologous sequence. This heterologous sequence facilitates the purification, enrichment, detection, stabilization, or secretion of a polypeptide that can be enzymatically cleaved, in part or in whole, from the fragment, derivative, or analog.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の実施の形態は、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドのうちの１つ、又は少なくともその５０、７５、１００、１５０、２００、若しくは３００の連続したアミノ酸を含むフラグメントに対して、少なくとも７０％、少なくとも８０％、少なくとも８５％、少なくとも９０％、又は９５％より高い同一性を有するポリペプチド又はそのフラグメントである。「ほぼ同一な」アミノ酸には、上述のような保存された置換が含まれることは、理解されるであろう。
</span>
&nbsp;&nbsp;Another embodiment of the present invention is SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 At least 70%, at least 80%, at least 85%, for a fragment comprising one of the polypeptides represented by or at least 50, 75, 100, 150, 200, or 300 consecutive amino acids thereof, A polypeptide or fragment thereof having at least 90% or greater than 95% identity. It will be understood that “substantially identical” amino acids include conservative substitutions as described above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドのうちの１つ、又は少なくともその５０、７５、１００、１５０、２００、若しくは３００の連続したアミノ酸を含むフラグメントに対して、ホモロジーを有するポリペプチド又はそのフラグメントを、上述の技術を用いて、これらをコードする核酸を単離することによって得てもよい。<br class="style-scope patent-text">
或いは、相同的なポリペプチド又はフラグメントを、生化学的に縮合する又は精製する手順によって得てもよい。相同的なポリペプチド又はフラグメントの候補の配列は、タンパク質分解、ゲル電気泳動、及び／又はマイクロシーケンシングによって決定してもよい。相同的なポリペプチド又はフラグメントの候補の配列を、配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチドの１つ、又は少なくともその５、１０、１５、２０、２５、３０、３５、４０、５０、７５、１００、若しくは１５０の連続したアミノ酸を含むフラグメントと比較することができる。
</span>SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, One of the polypeptides represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Or a fragment thereof containing homology to a fragment containing at least 50, 75, 100, 150, 200, or 300 consecutive amino acids or a fragment thereof using the above-described techniques May be obtained by isolating. <br class="style-scope patent-text"> Alternatively, homologous polypeptides or fragments may be obtained by biochemical condensation or purification procedures. Candidate sequences for homologous polypeptides or fragments may be determined by proteolysis, gel electrophoresis, and / or microsequencing. Candidate sequences for homologous polypeptides or fragments are represented by SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36. , 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86 And a polypeptide comprising at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids of one of the polypeptides represented by be able to.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４１、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７０、７１、７４、７６、７８、８０、８２、８４、８６、及び８８で表されるポリペプチド、又は少なくともその４０、５０、７５、１００、２００、若しくは３００の連続したアミノ酸を含む本発明のそのフラグメント、誘導体若しくはアナログを、様々な用途に使用してもよい。本明細書の他の箇所に記載したように、例えば、ポリペプチド又はそのフラグメント、誘導体、若しくはアナログを使用して、生化学反応を触媒してもよい。
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, A polypeptide represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88, or at least its The fragments, derivatives or analogs of the invention comprising 40, 50, 75, 100, 200, or 300 consecutive amino acids may be used for various applications. As described elsewhere herein, biochemical reactions may be catalyzed, for example, using polypeptides or fragments, derivatives or analogs thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
VI．<u class="style-scope patent-text">ファルネシルジベンゾジアゼピノンを含む医薬組成物</u> <br class="style-scope patent-text">
別の実施の形態において、本発明は、前述の項に記載のファルネシルジベンゾジアゼピノンと、以下に記載の薬学的に許容されるキャリアとを含む医薬組成物に関する。ファルネシルジベンゾジアゼピノンを含む医薬組成物は、癌、炎症及び細菌感染を含む様々な疾病や疾患の治療に有用である。
</span>VI. <u class="style-scope patent-text">Pharmaceutical composition comprising farnesyl dibenzodiazepinone In</u> another embodiment, the present invention provides farnesyl dibenzodiazepinone as described in the preceding section and a pharmaceutically acceptable carrier as described below. The present invention relates to a pharmaceutical composition comprising Pharmaceutical compositions containing farnesyl dibenzodiazepinone are useful for the treatment of various diseases and disorders including cancer, inflammation and bacterial infection.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物、又はその薬学的に許容される塩を、疾病、特に細菌感染、急性炎症、慢性炎症及び癌の治療又は予防的治療のための、経口、静脈内、筋肉内、皮下、局所的、又は非経口投与用に処方することができる。経口又は非経口投与には、本発明の化合物を従来の医薬的キャリア及び賦形剤と混合して、錠剤、カプセル剤、エリキシル剤、懸濁剤、シロップ剤、ウエファー等の形で使用することができる。本発明の化合物を含む組成物は、重量の約０．１〜約９９．９％、約１〜約９８％、約５〜９５％、約１０〜約８０％、又は約１５〜６０％の活性化合物を含む。
</span>
&nbsp;&nbsp;A compound of the invention, or a pharmaceutically acceptable salt thereof, is administered orally, intravenously, intramuscularly, subcutaneously, topically for the treatment or prophylactic treatment of diseases, in particular bacterial infections, acute inflammation, chronic inflammation and cancer. Can be formulated for oral or parenteral administration. For oral or parenteral administration, the compound of the present invention is mixed with conventional pharmaceutical carriers and excipients and used in the form of tablets, capsules, elixirs, suspensions, syrups, wafers, etc. Can do. Compositions comprising compounds of the present invention may comprise from about 0.1 to about 99.9%, from about 1 to about 98%, from about 5 to 95%, from about 10 to about 80%, or from about 15 to 60% by weight Contains active compound.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に開示される医薬製剤は、標準的な手順に従って調製され、細菌感染、癌、又は炎症を減少、予防又は除去するために選択される投与量で投与される（Remington’s Pharmaceutical Sciences, Mack Publishing Company, Easton, PA; 及び Goodman and Gilman, Pharmaceutical Basis of Therapeutics, Pergamon Press, New York, NY参照。ヒトの治療に様々な抗菌剤を投与する方法の概要に関して、これらの内容は参照することによって本明細書に組み込まれる。)。放出制御送達システム（カプセル剤等）又は持続放出送達システム（生体侵食性マトリックス(bioerodable matrices)等）を使用して、本発明の組成物を送達することができる。本発明の組成物（好ましくは式Ｉ）の投与に適した薬剤送達の遅延放出システムの例は、米国特許第４，４５２，７７５号（Kent）、 第５，２３９，６６０号（Leonard）、第３，８５４，４８０号（Zaffaroni）に記載されている。
</span>
&nbsp;&nbsp;The pharmaceutical formulations disclosed herein are prepared according to standard procedures and are administered at a dosage selected to reduce, prevent or eliminate bacterial infection, cancer, or inflammation (Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, PA; and Goodman and Gilman, Pharmaceutical Basis of Therapeutics, Pergamon Press, New York, NY For a summary of how to administer various antibacterial agents for human therapy, these contents are by reference. Incorporated herein). Controlled release delivery systems (such as capsules) or sustained release delivery systems (such as bioerodable matrices) can be used to deliver the compositions of the invention. Examples of drug delivery delayed release systems suitable for administration of the compositions of the invention (preferably Formula I) are described in US Pat. Nos. 4,452,775 (Kent), 5,239,660 (Leonard), No. 3,854,480 (Zaffaroni).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本出願の薬学的に許容される組成物は、本明細書で集合的に「キャリア」物質と称される、１又は２の非毒性の薬学的に許容されるキャリア及び／又は希釈剤及び／又はアジュバント及び／又は賦形剤に関連し、必要であれば他の有効成分に関連する、１又は２以上の本発明の化合物を含む。かかる組成物は、コーンスターチ又はゼラチン、ラクトース、スクロース、微結晶性セルロース、カオリン、マンニトール、第二リン酸カルシウム、塩化ナトリウム及びアルギン酸等の一般的なキャリア及び賦形剤を含んでもよい。かかる組成物は、クロスカルメロースナトリウム、微結晶性セルロース、グリコール酸スターチナトリウム(sodium starch glycolate)、及びアルギン酸を含んでもよい。
</span>
&nbsp;&nbsp;The pharmaceutically acceptable compositions of this application comprise one or two non-toxic pharmaceutically acceptable carriers and / or diluents, collectively referred to herein as “carrier” materials, and / or Or one or more compounds of the invention related to adjuvants and / or excipients and, if necessary, related to other active ingredients. Such compositions may include common carriers and excipients such as corn starch or gelatin, lactose, sucrose, microcrystalline cellulose, kaolin, mannitol, dicalcium phosphate, sodium chloride and alginic acid. Such compositions may include croscarmellose sodium, microcrystalline cellulose, sodium starch glycolate, and alginic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  包含可能な錠剤結合剤は、アラビアゴム、メチルセルロース、カルボキシメチルセルロースナトリウム、ポリビニルピロリドン（プロビドン）、ヒドロキシプロピルメチルセルロース、スクロース、デンプン及びエチルセルロースである。
</span>
&nbsp;&nbsp;Possible tablet binders are gum arabic, methylcellulose, sodium carboxymethylcellulose, polyvinylpyrrolidone (Providone), hydroxypropylmethylcellulose, sucrose, starch and ethylcellulose.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  使用可能な潤滑剤には、マグネシウムステアリン酸又は他のステアリン酸金属塩、ステアリン酸、シリコン液(silicon fluid)、タルク、ワックス、オイル及びコロイダルシリカが含まれる。
</span>
&nbsp;&nbsp;Lubricants that can be used include magnesium stearate or other metal stearates, stearic acid, silicon fluid, talc, waxes, oils and colloidal silica.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ペパーミント、ウインターグリーン油、チェリー着香料等の着香料を使用することもできる。着色料を添加して、外観がより美しい剤形を作成したり、本発明の化合物を含む製品を識別しやすくすることが望ましい。
</span>
&nbsp;&nbsp;Flavoring agents such as peppermint, winter green oil, cherry flavoring can also be used. It is desirable to add a colorant to create a more beautiful dosage form or to facilitate identification of products containing the compounds of the present invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  経口用には、錠剤やカプセル剤等の固形剤が特に有用である。持続放出製剤又は腸溶性剤を工夫してもよい。小児又は老人への投与に関しては、懸濁液、シロップ剤及びチュアブル錠が特に適切である。経口投与用としては、医薬組成物は例えば、錠剤、カプセル剤、懸濁液又は液剤の形を取る。医薬組成物は、好ましくは医薬的に効果的な量の有効成分を含む投与単位の形に作成される。そのような投与単位の例は、錠剤及びカプセル剤である。治療用には、錠剤及びカプセル材は、有効成分に加えて、アラビアゴム、ゼラチン、ポリビニルピロリドン、ソルビトール、又はトラガカント等の結合剤、リン酸カルシウム、グリシン、ラクトース、コーンスターチ、ソルビトール、又はスクロース等の賦形剤、ステアリン酸マグネシウム、ポリエチレングリコール、シリカ、又はタルク等の潤滑剤、ポテトスターチ等の錠剤分解物質、着香料、着色料、又は許容される湿潤剤等の、従来のキャリアを含むことができる。経口の液体製剤は、一般的に、水溶液又は油性溶液、懸濁液、乳濁液、シロップ剤、又はエリキシル剤であり、懸濁剤、乳化剤、非水溶性剤、保存料、着色料、及び着香料等の従来の添加剤を含んでいてもよい。液体製剤の添加剤の例には、アラビアゴム、アーモンド油、エチルアルコール、ヤシ油、ゼラチン、グルコースシロップ、グリセリン、硬化食用油、レシチン、メチルセルロース、メチル又はプロピルパラ−ヒドロキシベンゾエート、プロピレングリコール、ソルビトール又はソルビン酸が含まれる。
</span>
&nbsp;&nbsp;For oral use, solid preparations such as tablets and capsules are particularly useful. Sustained release formulations or enteric agents may be devised. For administration to children or the elderly, suspensions, syrups and chewable tablets are particularly suitable. For oral administration, the pharmaceutical composition takes the form of, for example, a tablet, capsule, suspension or liquid. The pharmaceutical composition is preferably made in the form of a dosage unit containing a pharmaceutically effective amount of the active ingredient. Examples of such dosage units are tablets and capsules. For treatment, tablets and capsules are shaped into active ingredients, binders such as gum arabic, gelatin, polyvinylpyrrolidone, sorbitol, or tragacanth, calcium phosphate, glycine, lactose, corn starch, sorbitol, or sucrose. Conventional carriers can be included, such as lubricants, lubricants such as magnesium stearate, polyethylene glycol, silica, or talc, tablet disintegrants such as potato starch, flavorings, colorants, or acceptable wetting agents. Oral liquid formulations are generally aqueous or oily solutions, suspensions, emulsions, syrups, or elixirs, suspensions, emulsifiers, water-insoluble agents, preservatives, colorants, and Conventional additives such as flavoring agents may be included. Examples of liquid formulation additives include gum arabic, almond oil, ethyl alcohol, coconut oil, gelatin, glucose syrup, glycerin, hydrogenated edible oil, lecithin, methylcellulose, methyl or propyl para-hydroxybenzoate, propylene glycol, sorbitol or Sorbic acid is included.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  静脈（iv）への使用には、本発明の化合物を一般的に使用されている静脈内輸液のいずれかに溶解又は懸濁し、注射によって投与することができる。静脈内輸液には生理的食塩水又はリンガー溶液が含まれるが、これらに限定されない。
</span>
&nbsp;&nbsp;For intravenous (iv) use, the compounds of the invention can be dissolved or suspended in any of the commonly used intravenous infusions and administered by injection. Intravenous infusion includes, but is not limited to, physiological saline or Ringer's solution.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  非経口用の剤形は、水性又は非水性の等張滅菌注射用溶液又は懸濁液の形をとることができる。これらの溶液又は懸濁液は、経口投与用の剤形における使用に関して述べた１又は２以上のキャリアを有する滅菌粉体又は微粒子から調製することができる。該化合物を、ポリエチレングリコール、プロピレングリコール、エタノール、コーンオイル、ベンジルアルコール、塩化ナトリウム、及び／又は様々な緩衝液に溶解することができる。<br class="style-scope patent-text">
筋内投与用の調製に関しては、本発明の化合物の滅菌製薬、又は該化合物を形成する適切な可溶性塩を、注射用水(Water-for-Injection (ＷＦＩ))、生理食塩水又は５％グルコース等の医薬用希釈剤に溶解し、投与することができる。該化合物の適当な不溶性の形態を、オレイン酸エステル等の長鎖脂肪酸のエステル等の水性の基剤又は薬学的に許容される油性の基剤に懸濁した懸濁液として、調製し、投与してもよい。
</span>Parenteral dosage forms can take the form of aqueous or non-aqueous isotonic sterile injection solutions or suspensions. These solutions or suspensions can be prepared from sterile powders or microparticles with one or more carriers as described for use in dosage forms for oral administration. The compound can be dissolved in polyethylene glycol, propylene glycol, ethanol, corn oil, benzyl alcohol, sodium chloride, and / or various buffers. <br class="style-scope patent-text"> For preparation for intramuscular administration, sterile pharmaceutical preparations of the compounds of the invention, or suitable soluble salts forming the compounds, such as water-for-injection (WFI), saline or 5% glucose, etc. And can be administered in a pharmaceutical diluent. A suitable insoluble form of the compound is prepared and administered as a suspension in an aqueous base such as an ester of a long chain fatty acid such as an oleate or a pharmaceutically acceptable oil base. May be.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  局所的な使用に関しては、本発明の化合物を、皮膚、鼻又はのどの粘膜への塗布に適する形で調製することもできる。また、クリーム、軟膏、液体スプレー若しくは吸入剤、薬用ドロップ、又はのど用塗布剤(throat paints)の形をとることができる。有効成分の表面への浸透を促進するために、これらの局所的な剤形には、更にジメチルスルホキシド（ＤＭＳＯ）等の化合物が含まれる。
</span>
&nbsp;&nbsp;For topical use, the compounds of the present invention can also be prepared in a form suitable for application to the skin, nose or throat mucosa. It can also take the form of creams, ointments, liquid sprays or inhalants, medicinal drops, or throat paints. These topical dosage forms further include compounds such as dimethyl sulfoxide (DMSO) to facilitate penetration of the active ingredient into the surface.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  眼又は耳への使用に関しては、本発明の化合物は、軟膏、クリーム、ローション、塗付剤、又は粉剤等のような疎水性又は親水性の基剤に処方された、液体又は半流動状の形を呈することができる。
</span>
&nbsp;&nbsp;For eye or ear use, the compounds of the present invention are liquid or semi-fluid formulated into hydrophobic or hydrophilic bases such as ointments, creams, lotions, smears, powders, etc. It can take on a shape.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  直腸の投与に関しては、本発明の化合物を、ココアバター、ワックス、又は他のグリセリド等の従来のキャリアと混合した座薬の形で投与することができる。
</span>
&nbsp;&nbsp;For rectal administration, the compounds of the invention can be administered in the form of suppositories mixed with a conventional carrier such as cocoa butter, wax or other glycerides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  或いは、本発明の化合物を、送達時に適当な薬学的に許容されるキャリアに溶かすために粉末の形とすることもできる。別の実施の形態においては、該化合物の投与単位の形態を、該化合物又はその塩の溶液が、適切な滅菌された希釈剤に添加され、密封アンプルに入れられた状態とすることができる。
</span>
&nbsp;&nbsp;Alternatively, the compounds of the present invention can be in powder form for dissolution in a suitable pharmaceutically acceptable carrier at the time of delivery. In another embodiment, the dosage unit form of the compound may be such that a solution of the compound or salt thereof is added to a suitable sterilized diluent and placed in a sealed ampoule.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １投与単位中の本発明の化合物の量には、少なくとも本発明の１つの活性化合物の治療に効果的な量が含まれるが、これは、投与対象、投与経路、及び投与頻度によって変化する。投与対象とは、プラント(plant)、細胞培養物、又は羊若しくはヒトを含む哺乳動物等の動物をいう。
</span>
&nbsp;&nbsp;The amount of a compound of the invention in a dosage unit includes an amount effective to treat at least one active compound of the invention, but this will vary with the subject administered, the route of administration and the frequency of administration. The subject of administration refers to plants, cell cultures, or animals such as mammals including sheep or humans.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明のかかる実施の形態に関して、本明細書に開示された新規組成物を、薬学的に許容されるキャリアに配置し、公知の薬物伝達方法に従って、投与対象（ヒトの対象を含む）に伝達する。一般に、本発明の組成物をインビボで伝達する本発明の方法では、当該分野で認められた薬剤の伝達プロトコルを使用する。その際行われる唯一の実質的なプロトコルの修正は、当該分野で認められたプロトコルに従い本発明の化合物を薬剤で置換することである。
</span>
&nbsp;&nbsp;With respect to such embodiments of the present invention, the novel compositions disclosed herein are placed in a pharmaceutically acceptable carrier and delivered to an administered subject (including a human subject) according to known drug delivery methods. To do. In general, the methods of the invention for delivering the compositions of the invention in vivo use art recognized drug delivery protocols. The only substantial protocol modification that is made is to replace the compounds of the invention with drugs according to protocols recognized in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  同様に、培地で細胞を処理するために、特許を請求している組成物を使用する方法は、例えば細胞培地の細菌汚染を除去する又は細菌汚染のレベルを低下するために、抗菌剤で細胞培地を処理するための当該分野で認められたプロトコルを使用する。その際行われる唯一の実質的な手続きの修正は、当該分野で認められたプロトコルで、使用した薬剤で本発明の化合物を置換することである。
</span>
&nbsp;&nbsp;Similarly, methods of using the claimed composition to treat cells with media include cells with antibacterial agents, eg, to remove bacterial contamination of the cell culture media or to reduce the level of bacterial contamination. Use art-recognized protocols for processing the media. The only substantial procedural modification that is made is to replace the compounds of the present invention with the drugs used in an art-recognized protocol.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物は、細菌感染、前癌状態又は癌疾患、及び急性炎症疾患または慢性炎症疾患を治療する方法を提供する。本明細書に使用されるように、「投与単位」なる語は、望ましい治療反応を誘発する、本発明の化合物の治療に効果的な量に関する。本明細書に使用されるように、「治療に効果的な量」なるフレーズは、細菌感染、炎症疾患、又は前癌状態若しくは癌疾患の発症を予防する、症状を軽減させる、又は進行を停止する、本発明の化合物の量を意味する。「治療する」なる語は、細菌感染、炎症又は前癌状態若しくは癌疾患の発生の予防と、細菌感染、炎症又は前癌状態又は癌疾患のコントロール又は除去とを目的として、治療に効果的な量の本発明の化合物の少なくとも１つを対象に投与することであると定義される。「望ましい治療反応」なる語は、患者の細菌疾患若しくは炎症疾患、又は前癌状態若しくは癌疾患が逆転する、阻害される、又は予防されるように、本発明の化合物で患者を治療することに関する。
</span>
&nbsp;&nbsp;The compounds of the present invention provide methods for treating bacterial infections, pre-cancerous conditions or cancer diseases, and acute or chronic inflammatory diseases. As used herein, the term “dosage unit” relates to a therapeutically effective amount of a compound of the invention that elicits a desired therapeutic response. As used herein, the phrase “therapeutically effective amount” refers to preventing, reducing, or stopping progression of a bacterial infection, inflammatory disease, or precancerous or cancerous disease. Means the amount of the compound of the invention. The term “treat” is effective for the purpose of preventing bacterial infection, inflammation or the development of precancerous or cancerous diseases and controlling or eliminating bacterial infection, inflammation or precancerous or cancerous diseases. Defined as administering to a subject an amount of at least one of the compounds of the invention. The term “desired therapeutic response” relates to treating a patient with a compound of the invention such that the patient's bacterial or inflammatory disease, or pre-cancerous or cancerous disease is reversed, inhibited or prevented. .
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物を１日に１回又は数回投与することができる。治療計画において数日又は２〜４週間等の長期間にわたる投与が必要となる場合もある。１回の投与量又は全投与量は、病状の種類又は程度、投与対象の年齢及び一般的な健康状態、投与対象の該化合物に対する耐性及び細菌感染若しくは炎症疾患の種類、又は癌の種類によって変わる。<br class="style-scope patent-text">
本発明による化合物を、患者又は動物の食事又は飼料に投与してもよい。動物の食餌は、該化合物を添加することができる通常の食餌とすることもできるし、プリミックスに該化合物を添加することもできる。
</span>The compounds of the invention can be administered once or several times daily. Treatment regimens may require administration over extended periods such as days or 2-4 weeks. A single dose or total dose will vary depending on the type or extent of the condition, the age and general health of the subject, the tolerance of the subject to the compound and the type of bacterial infection or inflammatory disease, or the type of cancer. . <br class="style-scope patent-text"> The compounds according to the invention may be administered to the diet or feed of a patient or animal. The animal diet can be a normal diet to which the compound can be added, or the compound can be added to the premix.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物を、治療を必要とする患者を治療するために、公知の臨床的に承認された抗生物質、炎症剤又は抗癌剤を組み合わせて摂取してもよいし、又はこれらと別々に摂取してもよい。
</span>
&nbsp;&nbsp;The compounds of the present invention may be taken in combination with or separately from known clinically approved antibiotics, inflammatory agents or anticancer agents to treat patients in need of treatment. May be.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
VII.  <u class="style-scope patent-text">腫瘍の増殖の阻害方法</u> <br class="style-scope patent-text">
  別の実施の形態において、本発明は腫瘍の増殖を阻害する方法に関する。本明細書に記載する化合物は、抗腫瘍活性を有することができる。該化合物は、白血病細胞、メラノーマ細胞、乳癌細胞、肺癌細胞、すい臓癌細胞、卵巣癌細胞、腎臓癌細胞、結腸癌細胞、前立腺癌細胞、及びグリオーマ細胞等の、哺乳動物の腫瘍細胞に対して有効である。本発明の抗腫瘍方法によって、腫瘍細胞が阻害される。「阻害」なる語は、抗腫瘍方法と共に用いられる場合は、腫瘍細胞の抑制、死滅、静止、又は破壊に関する。抗腫瘍方法によって、腫瘍細胞の侵入活性や関連する転移が好ましく予防される、減少する又は除去される。「効果的な量」なる語は、抗腫瘍方法と共に用いられる場合は、哺乳動物の腫瘍細胞を阻害するために十分な化合物の量に関する。
</span>VII. <u class="style-scope patent-text">Method for Inhibiting Tumor Growth In</u> another embodiment, the present invention relates to a method for inhibiting tumor growth. The compounds described herein can have antitumor activity. The compounds are directed against mammalian tumor cells such as leukemia cells, melanoma cells, breast cancer cells, lung cancer cells, pancreatic cancer cells, ovarian cancer cells, kidney cancer cells, colon cancer cells, prostate cancer cells, and glioma cells. It is valid. Tumor cells are inhibited by the antitumor method of the present invention. The term “inhibition”, when used in conjunction with an anti-tumor method, relates to tumor cell suppression, death, quiescence, or destruction. Anti-tumor methods preferably prevent, reduce or eliminate tumor cell invasion activity and related metastases. The term “effective amount” when used in conjunction with an anti-tumor method relates to the amount of compound sufficient to inhibit mammalian tumor cells.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本方法による哺乳動物の腫瘍増殖の阻害を、いくつかの方法で観察することができる。第一に、該化合物を用いてインビトロで増殖した腫瘍細胞を治療し、該化合物を使用せずに培養した同じ細胞と比較して、増殖又は死滅を観察することができる。増殖が休止すること又は例えば１０％以上増殖速度が減速（すなわち倍速）することは、腫瘍細胞が阻害されたことを示している。或いは、目的の腫瘍の動物モデルに該化合物を投与することによって、腫瘍細胞の阻害を観察することができる。実験動物腫瘍モデルは当分野に公知であり、本明細書の実施例に記載される。該化合物で治療されていないコントロール動物と比較して、本明細書に記載された化合物を用いて治療した動物において、腫瘍の増殖が休止すること（すなわちそれ以上サイズが大きくならない）又は腫瘍の大きさ（すなわち腫瘍の容積）又は細胞数（例えば、少なくとも１０％減少）のいずれかが減少することは、腫瘍増殖が阻害されたことを示している。
</span>
&nbsp;&nbsp;Inhibition of mammalian tumor growth by this method can be observed in several ways. First, tumor cells grown in vitro with the compound can be treated and observed to grow or die compared to the same cells cultured without the compound. A cessation of growth or a slowing (ie, doubling) of the growth rate, eg, by more than 10%, indicates that the tumor cells have been inhibited. Alternatively, tumor cell inhibition can be observed by administering the compound to an animal model of the tumor of interest. Experimental animal tumor models are known in the art and are described in the Examples herein. Tumor growth ceases (ie, does not increase in size further) or tumor size in animals treated with the compounds described herein compared to control animals not treated with the compound A decrease in either (ie, tumor volume) or cell number (eg, at least a 10% reduction) indicates that tumor growth has been inhibited.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ヒトでの腫瘍治療の有効性を観察するために、治療の開始前後に腫瘍の大きさ又は腫瘍細胞価を測定し、腫瘍の大きさ又は腫瘍細胞価のいずれかがそれ以上成長をしていない場合、又は腫瘍の大きさ又は腫瘍細胞価が、例えば少なくとも１０％以上（例えば２０％、３０％、４０％、５０％、６０％、７０％、８０％、９０％又は１００％、すなわち腫瘍が消滅）減少する場合は、治療が効果的であるとみなされる。インビボの腫瘍の大きさ又は腫瘍細胞価を測定する方法は、腫瘍の種類によって変わり、該方法には、組織学的技術及びフローサイトメトリーだけでなく、例えば、医学画像又は内科的腫瘍学の分野の当業者には公知である様々なイメージング技術（ＭＲＩ、ＣＡＴ、ＰＥＴ等）が含まれる。<br class="style-scope patent-text">
本発明の抗腫瘍方法に関しては、経口で又は非経口で投与される該化合物の効果的な投与量は一般的に、対象の体重の約５〜約１００ｍｇ／ｋｇであり、１日の投与量は対象の体重の約１５〜約３００ｍｇ／ｋｇである。
</span>To observe the effectiveness of tumor treatment in humans, measure tumor size or tumor cell titer before and after initiation of treatment, and either tumor size or tumor cell titer has not grown further Or if the tumor size or tumor cell value is at least 10% or more (eg 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or 100%) If (decrease) decreases, the treatment is considered effective. Methods for measuring tumor size or tumor cell value in vivo vary with the type of tumor and include not only histological techniques and flow cytometry, but also, for example, the field of medical imaging or medical oncology Various imaging techniques (MRI, CAT, PET, etc.) known to those skilled in the art are included. <br class="style-scope patent-text"> With respect to the antitumor methods of the present invention, the effective dosage of the compound administered orally or parenterally is generally about 5 to about 100 mg / kg of the subject's body weight, and the daily dosage Is about 15 to about 300 mg / kg of the subject's body weight.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
VIII.  <u class="style-scope patent-text">リポキシゲナーゼの阻害方法</u> <br class="style-scope patent-text">
  別の実施の形態において、本発明は、哺乳動物、特にヒトの患者の罹患状態、特に５−リポキシゲナーゼ系及び／又はロイコトリエンＢ<sub class="style-scope patent-text">４</sub>並びにロイコトリエンＣ<sub class="style-scope patent-text">４</sub>、Ｄ<sub class="style-scope patent-text">４</sub>、Ｅ<sub class="style-scope patent-text">４</sub>及びＦ<sub class="style-scope patent-text">４</sub>の合成に起因する炎症を治療する方法も提供する。かかる方法には、効果的な量のＥＣＯ−０４６０１を患者に投与することが含まれる。肺の異常、炎症、心臓血管の異常、中枢神経系の異常又は皮膚の異常を含む炎症に関する罹患状態を治療又は予防するために、化合物ＥＣＯ−０４６０１を単独で使用してもよく、他の抗炎症化合物と組み合わせて使用してもよい。更に具体的な疾患には、胃炎、びらん性食道炎、炎症性腸疾患、エタノールによる出血性びらん、肝虚血、虚血性神経細胞障害(ischemic neuronal injury)、有害物質による肝臓、膵臓、腎臓、神経細胞若しくは心筋組織の障害或いは壊死、ＣＣｌ<sub class="style-scope patent-text">４</sub>及びＤ−ガラクトサミン等の肝臓に有害な物質による(hapatoxic agent)肝実質障害、虚血性腎不全、疾患による肝障害、トラウマ又はストレスによる細胞障害、ぜんそく、多発性硬化症、虚血再潅流、水腫、関節リウマチ、ウイルス性脳炎、細菌性肺炎、神経変性、アルツハイマー病及びグリセロールによる腎不全が含まれる。
</span>VIII in. <u class="style-scope patent-text">How</u> another embodiment <u class="style-scope patent-text">inhibition of lipoxygenase,</u> the present invention is a mammal, in particular diseased condition of the human patient, in particular 5-lipoxygenase system and / or leukotriene B <sub class="style-scope patent-text">4</sub> and leukotriene C <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">4,</sub> </sub> </sub> D <sub class="style-scope patent-text">4,</sub> E <sub class="style-scope patent-text">4</sub> and method of treating inflammation caused by the synthesis of F <sub class="style-scope patent-text">4</sub> is also provided. Such methods include administering to the patient an effective amount of ECO-04601. Compound ECO-04601 may be used alone to treat or prevent morbidity related to inflammation, including pulmonary abnormalities, inflammation, cardiovascular abnormalities, central nervous system abnormalities or skin abnormalities. It may be used in combination with an inflammatory compound. More specific diseases include gastritis, erosive esophagitis, inflammatory bowel disease, hemorrhagic erosion due to ethanol, liver ischemia, ischemic neuronal injury, liver due to harmful substances, pancreas, kidney, failure or neuronal necrosis or myocardial tissue, CCl <sub class="style-scope patent-text">4</sub> and D- galactosamine like liver harmful substances by (hapatoxic agent) liver parenchyma disorders, ischemic renal failure, liver damage due to disease, trauma or stress due to cell damage, asthma , Multiple sclerosis, ischemia reperfusion, edema, rheumatoid arthritis, viral encephalitis, bacterial pneumonia, neurodegeneration, Alzheimer's disease and renal failure due to glycerol.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ５−リポキシゲナーゼ系及び／又はロイコトリエンの生合成に関する本発明の方法については、経口で又は非経口で投与されるＥＣＯ−０４６０１の効果的な投与量は一般的に、対象の体重の約５〜約１００ｍｇ／ｋｇであり、１日の投与量は対象の体重の約１５〜３００ｍｇ／ｋｇである。
</span>
&nbsp;&nbsp;For the methods of the invention relating to the 5-lipoxygenase system and / or leukotriene biosynthesis, an effective dosage of ECO-04601 administered orally or parenterally is generally about 5 to about the body weight of the subject. 100 mg / kg, and the daily dose is about 15-300 mg / kg of the subject's body weight.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  リポキシゲナーゼ酵素の阻害は、本明細書の実施例に記載されるように、当分野で公知の方法によって観察される。本明細書に記載される化合物を含まない場合の活性と比較して、酵素活性が少なくとも１０％低下することは、リポキシゲナーゼ活性が効果的に阻害されることを示している。
</span>
&nbsp;&nbsp;Inhibition of the lipoxygenase enzyme is observed by methods known in the art, as described in the examples herein. A decrease in enzyme activity of at least 10% compared to the activity without the compounds described herein indicates that lipoxygenase activity is effectively inhibited.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明による有用なファルネシルジベンゾジアゼピノン化合物を使用して、炎症を軽減又は予防することができる。局所的な急性炎症の顕著な特徴には、熱、発赤、腫れ、痛み及び機能の喪失が含まれる。これらの変化の多くは、血流や血管内径の変化、血管透過性や白血球の浸出(leukocyte exudation)の変化によって誘発される(Robbins et al., “Pathologic Basis of Disease”, 6<sup class="style-scope patent-text">th</sup> Ed., W.B. Saunders Co., Philadelphia, PA)。本発明の有用な化合物を用いて行われる抗炎症療法は、これらの変化のいずれかを追跡することによって、その治療の成功を観察することができる。例えば、腫れの減少（例えば、治療後少なくとも１０％減少）、又は報告された痛み（例えば、本疾病に関連して治療前に感じた最もひどい痛みを１０、痛みがない場合を０をとする１〜１０段階で、患者から報告された痛みが１ポイント以上持続して減少）を使用して、治療の成功を示すことができる。
</span>Useful farnesyl dibenzodiazepinone compounds according to the present invention can be used to reduce or prevent inflammation. Prominent features of local acute inflammation include fever, redness, swelling, pain and loss of function. Many of these changes are induced by changes in blood flow, vascular inner diameter, vascular permeability and leukocyte exudation (Robbins et al., “Pathologic Basis of Disease”, 6 <sup class="style-scope patent-text">th</sup> Ed., WB Saunders Co., Philadelphia, PA). Anti-inflammatory therapies performed with the useful compounds of the present invention can observe the success of the treatment by following any of these changes. For example, reduced swelling (eg, at least 10% reduction after treatment), or reported pain (eg, 10 most severe pain felt before treatment in connection with the disease, 0 if no pain) In steps 1-10, the pain reported by the patient can be used to indicate a successful treatment using a sustained decrease of 1 point or more.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他の測定可能な炎症の特徴には、白血球湿潤と炎症性サイトカインレベルとが含まれる。これらの特徴は、罹患組織の生検によって観察することができる。固定され、着色された組織における白血球湿潤が、治療前の同様の組織における湿潤と比較して１０％以上の減少している場合は、治療が効果的であることを示す。同様に、所定の炎症性サイトカインのレベルが、治療前のレベルと比較して１０％以上減少している場合も、治療が有効であることを示す。当業者であれば、組織、血液、又は他の液体サンプルの炎症性サイトカインのレベルについて容易に分析することができる。或いは、Ｃ反応タンパク質レベル及び赤血球沈澱率等の全身の炎症のインジケーターのレベルを観察することができる。これらによっては薬剤の正常の範囲がそれぞれ確立され、治療開始後に、これらのインジケーターの１又は２以上が異常範囲から正常範囲となる場合、治療は成功したとみなされる。
</span>
&nbsp;&nbsp;Other measurable inflammatory features include leukocyte wetting and inflammatory cytokine levels. These features can be observed by biopsy of the affected tissue. A leukocyte wetting in fixed and colored tissue is reduced by more than 10% compared to wetting in similar tissue prior to treatment, indicating that the treatment is effective. Similarly, if the level of a given inflammatory cytokine is reduced by 10% or more compared to the pre-treatment level, this indicates that the treatment is effective. One skilled in the art can readily analyze the levels of inflammatory cytokines in tissue, blood, or other fluid samples. Alternatively, systemic inflammation indicator levels such as C-reactive protein levels and erythrocyte sedimentation rates can be observed. Each of these establishes a normal range of drug, and after one or more of these indicators change from an abnormal range to a normal range after the start of treatment, the treatment is considered successful.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">IX. 細菌増殖を阻害する方法</u> <br class="style-scope patent-text">
  別の実施の形態において、本発明は、治療を必要とする哺乳動物の対象において細菌感染を治療する方法に関する。かかる方法は、本明細書に記載される化合物である、化合物ＥＣＯ−０４６０１又は薬学的に許容されるその誘導体若しくはそのプロドラッグを、治療に効果的な量哺乳動物に投与するステップを含む。
</span> <u class="style-scope patent-text">IX. Methods of Inhibiting Bacterial Growth In</u> another embodiment, the invention relates to a method of treating a bacterial infection in a mammalian subject in need of treatment. Such methods comprise administering to the mammal a therapeutically effective amount of a compound described herein, Compound ECO-04601, or a pharmaceutically acceptable derivative or prodrug thereof.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施の形態において、本発明は、生体サンプルにおける細菌量を減少させる方法を提供する。かかる方法は、本明細書に記載された化合物であるＥＣＯ−０４６０１、又は薬学的に許容されるその誘導体若しくはそのプロドラッグに、生体サンプルを接触させるステップを含む。本明細書に記載された化合物であるを化合物ＥＣＯ−０４６０１、又は薬学的に許容されるその誘導体若しくはそのプロドラッグに、生体サンプルを接触させた後、少なくとも１０％、好ましくは１０％より多く、例えば２５％、５０％、又は１００％までも、細菌数が減少する場合、かかる方法は効果的である。
</span>
&nbsp;&nbsp;In another embodiment, the present invention provides a method for reducing the amount of bacteria in a biological sample. Such methods comprise contacting a biological sample with ECO-04601, a compound described herein, or a pharmaceutically acceptable derivative or prodrug thereof. At least 10%, preferably more than 10% after contacting the biological sample with compound ECO-04601, or a pharmaceutically acceptable derivative or prodrug thereof, which is a compound described herein. Such a method is effective when the bacterial count is reduced by, for example, 25%, 50%, or even 100%.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  細菌量の減少を測定できる程十分な量の、本明細書に記載される化合物であるＥＣＯ−０４６０１、又は薬学的に許容されるその誘導体若しくはそのプロドラッグ、及び薬学的に許容されるキャリアを含む、細菌感染の治療又は予防に有効なこれらの医薬組成物は、本発明の別の実施の形態である。本明細書に用いられる「細菌量の減少を測定できる程十分な」なる語は、阻害剤を含むサンプルと阻害剤を含まないサンプルとの間の細菌数の測定可能な変化を意味する。
</span>
&nbsp;&nbsp;ECO-04601, a compound described herein, or a pharmaceutically acceptable derivative or prodrug thereof, and a pharmaceutically acceptable carrier in an amount sufficient to determine a reduction in bacterial mass. These pharmaceutical compositions effective for treating or preventing bacterial infections are another embodiment of the present invention. As used herein, the term “sufficient to measure a reduction in bacterial load” means a measurable change in the number of bacteria between a sample with an inhibitor and a sample without an inhibitor.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  細菌性生物の抗生物質に対する感受性を増加させる薬剤は公知である。例えば、米国特許第５，５２３，２８８号、米国特許第５，７８３，５６１号及び米国特許第６，１４０，３０６号は、グラム陽性菌及びグラム陰性菌の抗生物質感受性を増加させるために殺菌性/透過性亢進タンパク質（ＢＰＩ）を用いる方法を記載している。細菌性生物の外膜の透過性を亢進させる薬剤は、Vaara, M. in Microbiological Reviews (1992) pp. 395-411に記載され、グラム陰性菌の感化は、Tsubery, H., et al, in J. Med. Chem. (2000) pp. 3085-3092に記載されている。
</span>
&nbsp;&nbsp;Agents that increase the susceptibility of bacterial organisms to antibiotics are known. For example, US Pat. No. 5,523,288, US Pat. No. 5,783,561 and US Pat. No. 6,140,306 are sterilized to increase the antibiotic susceptibility of gram positive and gram negative bacteria. Describes a method of using enhanced permeability / permeability protein (BPI). Agents that increase the permeability of the outer membrane of bacterial organisms are described in Vaara, M. in Microbiological Reviews (1992) pp. 395-411, and sensitization of gram-negative bacteria is described in Tsubery, H., et al, in J. Med. Chem. (2000) pp. 3085-3092.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  細菌に感染した対象の治療に関する本発明の方法に関して、経口で又は非経口で投与される本明細書に記載された化合物ＥＣＯ−０４６０１、又は薬学的に許容されるその誘導体若しくはそのプロドラッグの有効な投与量は一般的に、対象の体重の約５〜約１００ｍｇ／ｋｇであり、１日の投与量は対象の体重の約１５〜３００ｍｇ／ｋｇである。
</span>
&nbsp;&nbsp;Effectiveness of Compound ECO-04601 described herein, or a pharmaceutically acceptable derivative or prodrug thereof, administered orally or parenterally with respect to the methods of the invention for the treatment of subjects infected with bacteria A typical dosage is about 5 to about 100 mg / kg of the subject's body weight, and a daily dosage is about 15 to 300 mg / kg of the subject's body weight.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の好ましい実施の形態は、上述のように、治療を必要とする哺乳動物において細菌感染を治療する方法に関する。しかし、かかる実施の形態は、抗生物質に対する細菌性生物の感受性を亢進する薬剤を、哺乳動物に投与するステップを更に含む。
</span>
&nbsp;&nbsp;Another preferred embodiment of the invention relates to a method of treating a bacterial infection in a mammal in need of treatment, as described above. However, such embodiments further comprise the step of administering to the mammal an agent that enhances the susceptibility of the bacterial organism to the antibiotic.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の好ましい実施の形態によれば、本発明は、上述のように、生体サンプルにおいて細菌量を減少させる方法を提供する。しかし、かかる実施の形態は、抗生物質に対する細菌性生物の感受性を亢進する薬剤に、生体サンプルを接触させるステップを更に含む。
</span>
&nbsp;&nbsp;According to another preferred embodiment, the present invention provides a method for reducing the amount of bacteria in a biological sample, as described above. However, such embodiments further comprise contacting the biological sample with an agent that enhances the susceptibility of the bacterial organism to antibiotics.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に記載する化合物である化合物ＥＣＯ−０４６０１、又は薬学的に許容されるその誘導体若しくはそのプロドラッグに生検サンプルを接触させた後、少なくとも１０％、好ましくは１０％より多く、例えば２５％、５０％、７５％、又は１００％等、細菌数が減少する場合は、細菌量を減少させる方法は効果的である。
</span>
&nbsp;&nbsp;After contacting the biopsy sample with compound ECO-04601, a pharmaceutically acceptable derivative or prodrug thereof, which is a compound described herein, at least 10%, preferably more than 10%, such as 25 When the number of bacteria decreases, such as%, 50%, 75%, or 100%, a method of reducing the amount of bacteria is effective.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の医薬組成物及び方法は、一般的に、インビボでの細菌感染のコントロールに有用である。本発明の組成物及び方法でコントロールされる可能性のある細菌性生物の例には、Streptococcus pneumoniae、Streptococcus pyrogenes、Enterocuccus facalis、Enterococcus faecium、Klebsiella pneumoniae、Enterobacter spp., Proteus spp., Pseudomonas aeruginosa、E.coli、Serratia marcesens、Staphylococcus aureus、Coagulase negative Staphylococcus、Haemophilus infuenzae、Bacillus anthracis、Mycroplasma pneumoniae及びStaphylococcus epidermidisが含まれるが、これらに限定されない。したがって、該組成物及び方法は、院内又は院外感染の進行、程度、又は影響をコントロール、治療又は低下させる際に有効である。院内での使用には、尿道管感染、肺炎、手術創感染、菌血症、及び発熱性好中球減少症の患者が含まれるが、これらに限定されない。院外での使用には、尿道管感染、肺炎、前立腺炎、皮膚感染症、軟部組織感染症、及び腹腔内感染症が含まれるが、これらに限定されない。
</span>
&nbsp;&nbsp;The pharmaceutical compositions and methods of the invention are generally useful for controlling bacterial infection in vivo. Examples of bacterial organisms that may be controlled with the compositions and methods of the present invention include Streptococcus pneumoniae, Streptococcus pyrogenes, Enterocuccus facalis, Enterococcus faecium, Klebsiella pneumoniae, Enterobacter spp., Proteus spp., Pseudomonas aeruginosa, E .coli, Serratia marcesens, Staphylococcus aureus, Coagulase negative Staphylococcus, Haemophilus infuenzae, Bacillus anthracis, Mycroplasma pneumoniae and Staphylococcus epidermidis. Thus, the compositions and methods are effective in controlling, treating or reducing the progression, extent, or impact of nosocomial or out-of-hospital infections. In-hospital use includes, but is not limited to, patients with urethral infection, pneumonia, surgical wound infection, bacteremia, and febrile neutropenia. Out-of-hospital use includes, but is not limited to, ureteral infections, pneumonia, prostatitis, skin infections, soft tissue infections, and intraperitoneal infections.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物に加え、本発明の薬学的に許容される誘導体又はプロドラッグが、上述の疾患を治療又は予防するための組成物に使用されることもある。
</span>
&nbsp;&nbsp;In addition to the compounds of the present invention, the pharmaceutically acceptable derivatives or prodrugs of the present invention may be used in compositions for treating or preventing the above-mentioned diseases.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  「薬学的に許容される誘導体又はプロドラッグ」は、本発明の化合物の薬学的に許容される塩、エステル、エステルの塩又は他の誘導体を意味し、これらは受容体に投与される場合に、本発明の化合物又は阻害的な活性代謝生成物若しくはその残基を直接的又は間接的に提供することができる。これらの化合物を哺乳動物に使用する場合に（例えば、経口投与される化合物を、より血液中に吸収されやすくすることによって）、又は親種と比較して、化合物が、生物コンパートメント（例えば、脳又はリンパ系）への親化合物の伝達を亢進する場合に、特に好ましい誘導体又はプロドラッグは、本発明の化合物の生物学的利用率を増加させる誘導体又はプロドラッグである。
</span>
&nbsp;&nbsp;“Pharmaceutically acceptable derivative or prodrug” means a pharmaceutically acceptable salt, ester, ester salt or other derivative of a compound of the invention when administered to a receptor. The compounds of the present invention or inhibitory active metabolites or residues thereof can be provided directly or indirectly. When these compounds are used in mammals (eg, by making the orally administered compound more readily absorbed into the blood) or compared to the parent species, the compound is in a biological compartment (eg, brain A particularly preferred derivative or prodrug when enhancing the transmission of the parent compound to the lymphatic system) is a derivative or prodrug that increases the bioavailability of the compound of the invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の化合物の薬学的に許容されるプロドラッグには、エステル、アミノ酸エステル、リン酸エステル、金属塩及び硫酸エステルが含まれるが、これらに限定されない。<br class="style-scope patent-text">
特別な記載がない限り、明細書及び請求の範囲に使用される分子量、反応条件、ＩＣ<sub class="style-scope patent-text">５０</sub>等の材料の量又は属性を示す数字はすべて、全ての例において「約」なる語によって修正されることが理解されるであろう。したがって、矛盾する記載がない限り、本明細書及び添付の請求の範囲に示される数値変数は、近似値である。少なくとも、均等論の適用を請求の範囲に限定しようとするのではなく、それぞれの数値変数を、少なくとも通常の四捨五入の技術を適用して、また有効数字の数に照らして解釈しなくてはならない。本発明の広い範囲を示す数値の範囲と数値変数は近似値であるが、実施例、表及び図に示された数値はできるだけ正確に記載されている。あらゆる数値には、実験、試験の測定、統計分析等の変動性から生じる特定のエラーが本質的に含まれている。
</span>Pharmaceutically acceptable prodrugs of the compounds of this invention include, without limitation, esters, amino acid esters, phosphate esters, metal salts and sulfate esters. <br class="style-scope patent-text"> Unless indicated otherwise, all numbers indicating molecular weights, reaction conditions, material amounts or attributes such as IC <sub class="style-scope patent-text">50</sub> used in the specification and claims are modified by the word “about” in all examples. It will be understood. Accordingly, unless indicated to the contrary, the numerical variables set forth in this specification and the appended claims are approximations. Rather than trying to limit the application of the doctrine to the claims, each numeric variable must be interpreted at least using the usual rounding technique and in light of the number of significant figures. . The numerical ranges and numerical variables indicating the wide range of the present invention are approximate values, but the numerical values shown in the examples, tables and figures are described as accurately as possible. Every numerical value inherently contains certain errors resulting from variability in experiments, test measurements, statistical analysis, etc.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  特別な規定がない限り、本明細書に使用される技術用語及び科学用語はすべて、本発明の属する分野の通常の当業者によって共通して理解されるものと同一の意味を有する。本発明に記載される方法及び材料と同様又は同等の方法及び材料を本発明の実施又はテストに使用することができるが、適当な方法及び材料を下記に記載する。刊行物、特許出願、特許及び本明細書に示される他の引用文献はすべて、参照することによって全体として本明細書に組み込まれる。矛盾する場合は、定義を含め、本明細書による。更に、材料、方法、及び実施例は例示に過ぎず、これらに限定するためのものではない。
</span>
&nbsp;&nbsp;Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described in the present invention can be used in the practice or testing of the present invention, suitable methods and materials are described below. All publications, patent applications, patents and other references cited herein are hereby incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">実施例１：生成培養物の調製</u> <br class="style-scope patent-text">
特別な記載がない限り、すべての試薬をSigma Chemical社(St. Louis, MO), (Aldrich)から購入した。Micromonospora spp.（ＩＤＡＣ寄託アクセッション番号第０７０３０３−０１）をＩＳＰ２アガー(Difco Laboratories, Detroit, MI)のアガープレートに維持した。ポテトデキストリン２４ｇ、ビーフ抽出物３ｇ、バクトカジトン５ｇ、グルコース５ｇ、酵母エキス５ｇ、及びＣａＣＯ<sub class="style-scope patent-text">３</sub>４ｇからなり、蒸留水を加えて１リットルにした無菌培地２５ｍＬ（ｐＨ７．０）を含む１２５ｍＬのフラスコに、アガープレートから、表面に増殖したMicromonospora spp.を転移することによって、生成期(production phase)の接種源を調製した。約２８℃で約６０時間、２５０ｒｐｍに設定した回転式振とう培養機で培養物を培養した。培養後、ポテトデキストリン２０ｇ／Ｌ、グリセロール２０ｇ／Ｌ、魚粉１０ｇ／Ｌ、バクトペプトン５ｇ／Ｌ、ＣａＣＯ<sub class="style-scope patent-text">３</sub>２ｇ／Ｌ、及び（ＮＨ<sub class="style-scope patent-text">４</sub>）<sub class="style-scope patent-text">２</sub>ＳＯ<sub class="style-scope patent-text">４</sub>２ｇ／Ｌを含有するｐＨ７．０の無菌産生培地５００ｍＬを含む２Ｌのバッフルフラスコに、培養物１０ｍＬを移した。２５０ｒｐｍに設定した回転式振とう培養機で生成培養物を２８℃で１週間培養して、発酵ブロスを調製した。
</span> <u class="style-scope patent-text">Example</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">Example 1: Production culture preparation</u> All reagents were purchased from Sigma Chemical (St. Louis, MO), (Aldrich) unless otherwise stated. Micromonospora spp. (IDAC deposit accession number 070303-01) was maintained on an agar plate of ISP2 agar (Difco Laboratories, Detroit, MI). A 125 mL flask containing 24 mL of potato dextrin, 3 g of beef extract, 5 g of bactocaditone, 5 g of glucose, 5 g of yeast extract, and 4 g of CaCO <sub class="style-scope patent-text">3</sub> , and containing 25 mL of sterile medium (pH 7.0) made up to 1 liter by adding distilled water, A production phase inoculum was prepared by transferring Micromonospora spp. Grown on the surface from an agar plate. The culture was cultured on a rotary shaker set at 250 rpm for about 60 hours at about 28 ° C. After culturing, sterility at pH 7.0 containing 20 g / L of potato dextrin, 20 g / L of glycerol, 10 g / L of fish meal, 5 g / L of bactopeptone, 2 g / L of CaCO <sub class="style-scope patent-text">3 and</sub> 2 g / L of (NH <sub class="style-scope patent-text">4</sub> ) <sub class="style-scope patent-text">2</sub> SO <sub class="style-scope patent-text">4</sub> 10 mL of the culture was transferred to a 2 L baffle flask containing 500 mL of production medium. The production culture was cultured at 28 ° C. for 1 week in a rotary shaker set at 250 rpm to prepare a fermentation broth.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例２：単離</u> <br class="style-scope patent-text">
上述の実施例１に記載したように調製した発酵ブロス５００ｍＬに、エチルアセテート５００ｍＬを添加した。２００ｒｐｍのオービタルシェーカーでかかる混合物を３０分攪拌し、乳濁液を作成した。遠心分離とデカントによって層を分離した。４〜５ｇの無水ＭｇＳＯ<sub class="style-scope patent-text">４</sub>を有機層に添加し、次にろ過して溶媒を真空で除去した。
</span> <u class="style-scope patent-text">Example 2: Isolation To</u> 500 mL of fermentation broth prepared as described in Example 1 above, 500 mL of ethyl acetate was added. The mixture was stirred for 30 minutes with a 200 rpm orbital shaker to prepare an emulsion. The layers were separated by centrifugation and decanting. 4-5 g of anhydrous MgSO <sub class="style-scope patent-text">4</sub> was added to the organic layer, then filtered and the solvent removed in vacuo.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ２Ｌの発酵物由来のエチルアセテート抽出物とＨＰ−２０樹脂（１００ｍＬ；三菱化成株式会社、日本、東京）とを水（３００ｍＬ）に混合した。エチルアセテートを真空で除去し、樹脂をブフナー漏斗でろ過し、ろ液を廃棄した。次に吸収されたＨＰ−２０樹脂を、１２５ｍＬの５０％アセトニトリルを用いて２回、１２５ｍＬの７５％アセトニトリルで２回、それぞれ水中で洗浄し、次に１２５ｍＬのアセトニトリルで２回洗浄した。
</span>
&nbsp;&nbsp;A 2 L fermented ethyl acetate extract and HP-20 resin (100 mL; Mitsubishi Kasei, Tokyo, Japan) were mixed in water (300 mL). The ethyl acetate was removed in vacuo, the resin was filtered through a Buchner funnel and the filtrate was discarded. The absorbed HP-20 resin was then washed twice with 125 mL 50% acetonitrile, twice with 125 mL 75% acetonitrile, each in water, and then twice with 125 mL acetonitrile.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式IIで表される化合物を含むフラクションを乾燥するまで蒸発させ、クロロホルム、シクロヘキサン、メタノール及び水から５：２：１０：５の体積比で調製された混合液の上層液５ｍＬに１００ｍｇを温浸した。２００ｍＬのカートリッジを取り付け、高速向流（ＨＳＣＣ）システム(Kromaton Technologies社製, Angers, France)である二層システムの上層に予め充填したサンプルに、かかるシステムを用いて遠心分配クロマトグラフィーを行った。ＨＳＣＣは低い移動相で行われ、式IIで表される化合物はカラムの容積の約半分で溶出された。フラクションを回収し、市販のKieselgel６０Ｆ<sub class="style-scope patent-text">２５４</sub>プレート上のフラクションのアリコートのＴＬＣによって、式IIで表される化合物を検出した。乾燥したプレートを紫外線下で検査することによって、又はバニリン（０．７５％）と濃硫酸（１．５％、ｖ／ｖ）とをエタノール中に含有するスプレー剤をプレートに噴霧し、続いて該プレートを加熱することによって、化合物を視覚化することができた。フラクションは、かなり着色されているものの、非常に純粋な式IIで表される化合物を含有していた。以下の通り、高速液体クロマトグラフィー（ＨＰＬＣ）で淡黄褐色のサンプルを得ることができた。
</span>The fraction containing the compound represented by Formula II was evaporated to dryness, and 100 mg was digested in 5 mL of the upper layer of a mixture prepared from chloroform, cyclohexane, methanol and water at a volume ratio of 5: 2: 10: 5. did. A 200 mL cartridge was attached and the sample was pre-filled in the upper layer of a bilayer system, a high-speed countercurrent (HSCC) system (Kromaton Technologies, Angers, France), and centrifugal partition chromatography was performed using such a system. HSCC was performed in a low mobile phase and the compound of formula II was eluted at approximately half the column volume. Fractions were collected and the compound of formula II was detected by TLC on aliquots of fractions on commercially available Kieselgel 60F <sub class="style-scope patent-text">254</sub> plates. By inspecting the dried plate under UV light or by spraying the plate with a spray containing vanillin (0.75%) and concentrated sulfuric acid (1.5%, v / v) in ethanol, followed by The compound could be visualized by heating the plate. The fraction, although highly colored, contained very pure compound of formula II. A light tan sample could be obtained by high performance liquid chromatography (HPLC) as follows.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  サンプル６ｍｇをアセトニトリルに溶解し、調整用のＨＰＬＣカラム（ＸＴｅｒｒａ  ＯＤＳ（１０μｍ)、１９×１５０ｍｍ、Waters社製、Milford, MA）に流量９ｍＬ／分、ＵＶピーク検出３００ｎｍで注入した。表１に示す以下のグラジエントで、アセトニトリル／緩衝液（２０ｍＭのＮＨ<sub class="style-scope patent-text">４</sub>ＨＣＯ<sub class="style-scope patent-text">３</sub>）でカラムを溶出した。
</span>6 mg of the sample was dissolved in acetonitrile, and injected into a preparative HPLC column (XTerra ODS (10 μm), 19 × 150 mm, Waters, Milford, Mass.) At a flow rate of 9 mL / min and UV peak detection of 300 nm. The column was eluted with acetonitrile / buffer (20 mM NH <sub class="style-scope patent-text">4</sub> HCO <sub class="style-scope patent-text">3</sub> ) with the following gradient shown in Table 1.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式IIで表される化合物を含有するフラクションを約１１：０分で溶出し、混合し、濃縮し、凍結乾燥し、３．８ｍｇの化合物の収量を得た。
</span>
Fractions containing the compound of Formula II were eluted at about 11: 0 minutes, mixed, concentrated and lyophilized to give a yield of 3.8 mg of compound.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">代替のプロトコル１</u> <br class="style-scope patent-text">
  以下の代替のプロトコルにしたがって、式IIで表される化合物を単離した。培養期間の終わりに、実施例１のバッフルフラスコの発酵ブロスを遠心分離し、細菌の菌糸体を含むペレットから上清をデカントした。１００ｍＬの１００％ＭｅＯＨを菌糸体のペレットに添加し、サンプルを１０分間攪拌し、１５分間遠心分離を行った。メタノール上清をデカントし、取っておいた。次に１００ｍＬのアセトンを菌糸体のペレットに添加し、１０分間攪拌した後、１５分間遠心分離を行った。アセトンの上清をデカントし、メタノール上清と混合した。最後に、１００ｍＬの２０％ＭｅＯＨ／Ｈ<sub class="style-scope patent-text">２</sub>Ｏを菌糸体のペレットに添加し、１０分間攪拌し、１５分間遠心分離を行った。アセトンの上清とメタノールの上清にその上清を混合した。
</span> <u class="style-scope patent-text">Alternative protocol 1</u> <br class="style-scope patent-text"> The compound of formula II was isolated according to the following alternative protocol. At the end of the culture period, the fermentation broth of the baffle flask of Example 1 was centrifuged and the supernatant was decanted from the pellet containing the bacterial mycelium. 100 mL of 100% MeOH was added to the mycelium pellet and the sample was stirred for 10 minutes and centrifuged for 15 minutes. The methanol supernatant was decanted and set aside. Next, 100 mL of acetone was added to the mycelium pellet, stirred for 10 minutes, and then centrifuged for 15 minutes. The acetone supernatant was decanted and mixed with the methanol supernatant. Finally, 100 mL of 20% MeOH / H <sub class="style-scope patent-text">2</sub> O was added to the mycelium pellet, stirred for 10 minutes, and centrifuged for 15 minutes. The supernatant was mixed with the acetone supernatant and the methanol supernatant.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  混合した上清を水１０００ｍＬ中のＨＰ−２０樹脂４００ｍＬに添加し、有機物を真空で除去した。得られたスラリーをブフナー漏斗でろ過し、ろ液を廃棄した。吸収されたＨＰ−２０樹脂を、５００ｍＬの５０％ＭｅＯＨ／Ｈ<sub class="style-scope patent-text">２</sub>Ｏで２回、５００ｍＬの７５％ＭｅＯＨ／Ｈ<sub class="style-scope patent-text">２</sub>Ｏで２回、ＭｅＯＨ５００ｍＬで２回、連続して洗浄した。
</span>The mixed supernatant was added to 400 mL of HP-20 resin in 1000 mL of water and the organics were removed in vacuo. The resulting slurry was filtered through a Buchner funnel and the filtrate was discarded. The absorbed HP-20 resin was washed in succession twice with 500 mL 50% MeOH / H <sub class="style-scope patent-text">2</sub> O, twice with 500 mL 75% MeOH / H <sub class="style-scope patent-text">2</sub> O, and twice with 500 mL MeOH.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  それぞれの洗浄物を別々に回収し、上述のようにＴＬＣによって分析した。式IIで表される化合物を含むこれらのフラクションを、ほぼ乾燥するまで蒸発させ、凍結乾燥した。かかる凍結乾燥物をメタノールに溶解し、調整用のＨＰＬＣカラム（ＸＴｅｒｒａ  ＯＤＳ（１０μｍ)、１９×１５０ｍｍ、Waters社製、 Milford, MA）に流量９ｍＬ／分、紫外線ピーク検出３００ｎｍで注入した。
</span>
&nbsp;&nbsp;Each wash was collected separately and analyzed by TLC as described above. These fractions containing the compound of formula II were evaporated to near dryness and lyophilized. The lyophilized product was dissolved in methanol and injected into a preparative HPLC column (XTerra ODS (10 μm), 19 × 150 mm, Waters, Milford, Mass.) At a flow rate of 9 mL / min and ultraviolet peak detection at 300 nm.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
表２に示すグラジエントで、アセトニトリル／緩衝液（５ｍＭのＮＨ<sub class="style-scope patent-text">４</sub>ＨＣＯ<sub class="style-scope patent-text">３</sub>）でカラムを溶出した。
</span>The column was eluted with acetonitrile / buffer (5 mM NH <sub class="style-scope patent-text">4</sub> HCO <sub class="style-scope patent-text">3</sub> ) with the gradient shown in Table 2.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
式IIで表される化合物を含有するフラクションを混合し、濃縮し、凍結乾燥し、約３３．７ｍｇの化合物を生じた。
</span>
Fractions containing the compound of formula II were combined, concentrated and lyophilized to yield approximately 33.7 mg of compound.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">代替プロトコル２</u> <br class="style-scope patent-text">
  実施例１の全ブロス１０リットルを等量のエチルアセテートで２度抽出し、２つの抽出物を混合し、乾燥するまで縮合する。乾燥した抽出物を測量し、乾燥抽出物１グラムにつき、１００ｍＬのＭｅＯＨ−Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（２：１、ｖ／ｖ）及び１００ｍＬのヘキサンを添加する。かかる混合物を静かによくかき混ぜ、溶解させる。２層を分離し、１００ｍＬのヘキサンで水層を洗浄する。２つのへキサン層を混合し、混合したヘキサン溶液を１００ｍＬのメタノール：水（２：１、ｖ／ｖ）で洗浄する。メタノール：水の２層を混合し、２００ｍＬのＥｔＯＡｃと４００ｍＬの水とで処理する。それらの層を分離し、水層を２００ｍＬポーションのＥｔＯＡｃで更に２回抽出する。ＥｔＯＡｃ層を混合し、縮合する。得られた残留物は、上述のＨＳＣＣ又はＨＰＬＣのいずれかを用いた最終的な精製に適している。この抽出プロセスによると、上記に使用され抽出プロトコルと比較して、１０倍の精度が得られる。
</span> <u class="style-scope patent-text">Alternative protocol 2</u> <br class="style-scope patent-text"> Extract 10 liters of the total broth from Example 1 twice with an equal volume of ethyl acetate, mix the two extracts and condense to dryness. Weigh the dried extract and add 100 mL MeOH-H <sub class="style-scope patent-text">2</sub> O (2: 1, v / v) and 100 mL hexane per gram of dry extract. Stir the mixture gently and dissolve. Separate the two layers and wash the aqueous layer with 100 mL of hexane. The two hexane layers are mixed and the combined hexane solution is washed with 100 mL methanol: water (2: 1, v / v). Mix two layers of methanol: water and treat with 200 mL EtOAc and 400 mL water. The layers are separated and the aqueous layer is extracted two more times with 200 mL portions of EtOAc. Mix the EtOAc layers and condense. The resulting residue is suitable for final purification using either HSCC or HPLC as described above. According to this extraction process, 10 times more accuracy is obtained compared to the extraction protocol used above.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例３：式IIで表される化合物の構造の解明</u> <br class="style-scope patent-text">
  質量分析、ＵＶ（紫外吸収）及びＮＭＲ（核磁気共鳴）スペクトロスコピーを含む分光分析データから、式IIで表される化合物の構造を導出した。エレクトロスプレー質量分析法によって質量が４６２．６（図１）、最大紫外線量が２３０ｎｍでショルダーが２９０ｎｍ（図２）であると測定した。プロトンを含むＭｅＯＨ−ｄ４に溶解したＮＭＲデータを回収し（図３）、多次元パルスは、ｇＤＱＣＯＳＹ（図４）、ｇＨＳＱＣ、（図５）、ｇＨＭＢＣ（図６）及びＮＯＥＳＹ（図７）をシーケンスしている。
</span> <u class="style-scope patent-text">Example 3: Elucidation of the structure of the compound represented by Formula II The structure of the</u> compound represented by Formula II was derived from spectroscopic data including mass spectrometry, UV (ultraviolet absorption) and NMR (nuclear magnetic resonance) spectroscopy. did. It was measured by electrospray mass spectrometry that the mass was 462.6 (FIG. 1), the maximum ultraviolet ray amount was 230 nm, and the shoulder was 290 nm (FIG. 2). The NMR data dissolved in MeOH-d4 containing protons was collected (Fig. 3), and the multidimensional pulse sequenced gDQCOSY (Fig. 4), gHSQC, (Fig. 5), gHMBC (Fig. 6) and NOESY (Fig. 7). is doing.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＥＣＯ−０４６０１の二次元スペクトルにおけるクロスピークの数は、構造を決定する上での手がかりとなる。例えば、ｇＨＭＢＣ実験においてファルネシル鎖末端のメチレンのプロトンシグナル４．５２ｐｐｍとアミドカルボニル炭素１７０ｐｐｍとの間の強いクロスピークによって、ファルネシル鎖をアミド窒素上に配置する。この結論は、４．５２ｐｐｍの同じメチレンシグナルと、テトラの２つのプロトンのうち１つがベンゼノイド環で置換された６．２５ｐｐｍの芳香族のプロトンシグナルとの間の、ＮＯＥＳＹスペクトラのクロスピークによって立証される。
</span>
&nbsp;&nbsp;The number of cross peaks in the two-dimensional spectrum of ECO-04601 is a clue in determining the structure. For example, in a gHMBC experiment, the farnesyl chain is placed on the amide nitrogen by a strong cross peak between 4.52 ppm of the methylene proton signal at the farnesyl chain end and 170 ppm of the amide carbonyl carbon. This conclusion is evidenced by the NOESY Spectra cross-peak between the same methylene signal of 4.52 ppm and the aromatic proton signal of 6.25 ppm with one of the tetra protons replaced with a benzenoid ring. The
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  質量分析、ＵＶ及びＮＭＲデータに基づき、該化合物の構造が式IIの構造であると決定した。
</span>
&nbsp;&nbsp;Based on mass spectrometry, UV and NMR data, the structure of the compound was determined to be that of formula II.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例４：抗細菌活性（最小発育阻止濃度の決定）</u> <br class="style-scope patent-text">
  最小発育阻止濃度（ＭＩＣ）は、細菌数の９９％より多くを阻害する薬剤の最低濃度であると定義される。ブロス微量希釈アッセイ(Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition. NCCLS document M7-A5 (ISBN 1-56238-394-9). NCCLS, 940 West Valley Road, Suite 1400 Wayne, Pennsylvania 19087-1898 USA)を用いて、 細菌株（Bacillus subtilis−ＡＴＣＣ第２３８５７、Micrococcus luteus−ＡＴＣＣ第９３４１）に対するＥＣＯ−０４６０１のＭＩＣが決定された。
</span> <u class="style-scope patent-text">Example 4: Antibacterial activity (determination of minimum inhibitory concentration)</u> <br class="style-scope patent-text"> The minimum inhibitory concentration (MIC) is defined as the lowest concentration of an agent that inhibits more than 99% of the bacterial count. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition.NCCLS document M7-A5 (ISBN 1-56238-394-9). NCCLS, 940 West Valley Road, Suite 1400 Wayne, Pennsylvania 19087-1898 USA) was used to determine the MIC of ECO-04601 against bacterial strains (Bacillus subtilis-ATCC 23857, Micrococcus luteus-ATCC 9341).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">テスト化合物の調製：</u>濃度範囲が３．２ｍｇ／ｍｌから０．０６２５ｍｇ／ｍｌ（１０ポイントより多い２倍連続希釈）であるＤＭＳＯ中、被験物質ＥＣＯ−０４６０１を１００倍原液として調製する。各被験物質の０．５ｍｇを１５６．２５μｌのＤＭＳＯに再懸濁して、１回目の希釈液（３．２ｍｇ／ｍｌ）を調製した。次にかかる原液を２倍減衰によって連続して希釈し、所望の濃度範囲を得る。
</span> <u class="style-scope patent-text">Test compound preparation:</u> Test substance ECO-04601 is prepared as a 100-fold stock solution in DMSO with a concentration range of 3.2 mg / ml to 0.0625 mg / ml (2-fold serial dilution greater than 10 points). 0.5 mg of each test substance was resuspended in 156.25 μl DMSO to prepare a first dilution (3.2 mg / ml). The stock solution is then serially diluted by 2-fold attenuation to obtain the desired concentration range.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">接種源の調整：</u>ミュラーヒルトン（ＭＨ）ブロスで１晩培養した培養物から、各指示株(Bacillus subtilis; Micrococcus luteus)の細胞密度を０．５McFarland単位に０．８５％食塩水中で調整し、続いて、適当なアッセイ培地で１／１００に更に希釈した（〜１×１０<sup class="style-scope patent-text">６</sup>細胞／ｍｌ）。
</span> <u class="style-scope patent-text">Inoculum adjustment: From</u> overnight cultures in Muller Hilton (MH) broth, the cell density of each indicator strain (Bacillus subtilis; Micrococcus luteus) was adjusted to 0.5 McFarland units in 0.85% saline, followed by Was further diluted 1/100 with the appropriate assay medium (˜1 × 10 <sup class="style-scope patent-text">6</sup> cells / ml).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">ＭＩＣの決定：</u>１００倍のＥＣＯ−０４６０１溶液をＭＨブロスで５０倍に希釈し、９６ウェルプレートに分配した。ウェルのカラム１つにつき１被験濃度とし、全体で１０カラムである。ウェルの１１番目のカラムは１％ＤＭＳＯを含むＭＨブロスを含有し、ウェルの１２番目のカラムはブロスのみ１００μｌを含有していた。各指示株の最終的な細胞希釈物５０μｌを、希釈した薬剤５０μｌ又は培地のみを含有するマイクロプレートのそれぞれの対応するウェルに添加した。アッセイプレートを３５℃で２４時間培養した。
</span> <u class="style-scope patent-text">MIC determination:</u> 100-fold ECO-04601 solution was diluted 50-fold with MH broth and dispensed into 96-well plates. One test concentration per column of well, for a total of 10 columns. The eleventh column of the well contained MH broth containing 1% DMSO, and the twelfth column of the well contained 100 μl of broth alone. A final cell dilution of 50 μl of each indicator strain was added to each corresponding well of a microplate containing 50 μl of diluted drug or medium alone. The assay plate was incubated at 35 ° C. for 24 hours.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  表３に示すように、化合物ＥＣＯ−０４６０１のＭＩＣの結果は、抗細菌効果の範囲を表している。
</span>
&nbsp;&nbsp;As shown in Table 3, the MIC results for compound ECO-04601 represent a range of antibacterial effects.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例５：ヒト及び動物の、様々な組織の腫瘍細胞株に対するインビトロ抗癌活性</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">培養条件</u>：表４に列挙した細胞株を使用して、ヒト及び動物の腫瘍細胞株に対するＥＣＯ−０４６０１の細胞毒性を特徴付けた。これらの細胞株はマイコプラズマに感染していないことがわかり、１０％の熱不活化ウシ胎児血清と１％のペニシリンストレプトマイシンを補充した適当な培地（表４）に、５％のＣＯ<sub class="style-scope patent-text">２</sub>下、３７℃で維持した。細胞を１週間に２回から３回継代培養した。０．２５％トリパンブルーで着色することによって、生存度を調べ、細胞の生存度が９５％＞であるフラスコだけを今回の研究に使用した。
</span> <u class="style-scope patent-text">Example 5: In vitro anti-cancer activity against human and animal tumor cell lines of various tissues</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">Culture conditions</u> : The cell lines listed in Table 4 were used to characterize the cytotoxicity of ECO-04601 against human and animal tumor cell lines. These cell lines were found not to be infected with mycoplasma and were added to a suitable medium (Table 4) supplemented with 10% heat-inactivated fetal calf serum and 1% penicillin streptomycin under 5% CO <sub class="style-scope patent-text">2</sub> at 37 ° C. Maintained at ° C. Cells were subcultured 2 to 3 times per week. Viability was examined by coloring with 0.25% trypan blue and only flasks with cell viability&gt; 95% were used in this study.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">細胞株の増幅とプレーティング</u>：９６ウェルのフラットボトムマイクロタイタープレートに腫瘍細胞を播種し（１００μＬにつき１〜３×１０<sup class="style-scope patent-text">３</sup>細胞）、１０％血清を補充された薬剤を含まない培地で、５％ＣＯ<sub class="style-scope patent-text">２</sub>下、３７℃で１６時間、処理の前に培養した。
</span> <u class="style-scope patent-text">Cell line amplification and plating</u> : 96-well flat bottom microtiter plates seeded with tumor cells (1-3 × 10 <sup class="style-scope patent-text">3</sup> cells per 100 μL), 5% in medium without drug supplemented with 10% serum Incubate at 37 ° C. for 16 hours under CO <sub class="style-scope patent-text">2</sub> before treatment.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">細胞増殖に対する阻害活性の評価</u>：１０μｇ／ｍｌ（２０μＭ）から始めて被験物質の６ｌｏｇ<sub class="style-scope patent-text">１０</sub>倍の濃度で、細胞を９６時間培養した。血清を補充した培地で、被験物質の原液（５ｍｇ／ｍＬ）を予め１／７０倍に希釈した。同様に補充した培地で１／１０倍に連続して希釈し、他の濃度を得た。ｐＨ７．４の４−（２−ヒドロキシエチル）−１−ピペラジンエタンスルホン酸緩衝液１０ｍＭを含む新しい培地１５０μｌと培地とを取り替えることによって、９６時間後に細胞の生存を評価した。次に、リン酸緩衝液中のｐＨ７．４の３−（４，５−ジメチルチアゾ−２−イル）−２，５−ジフェニルテトラゾリウムブロミド（ＭＴＴ）の２．５ｍｇ／ｍＬの５０μＬを添加した。３７℃で培養を行ってから３〜４時間後に、培地と可溶性ＭＴＴとを除去し、ジメチルスルホキシド２００μＬを添加し、還元したＭＴＴの沈殿物を溶解し、次にグリシン緩衝液（グリシン０．１Ｍ＋ＮａＣｌ０．１Ｍ、ｐＨ１０．５）２５μＬを添加した。吸光度を、マイクロプレートリーダーを用いて５７０ｎｍで測定した。細胞増殖の５０％を阻害する薬剤の濃度（ＩＣ<sub class="style-scope patent-text">５０</sub>）として、結果が示された。表４に示したＩＣ<sub class="style-scope patent-text">５０</sub>の値は、白血病、メラノーマ、膵臓癌及び乳癌等の様々な腫瘍のタイプに対する、ＥＣＯ−０４６０１の薬学的に意義ある細胞毒性活性を示している。
</span> <u class="style-scope patent-text">Evaluation of inhibitory activity on cell proliferation</u> : The cells were cultured for 96 hours at a concentration of 6 log <sub class="style-scope patent-text">10</sub> times the test substance starting from 10 μg / ml (20 μM). A stock solution of the test substance (5 mg / mL) was previously diluted 1/70 times in a medium supplemented with serum. Similarly, other concentrations were obtained by serially diluting 1/10 times with supplemented medium. Cell viability was assessed after 96 hours by replacing the medium with 150 μl of fresh medium containing 10 mM 4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid buffer at pH 7.4. Next, 50 μL of 2.5 mg / mL 3- (4,5-dimethylthiazo-2-yl) -2,5-diphenyltetrazolium bromide (MTT) at pH 7.4 in phosphate buffer was added. Three to four hours after culturing at 37 ° C., the medium and soluble MTT were removed, 200 μL of dimethyl sulfoxide was added to dissolve the reduced MTT precipitate, and then glycine buffer (glycine 0.1 M + NaCl 0 .1M, pH 10.5) 25 μL was added. Absorbance was measured at 570 nm using a microplate reader. Results were expressed as the concentration of drug that inhibits 50% of cell growth (IC <sub class="style-scope patent-text">50</sub> ). The IC <sub class="style-scope patent-text">50</sub> values shown in Table 4 indicate the pharmaceutically significant cytotoxic activity of ECO-04601 against various tumor types such as leukemia, melanoma, pancreatic cancer and breast cancer.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例６：米国国立癌研究所パネルの様々なヒト腫瘍細胞株に対するインビトロでの抗癌活性</u> <br class="style-scope patent-text">
  細胞増殖の５０％阻害（ＣＩ<sub class="style-scope patent-text">５０</sub>）を得るために必要なＥＣＯ−０４６０１濃度を決定するために、ヒト癌細胞株のパネルに対するＥＣＯ−０４６０１のインビトロでの抗癌活性を測定する研究が、国立癌研究所（国立衛生研究所、Bethesda, Maryland, USA）によって行われた。この独特のスクリーニングの操作には、白血病、メラノーマ、並びに肺癌、結腸癌、脳癌、卵巣癌、乳癌、前立腺癌、及び腎臓癌に代表される５０の異なるヒト腫瘍細胞株が用いられる。
</span> <u class="style-scope patent-text">Example 6:</u> To determine the concentration of ECO-04601 required to obtain 50% inhibition (CI <sub class="style-scope patent-text">50</sub> ) <u class="style-scope patent-text">of anticancer active</u> cell proliferation in <u class="style-scope patent-text">vitro against various human tumor cell lines of the National Cancer Institute panel</u> . A study to measure the in vitro anticancer activity of ECO-04601 against a panel of human cancer cell lines was conducted by the National Cancer Institute (National Institutes of Health, Bethesda, Maryland, USA). This unique screening procedure uses leukemia, melanoma, and 50 different human tumor cell lines represented by lung cancer, colon cancer, brain cancer, ovarian cancer, breast cancer, prostate cancer, and kidney cancer.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">培養条件及びプレーティング：</u> <br class="style-scope patent-text">
  ５％ウシ胎児血清とＬグルタミン２ｍＭとを含むＰＲＭＩ１６４０培地で、癌スクリーニングパネルのヒト腫瘍細胞株を培養した。典型的なスクリーニングの実験については、各細胞株の倍加時間に応じて５０００から４００００細胞／ウェルの濃度で、細胞を１００μＬの９６ウェルマイクロタイタープレートに播種した（表５）。播種後、実験薬を添加する前に、マイクロタイタープレートを５％、空気９５％、及び相対湿度１００％で２４時間、３７℃で培養した。２４時間後、薬剤添加時（Ｔｚ）の各細胞株の細胞数の測定値を示すために、ＴＣＡを用いて各細胞株の２つのプレートをインサイチュで固定した。
</span> <u class="style-scope patent-text">Culture conditions and plating:</u> <br class="style-scope patent-text"> The human tumor cell line of the cancer screening panel was cultured in a RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-glutamine. For a typical screening experiment, cells were seeded in 100 μL 96-well microtiter plates at a concentration of 5000 to 40,000 cells / well depending on the doubling time of each cell line (Table 5). After seeding, before adding the experimental drug, the microtiter plate was incubated at 37 ° C. for 24 hours at 5%, air 95%, and relative humidity 100%. Twenty-four hours later, two plates of each cell line were fixed in situ using TCA to show a measurement of the number of cells in each cell line at the time of drug addition (Tz).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">細胞増殖における阻害活性の評価：</u> <br class="style-scope patent-text">
  ＥＣＯ−０４６０１は推定純度９０＋％の凍結乾燥粉末として提供された。該化合物を使用する日まで−２０℃で保管した。ＥＣＯ−０４６０１を所望の最終的な最大テスト濃度の４００倍のジメチルスルホキシド中で可溶化した。薬剤添加時に、凍結した濃縮物質のアリコートを解凍し、ゲンタマイシン５０μｇ／ｍＬを含む完全培地で所望の最終的な最大テスト濃度の２倍に希釈した。更に４倍、１０倍又は１／２ｌｏｇの連続希釈を行い、全部で５種の薬剤濃度及びコントロールを得た。これらの異なる薬剤希釈液の１００μｌのアリコートを、既に１００μｌの培地を含む適当なマイクロタイターウェルに添加した結果、必要な最終的な薬剤濃度を得た（８．０×１０<sup class="style-scope patent-text">−５</sup>Ｍから８．０×１０<sup class="style-scope patent-text">−９</sup>Ｍ）。
</span> <u class="style-scope patent-text">Evaluation of inhibitory activity on cell proliferation:</u> <br class="style-scope patent-text"> ECO-04601 was provided as a lyophilized powder with an estimated purity of 90 +%. The compound was stored at −20 ° C. until the day of use. ECO-04601 was solubilized in dimethyl sulfoxide 400 times the desired final maximum test concentration. At the time of drug addition, aliquots of frozen concentrated material were thawed and diluted to 2 times the desired final maximum test concentration in complete medium containing 50 μg / mL gentamicin. Further, serial dilutions of 4 times, 10 times or 1/2 log were performed to obtain a total of 5 drug concentrations and controls. 100 μl aliquots of these different drug dilutions were added to appropriate microtiter wells already containing 100 μl of media, resulting in the required final drug concentration (from 8.0 × 10 <sup class="style-scope patent-text">−5</sup> M to 8. 0 × 10 <sup class="style-scope patent-text">−9</sup> M).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  薬剤添加に続き、プレートを更に４８時間、３７℃、ＣＯ<sub class="style-scope patent-text">２</sub>５％、空気９５％、及び相対湿度１００％で培養した。接着細胞については、低温のＴＣＡ（トリクロロ酢酸）を添加してアッセイを終了した。低温の５０％（ｗ／ｖ）ＴＣＡ５０μｌ（最終濃度、１０％ＴＣＡ）を静かに添加することによって細胞をインサイチュで固定し、６０分間４℃で培養した。上清を廃棄し、プレートを水道水で５回洗浄し、空気乾燥した。１％酢酸中の０．４％（ｗ／ｖ）のスルホローダミン(Sulforhodamine) B（ＳＲＢ）液（１００μｌ）を各ウェルに添加し、プレートを室温で１０分間培養した。着色後、１％酢酸で５回洗浄して、結合していない染料を除去し、プレートを空気乾燥した。続いて、結合したステインをtrizma base１０ｍＭで可溶化し、自動プレートリーダーを用いて波長５１５ｎｍで吸光度を読み取った。懸濁細胞に関しては、８０％ＴＣＡ５０μｌ（最終濃度、ＴＣＡ１６％）を静かに添加してウェルの底に定着細胞を固定してアッセイを終了させることを除いて、手順は同じであった。
</span>Following drug addition, the plates were incubated for an additional 48 hours at 37 ° C., 5% CO <sub class="style-scope patent-text">2</sub> , 95% air, and 100% relative humidity. For adherent cells, the assay was terminated by adding cold TCA (trichloroacetic acid). Cells were fixed in situ by gently adding 50 μl of cold 50% (w / v) TCA (final concentration, 10% TCA) and incubated for 60 minutes at 4 ° C. The supernatant was discarded and the plate was washed 5 times with tap water and air dried. 0.4% (w / v) Sulforhodamine B (SRB) solution (100 μl) in 1% acetic acid was added to each well and the plate was incubated at room temperature for 10 minutes. After coloring, it was washed 5 times with 1% acetic acid to remove unbound dye and the plate was air dried. Subsequently, the bound stain was solubilized with 10 mM trizma base, and the absorbance was read at a wavelength of 515 nm using an automatic plate reader. For suspended cells, the procedure was the same except that 50 μl of 80% TCA (final concentration, TCA 16%) was gently added to fix the established cells to the bottom of the wells and terminate the assay.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＥＣＯ−０４６０１の増殖阻害活性を、従来のＩＣ<sub class="style-scope patent-text">５０</sub>値ではなくＮＣＬを使用したＧＩ<sub class="style-scope patent-text">５０</sub>値によって測定した。ＧＩ<sub class="style-scope patent-text">５０</sub>値は、ゼロ時の細胞数の訂正を強調しており、７種の吸光度測定値（（ゼロ時（Ｔｚ）、コントロールの増殖（Ｃ）、及び５つの濃度レベルの薬剤の存在下でのテスト増殖（Ｔｉ））を用いて、［（Ｔｉ−Ｔｚ）／（Ｃ−Ｔｚ）］×１００＝−５０としてＧＩ<sub class="style-scope patent-text">５０</sub>を計算する。これは、薬剤培養中のコントロール細胞における正味タンパク質増加に５０％減少をもたらす（ＳＲＢ染色によって測定）薬剤濃度である。
</span>The growth inhibitory activity of ECO-04601 was measured by GI <sub class="style-scope patent-text">50</sub> values using NCL instead of conventional IC <sub class="style-scope patent-text">50</sub> values. The GI <sub class="style-scope patent-text">50</sub> value emphasizes the correction of the cell number at zero, with seven absorbance measurements ((zero (Tz), control growth (C), and in the presence of five concentration levels of the drug). GI <sub class="style-scope patent-text">50</sub> is calculated as [(Ti−Tz) / (C−Tz)] × 100 = −50, which is the net protein increase in control cells during drug culture. Drug concentration (measured by SRB staining) resulting in a 50% reduction.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">結果：</u> <br class="style-scope patent-text">
ＮＣＬスクリーニングによって明らかになったように、ＥＣＯ−０４６０１は、いくつかのタイプの腫瘍に対しては顕著な抗腫瘍活性を示す。スクリーニングの結果を表５に示し、グリオーマに対する活性に関する更に詳細な結果を実施例７（表６）に示す。
</span> <u class="style-scope patent-text">result:</u> <br class="style-scope patent-text"> As revealed by NCL screening, ECO-04601 shows significant anti-tumor activity against several types of tumors. The results of the screening are shown in Table 5, and more detailed results regarding the activity against glioma are shown in Example 7 (Table 6).</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  結果は、ＮＣＩのスクリーニングのパネルで分析されたヒトの腫瘍細胞株のほとんどに対して、ＥＣＯ−０４６０１が効果的であったことを示しており、いくつかのタイプのヒトの癌に対する広い抗癌活性が示唆される。
</span>
&nbsp;&nbsp;The results show that ECO-04601 was effective against most of the human tumor cell lines analyzed in the NCI screening panel, with broad anti-cancer against several types of human cancers Activity is suggested.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例７：グリオーマ細胞株のパネルに対するインビトロでの抗増殖性の研究</u> <br class="style-scope patent-text">
  表６に示すように、グリオーマ癌細胞株のパネルを用いてＥＣＯ−０４６０１の抗癌活性を評価し、細胞増殖の５０％阻害（ＩＣ<sub class="style-scope patent-text">５０</sub>）を測定した。
</span> <u class="style-scope patent-text">Example 7: In vitro anti-proliferative studies on a panel of glioma cell lines As</u> shown in Table 6, the panel of glioma cancer cell lines was used to evaluate the anti-cancer activity of ECO-04601 and 50% of cell proliferation. Inhibition (IC <sub class="style-scope patent-text">50</sub> ) was measured.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">培養条件：</u> <br class="style-scope patent-text">
  表６に列挙した細胞株はマイコプラズマに感染していないと見られ、５％ＣＯ<sub class="style-scope patent-text">２</sub>下、３７℃で、１０％熱不活化ウシ胎児血清と１％ペニシリンストレプトマイシンを補充したＤＭＥＭ培地（表４）に維持された。細胞を１週間に１度継代培養した。使用の前に、５〜１０分間トリプシンで処理することによって、かかる細胞を培養フラスコからカウントし、０．２５％トリパンブルー排除法によって、生存度を調べた。細胞の生存度が９５％＞であるフラスコのみを今回の研究に使用した。
</span> <u class="style-scope patent-text">Culture conditions:</u> <br class="style-scope patent-text"> The cell lines listed in Table 6 appear to be not infected with mycoplasma, DMEM medium supplemented with 10% heat-inactivated fetal calf serum and 1% penicillin streptomycin at 37 ° C. under 5% CO <sub class="style-scope patent-text">2</sub> (Table 4). Maintained. Cells were subcultured once a week. Prior to use, such cells were counted from the culture flasks by treatment with trypsin for 5-10 minutes and examined for viability by the 0.25% trypan blue exclusion method. Only flasks with cell viability&gt; 95% were used for this study.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">細胞株の増幅及びプレーティング：</u> <br class="style-scope patent-text">
  薬剤を含まず、１０％血清を補充した培地１００μＬ中、１ウェルあたり５×１０<sup class="style-scope patent-text">３</sup>細胞の細胞を、９６ウェルのフラットボトムマイクロタイタープレートに播種し、処理の前に３７℃で４８時間培養した。
</span> <u class="style-scope patent-text">Cell line amplification and plating:</u> <br class="style-scope patent-text"> In 100 μL of medium containing no drug and supplemented with 10% serum, 5 × 10 <sup class="style-scope patent-text">3</sup> cells per well were seeded in 96-well flat bottom microtiter plates and cultured at 37 ° C. for 48 hours before treatment. .</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">細胞増殖に対する阻害活性の評価</u>：<br class="style-scope patent-text">
  これらの細胞（トリプリケートウェル(triplicate well)中）を、５．０μｇ／ｍｌ（１０μＭ）から始まる異なる濃度のＥＣＯ−０４６０１を含有する培地で、９６時間培養した。該化合物を、Ｄ−ＭＥＮ又はＲＰＭＩ培地（又は他の同等な培地）で１％ＤＭＳＯ溶液に使用した。ＥＣＯ−０４６０１の濃度は、１０μＭ（５．０μｇ／ｍｌ）、１μＭ（０．５０μｇ／ｍｌ）、０．５μＭ（０．２５μｇ／ｍｌ）、０．１μＭ（０．０５０μｇ／ｍｌ）、０．５μＭ（０．０２５μｇ／ｍｌ）、０．０１μＭ（０．００５０μｇ／ｍｌ）、０．００１μＭ（０．０００５０μｇ／ｍｌ）であった。媒体のみ（培地中、１％ＤＭＳＯ）で処理した細胞をネガティブコントロールとした。増加濃度が４から６のシスプラチン（ＣＤＤＰ）で処理した細胞をポジティブコントロールとした（データ示さず）。各細胞株の増殖率を測定するために、培養前（０時間）及びそれに続く被験化合物による９６時間の培養中、培養の光学濃度を測定した。
</span> <u class="style-scope patent-text">Assessment of inhibitory activity on cell proliferation</u> : <br class="style-scope patent-text"> These cells (in triplicate wells) were cultured for 96 hours in media containing different concentrations of ECO-04601 starting at 5.0 μg / ml (10 μM). The compound was used in 1% DMSO solution in D-MEN or RPMI medium (or other equivalent medium). The concentrations of ECO-04601 are 10 μM (5.0 μg / ml), 1 μM (0.50 μg / ml), 0.5 μM (0.25 μg / ml), 0.1 μM (0.050 μg / ml), 0.5 μM. (0.025 μg / ml), 0.01 μM (0.0050 μg / ml), and 0.001 μM (0.00050 μg / ml). Cells treated with vehicle alone (1% DMSO in medium) served as negative controls. Cells treated with cisplatin (CDDP) at increasing concentrations of 4 to 6 served as positive controls (data not shown). In order to measure the growth rate of each cell line, the optical density of the culture was measured before the culture (0 hour) and during the subsequent 96 hours of culture with the test compound.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  処理の終わりに、ｐＨ７．４の４−（２−ヒドロキシエチル）−１−ピペラジンエタンスルホン酸緩衝液１０ｍＭを含有する新しい培地１５０μｌと、細胞培地とを取り替えた。次に、ＰＢＳ中ｐＨ７．４の臭化３−（４，５−ジメチルチアゾ−２−イル）−２，５−ジフェニルテトラゾリウム２．５ｍｇ／ｍｌの５０μｌを各ウェルに添加し、培養プレートを４時間３７℃で培養した。この結果生じた上清を除去し、ＤＭＳＯ２００μｌ、続いてグリシン緩衝液２５μｌ（グリシン０．１Ｍ＋ＮａＣｌ０．１Ｍ、ｐＨ１０．５）にホルマザン結晶を溶解した。単一波長分光光度計プレートリーダーを使用して、５７０ｎｍで各ウェルの光学濃度を読み取った。結果は、細胞増殖を５０％阻害する（ＩＣ<sub class="style-scope patent-text">５０</sub>）薬剤の濃度として示された。各細胞株を少なくとも３回の独立した実験においてテストした。
</span>At the end of the treatment, the cell medium was replaced with 150 μl of fresh medium containing 10 mM of pH 7.4 4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid buffer. Next, 50 μl of 2.5 mg / ml of 3- (4,5-dimethylthiazo-2-yl) -2,5-diphenyltetrazolium bromide at pH 7.4 in PBS is added to each well and the culture plate is left for 4 hours. Cultured at 37 ° C. The resulting supernatant was removed and formazan crystals were dissolved in 200 μl DMSO followed by 25 μl glycine buffer (glycine 0.1 M + NaCl 0.1 M, pH 10.5). The optical density of each well was read at 570 nm using a single wavelength spectrophotometer plate reader. Results were expressed as the concentration of drug that inhibits cell growth by 50% (IC <sub class="style-scope patent-text">50</sub> ). Each cell line was tested in at least 3 independent experiments.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  表６に示した結果によって、IV型多形成グリア芽腫の最も悪性型神膠経肉腫を含む異なる脳癌の細胞株に対するＥＣＯ−０４６０１の活性が確認された。神経膠肉腫はグリア細胞と内皮細胞とが合わさったもので、あらゆる化学療法に耐性を有する。
</span>
&nbsp;&nbsp;The results shown in Table 6 confirmed the activity of ECO-04601 against different brain cancer cell lines including the most malignant type of glioblastoma of the type IV pleomorphic glioblastoma. Gliosarcoma is a combination of glial cells and endothelial cells and is resistant to any chemotherapy.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例８：ヒトリポキシゲナーゼ（５−ＬＯ）の酵素活性に対する影響</u> <br class="style-scope patent-text">
５−リポキシゲナーゼは、アラキドン酸の５−ヒドロキシエイコサテトラエン酸（５−ＨＥＴＥ）への酸化的代謝に触媒作用を及す。この初期反応ではロイコトリエンが形成される。リポキシゲナーゼ又はシクロキシゲナーゼの作用によってアラキドン酸から生じたエイコサノイドが、神経変性（アルツハイマー病）、老化及び腫瘍の促進、進行、転移を含む様々な発癌のステップのみならず、急性炎症疾患及び慢性炎症疾患（すなわち、ぜんそく、多発性硬化症、関節リュウマチ、虚血、水腫）に関与することが見い出された。
</span> <u class="style-scope patent-text">Example 8 Effect of Human Lipoxygenase (5-LO) on Enzymatic Activity</u> 5-Lipoxygenase catalyzes the oxidative metabolism of arachidonic acid to 5-hydroxyeicosatetraenoic acid (5-HETE). In this initial reaction, leukotriene is formed. Eicosanoids generated from arachidonic acid by the action of lipoxygenase or cycloxygenase are not only various carcinogenic steps including neurodegeneration (Alzheimer's disease), aging and tumor promotion, progression, metastasis, but also acute inflammatory diseases and chronic inflammation It has been found to be involved in disease (ie, asthma, multiple sclerosis, rheumatoid arthritis, ischemia, edema).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本研究の課題は、ヒト５−ＬＯの酵素活性を阻害することによって、ＥＣＯ−０４６０１がロイコトリエンの形成を阻止できるかを確認することである。使用した方法は、Carter et al (1991) J.Pharmacol. Exp. Ther. 256(3):929-937及びSafayhi (2000), Planta Medica 66:110-113に基づいており、これらの文献は、参照することにより全体として本明細書に組み込まれる。
</span>
&nbsp;&nbsp;The task of this study is to confirm whether ECO-04601 can prevent the formation of leukotrienes by inhibiting the enzyme activity of human 5-LO. The method used is based on Carter et al (1991) J. Pharmacol. Exp. Ther. 256 (3): 929-937 and Safayhi (2000), Planta Medica 66: 110-113, which are Which is incorporated herein by reference in its entirety.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実験計画</u> <br class="style-scope patent-text">
  フィコール−パーク密度勾配(Ficoll-Paque density gradient)で、ヒト末梢血単核細胞（ＰＭＮ）を単離した。Ａ２３１８７（最終濃度３０μＭ）を添加してＰＭＮを刺激した。刺激したＰＭＮをＨＢＢＳ培地で５×１０<sup class="style-scope patent-text">６</sup>細胞／ｍＬの密度に調節し、媒体コントロール（ＤＭＳＯ）、（最終濃度が０．１、０．５、１、２．５、５、及び１０μＭの）ＥＣＯ−０４６０１、及びポジティブコントロールとしての（最終濃度が３、１、０．３、０．１、及び０．０３μＭの）ＮＤＧＡで、１５分間３７℃で培養した。培養後、サンプルをＮａＯＨで中和し、遠心分離を行った。上清のロイコトリエンＢ４含有量を酵素免疫測定法（ＥＩＡ）を用いて測定した。
</span> <u class="style-scope patent-text">Experimental design</u> Human peripheral blood mononuclear cells (PMN) were isolated using the Ficoll-Paque density gradient. A23187 (final concentration 30 μM) was added to stimulate PMN. Stimulated PMN was adjusted to a density of 5 × 10 <sup class="style-scope patent-text">6</sup> cells / mL with HBBS medium, vehicle control (DMSO), (final concentrations 0.1, 0.5, 1, 2.5, 5, and 10 μM) Incubated with ECO-04601 and NDGA as a positive control (final concentrations of 3, 1, 0.3, 0.1, and 0.03 μM) for 15 minutes at 37 ° C. After incubation, the sample was neutralized with NaOH and centrifuged. The leukotriene B4 content of the supernatant was measured using enzyme immunoassay (EIA).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">結果：</u> <br class="style-scope patent-text">
  明らかにＩＣ<sub class="style-scope patent-text">５０</sub>＝０．９３μＭ（ポジティブコントロールＮＤＧＡでは０．１μＭであるのに対して）であり、図８に示す結果は、ＥＣＯ−０４６０１がヒト５−ＬＯの活性を阻害したことを示している。したがって抗炎症性が示される。
</span> <u class="style-scope patent-text">result:</u> <br class="style-scope patent-text"> Clearly IC <sub class="style-scope patent-text">50</sub> = 0.93 μM (vs. 0.1 μM for the positive control NDGA) and the results shown in FIG. 8 indicate that ECO-04601 inhibited the activity of human 5-LO. Yes. Accordingly, anti-inflammatory properties are shown.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例９：グリオーマモデルにおけるインビボでの有効性</u> <br class="style-scope patent-text">
  本研究の目的は、ｉ．ｐ．ルートで投与されたＥＣＯ−０４６０１が、Ｃ６グリア芽腫細胞を有するマウスにおいて腫瘍の増殖を予防する又は遅らせるかをテストすること、及び効果的な投与計画を決定することである。
</span> <u class="style-scope patent-text">Example 9: In vivo efficacy in a glioma model The</u> purpose <u class="style-scope patent-text">of</u> this study is to: i. p. To test whether ECO-04601 administered by route prevents or delays tumor growth in mice with C6 glioblastoma cells, and to determine an effective dosing regimen.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">動物：</u> <br class="style-scope patent-text">
  体重１８〜２５ｇの全部で６０匹の６週齢の雌マウス（Mus musculus ヌードマウス）を、処理前７日間にわたって観察した。Ethical guidelines of animal experimentation (Charte du comite d’ethique du CNRS, Juillet 2003)、及びthe English guidelines for the welfare of animals in experimental neoplasia (WORKMAN, P., TWENTYMAN, P., BALKWILL, F., et al. (1998). United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (Second Edition, July 1997; British Journal of Cancer 77: 1-10) に従って、動物実験を行った。死亡したマウス又は明らかに罹患したマウスは全て速やかに除去し、健康なマウスと取り替えた。罹患したマウスはケージから除去した直後に安楽死させた。温度（２３±２℃）、湿度（４５±５％）、光周期（明期１２時間／暗期１２時間）、及び換気での条件のコントロール下、部屋に動物を維持した。水と食餌を供給する設備を備えたポリカーボネートのケージ（５匹／１ケージ）に、動物を収容した。動物の寝床は滅菌したおが屑製とし、一日おきに取り替えた。食餌はケージ上部の金属の蓋の中に置かれ、任意に供給された。加熱殺菌した水道水は任意に供給された。水用のビンにはゴム製のストッパーとストロー管を備えつけた。水用のビンをきれいに洗浄し、滅菌し、週に１度取り替えた。２つの異なる数字を彫ったリングを２つ動物の耳につけて識別した。各ケージに特定のコードのラベルを付けた。
</span> <u class="style-scope patent-text">animal:</u> <br class="style-scope patent-text"> A total of 60 6 week old female mice (Mus musculus nude mice) weighing 18-25 g were observed for 7 days prior to treatment. Ethical guidelines of animal experimentation (Charte du comite d'ethique du CNRS, Juillet 2003), and the English guidelines for the welfare of animals in experimental neoplasia (WORKMAN, P., TWENTYMAN, P., BALKWILL, F., et al. (1998). Animal experiments were conducted according to the United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (Second Edition, July 1997; British Journal of Cancer 77: 1-10). All mice or apparently affected mice were quickly removed and replaced with healthy mice, affected mice were euthanized immediately after removal from the cage, temperature (23 ± 2 ° C.), humidity (45 ± 5%) ), Photoperiod (light period 12 hours / dark period 12 hours), and animals were maintained in the room under control of ventilation conditions, polycarbonate cages (5 / l) equipped with water and food supply facilities Cage) Animals were housed, the animal bed was made of sterilized sawdust and changed every other day, food was placed in a metal lid on the top of the cage, and was optionally supplied. The water bottle was equipped with a rubber stopper and a straw tube, the water bottle was cleaned, sterilized and replaced once a week. Each cage was labeled with a specific code.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">腫瘍細胞株：</u> <br class="style-scope patent-text">
  一連の別の培養及び動物の継代培養を行った後、Premont et al.（Premont J, Benda P, Jard S., [3H] 培養におけるラットグリア細胞によるノルエピネフリン結合。結合とアデニル化シクラーゼ活性化との相互関係の欠如。Biochim Biophys Acta. 1975 Feb 13; 381(2):386-76）によるN-nitrosomethyurea（ＮＭＵ）によって誘発されたラットグリア腫瘍からＣ６細胞株のクローンを作成した。
</span> <u class="style-scope patent-text">Tumor cell lines:</u> <br class="style-scope patent-text"> After a series of separate cultures and subcultures of animals, norepinephrine binding by rat glial cells in Premont et al. (Premont J, Benda P, Jard S., [3H] culture. Binding and adenylation cyclase activation and C6 cell line was cloned from rat glial tumors induced by N-nitrosomethyurea (NMU) by Biochim Biophys Acta. 1975 Feb 13; 381 (2): 386-76).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  細胞を接着性単層(adherent monolayers)として加湿雰囲気下（ＣＯ<sub class="style-scope patent-text">２</sub>５％、空気９５％）３７℃で培養した。培地は、Ｌ−グルタミン２ｍＭ及び１０％ウシ胎児血清を補充したＤＭＥＭであった。実験に使用するために、１０分間トリプシン−ヴェルシンで処理を行って、腫瘍細胞を培養フラスコから分離した。血球計算器で細胞をカウントし、０．２５％トリパンブルー排除法でそれらの生存率を調べた。
</span>Cells were cultured as adherent monolayers at 37 ° C. in a humidified atmosphere (CO <sub class="style-scope patent-text">2</sub> 5%, air 95%). The medium was DMEM supplemented with 2 mM L-glutamine and 10% fetal calf serum. For use in the experiment, the tumor cells were separated from the culture flask by treatment with trypsin-versin for 10 minutes. Cells were counted with a haemocytometer and their viability was examined by 0.25% trypan blue exclusion.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">被験物質の調製：</u> <br class="style-scope patent-text">
  被験物質に関して、次に再構成のために以下の手続きを行った（注射の直前に実施）。媒体は、ベンジルアルコール（１．５％）、エタノール（８．５％）、プロピレングリコール（２７％）、ＰＥＧ４００（２７％）、ジメチルアセトアミド（６％）、及び水（３０％）からなる混合物で構成されていた。始めに、同種の液体を得るために、媒体溶液(vehicle solution)をボルテックスした。ボルテックスした媒体溶液０．６ｍＬを、被験物質（ＥＣＯ−０４６０１）を含む各バイアルに添加した。１分間ボルテックスしてバイアルを十分に混合し、反転させ、勢いよく振盪した。各動物に注射する前にバイアルを再び混合した。
</span> <u class="style-scope patent-text">Test substance preparation:</u> <br class="style-scope patent-text"> For the test substance, the following procedure was then performed for reconstitution (performed immediately before injection). The medium is a mixture consisting of benzyl alcohol (1.5%), ethanol (8.5%), propylene glycol (27%), PEG400 (27%), dimethylacetamide (6%), and water (30%). Was composed. First, the vehicle solution was vortexed to obtain the same type of liquid. 0.6 mL of vortexed media solution was added to each vial containing the test substance (ECO-04601). Vortex for 1 minute to mix the vial well, invert and shake vigorously. The vials were mixed again before injecting each animal.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">腫瘍細胞の動物への接種</u> <br class="style-scope patent-text">
実験は０日（Ｄ<sub class="style-scope patent-text">０</sub>）に開始した。Ｄ<sub class="style-scope patent-text">０</sub>に、０．１ｍＬのＤＭＥＭ完全培地で、マウスの右後肢上部にＣ６腫瘍細胞（５×１０<sup class="style-scope patent-text">５</sup>細胞）の表皮筋肉注射を行った。
</span> <u class="style-scope patent-text">Inoculation</u> &lt;br/&gt; experiment <u class="style-scope patent-text">to tumor cells the animals</u> began on day 0 (D <sub class="style-scope patent-text">0).</sub> At D <sub class="style-scope patent-text">0</sub> , intramuscular injection of C6 tumor cells (5 × 10 <sup class="style-scope patent-text">5</sup> cells) was performed in the upper right hind limb of mice with 0.1 mL DMEM complete medium.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">治療方法及び結果：</u> <br class="style-scope patent-text">
  始めの一連の実験では、Ｃ６細胞の接種から２４時間後に処理が開始された。処理日には、１００μＬの被験物質またはコントール物質をｉ．ｐ．ルートで各マウスにゆっくり注射した。全ての群について、生理的食塩水で処理したマウス（群１）の腫瘍の大きさが約３ｃｍ<sup class="style-scope patent-text">３</sup>になるまで（１６日頃）、処理を行った。群１のマウスには、生理的等浸透圧溶液で１６日間毎日処理を行った。群２のマウスには、媒体溶液で１６日間毎日処理を行った。群３のマウスには、１０ｍｇ／ｋｇのＥＣＯ−０４６０１で１６日間毎日処理を行った。群３のマウスに、３０ｍｇ／ｋｇのＥＣＯ−０４６０１で１６日間２日に１回、計８回処理を行った。群５のマウスには、３０ｍｇ／ｋｇのＥＣＯ−０４６０１で１６日間３日に１回、計６回処理を行った。腫瘍が触診可能となった直後に、腫瘍の大きさの測定を開始し（＞１００ｍｍ<sup class="style-scope patent-text">３</sup>；接種後１１日頃）、カリパスを使用した処理が終了するまで、１日おきに測定した。図７及び図９に示すように、ＥＣＯ−０４６０１で処理を行った全ての群の腫瘍の大きさの平均値（６匹／群）は、一元配置分散分析（Ａｎｏｖａ）テストや、それに続く処理群と生理的食塩水群とを比較するノンパラメトリックダネット多重比較テストによって示されるように、顕著に減少した。表７のＰ値カラムのアスタリスクは、統計的に重要な値を示し、「ｎｓ」は、重要ではないことを意味する。
</span> <u class="style-scope patent-text">Treatment methods and results:</u> <br class="style-scope patent-text"> In the first series of experiments, treatment started 24 hours after C6 cell inoculation. On the day of treatment, 100 μL of test substance or control substance is administered i. p. Each mouse was injected slowly by route. All groups were treated until the tumor size of mice treated with physiological saline (Group 1) was approximately 3 cm <sup class="style-scope patent-text">3</sup> (around 16 days). Group 1 mice were treated daily with a physiological isotonic solution for 16 days. Group 2 mice were treated daily with vehicle solution for 16 days. Group 3 mice were treated daily with 10 mg / kg ECO-04601 for 16 days. Group 3 mice were treated with 30 mg / kg ECO-04601 once every 2 days for 16 days for a total of 8 treatments. Group 5 mice were treated with 30 mg / kg ECO-04601 once every 3 days for 16 days for a total of 6 treatments. Immediately after the tumor became palpable, measurement of tumor size was started (&gt; 100 mm <sup class="style-scope patent-text">3</sup> ; around 11 days after inoculation) and measured every other day until the treatment using the caliper was completed. As shown in FIGS. 7 and 9, the mean tumor size (6 / group) of all groups treated with ECO-04601 is the one-way analysis of variance (Anova) test and subsequent treatments. There was a marked decrease as shown by the nonparametric Dunnett multiple comparison test comparing the group with the saline group. An asterisk in the P value column of Table 7 indicates a statistically significant value, and “ns” means not significant.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  次の一連の実験において、腫瘍が触診可能になった（約１００〜２００ｍｍ<sup class="style-scope patent-text">３</sup>）Ｃ６細胞の接種後１０日目に、処理を開始した。処理は５日間連続して毎日繰り返された。処理日に、１００μＬのＥＣＯ−０４６０１を、ｉ．ｐ．ルートで各マウスにゆっくり注射した。群１のマウスには、生理的等浸透圧溶液で毎日処理を行った。群２のマウスには、媒体溶液で毎日処理を行った。群３のマウスには、２０ｍｇ／ｋｇのＥＣＯ−０４６０１で毎日処理を行った。群４のマウスに、３０ｍｇ／ｋｇのＥＣＯ−０４６０１で毎日処理を行った。生理的食塩水で処理したコントロールマウス（群１）の腫瘍の大きさが約４ｃｍ<sup class="style-scope patent-text">３</sup>になるまでマウスを処理した。カリパスを使用した処理が終了するまで、腫瘍の大きさを１日おきに測定した。一元配置分散分析（Ａｎｏｖａ）テストや、それに続く処理群と生理的食塩水群とを比較するノンパラメトリックダネット多重比較テストによって示されるように、図８及び図１０に示すように、ＥＣＯ−０４６０１で処理を行った全ての群の腫瘍の大きさの平均値（６匹／群）は顕著に減少した。表８のＰ値カラムのアスタリスクは、統計的に重要な値を示し、「ｎｓ」は、重要ではないことを意味する。
</span>In the next series of experiments, treatment began on day 10 after inoculation of C6 cells when the tumor became palpable (approximately 100-200 mm <sup class="style-scope patent-text">3</sup> ). The treatment was repeated every day for 5 consecutive days. On the day of treatment, 100 μL of ECO-04601 was added i. p. Each mouse was injected slowly by route. Group 1 mice were treated daily with a physiological isotonic solution. Group 2 mice were treated daily with vehicle solution. Group 3 mice were treated daily with 20 mg / kg ECO-04601. Group 4 mice were treated daily with 30 mg / kg ECO-04601. Mice were treated until the tumor size of the control mice (Group 1) treated with saline was approximately 4 cm <sup class="style-scope patent-text">3</sup> . Tumor size was measured every other day until treatment with calipers was completed. As shown in FIGS. 8 and 10, ECO-04601 shows a one-way analysis of variance (Anova) test and subsequent non-parametric Dunnet multiple comparison test comparing treatment group and saline group. The mean tumor size (6 animals / group) of all groups treated was significantly reduced. An asterisk in the P value column of Table 8 indicates a statistically significant value, and “ns” means not significant.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  腫瘍切片の組織分析を行ったところ、ＥＣＯ−０４６０１処理腫瘍とコントロール群との間に明白な形態的変化が示された。ＥＣＯ−０４６０１（２０〜３０ｍｇ／ｋｇ）で処理した腫瘍においては、細胞密度は低下し、残存する腫瘍細胞の核は大きくなり、核濃縮されたように見えたが、媒体で処理したマウスでは、これらの変化は見られなかった（図１１）。
</span>
&nbsp;&nbsp;Histological analysis of tumor sections showed a clear morphological change between ECO-04601 treated tumors and the control group. In tumors treated with ECO-04601 (20-30 mg / kg), the cell density decreased and the nuclei of the remaining tumor cells increased and appeared to be nuclei-enriched, but in mice treated with vehicle, These changes were not seen (FIG. 11).
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１０：本発明のＥＣＯ−０４６０１の変異体の産生</u> <br class="style-scope patent-text">
  有機化学の標準的なアプローチによって、ＥＣＯ−０４６０１分子の変異体、例えば、式III〜LIXとして本明細書に同定される変異体を産生することができる。本明細書に記載される化合物を作製し操作するために必要な、官能基、反応性及び一般的なプロトコルを含む有機化学の原則は、例えば”Advanced Organic Chemistry,” 3<sup class="style-scope patent-text">rd</sup> Edition by Jerry March (1985) に記載されており、参照することによって全体として本明細書に組み込まれる。更に、当業者であれば、特別な記載がなくても、本明細書に記載された合成方法で様々な保護基を使用してもよいことを理解するであろう。本明細書に使用される「保護基」は、多官能化合物の別の反応部位で選択的に反応が行われるように、酸素、硫黄、又は窒素を含む反応基等の１又は２以上の官能基を阻止するために使用される基を意味する。保護基の使用の原則として、特定の官能基の利用可能性及びその使用は、例えばT. H. Greene and P. G. M. Wuts, Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, New York (1999)に記載されている。
</span> <u class="style-scope patent-text">Example 10: Production of ECO-04601 Variants of the Invention A</u> standard approach of organic chemistry <u class="style-scope patent-text">produces a variant of the</u> ECO-04601 molecule, eg, a variant identified herein as Formulas III-LIX. can do. The principles of organic chemistry, including functional groups, reactivity and general protocols, necessary to make and manipulate the compounds described herein can be found in, for example, “Advanced Organic Chemistry,” 3 <sup class="style-scope patent-text">rd</sup> Edition by Jerry March ( 1985), which is incorporated herein by reference in its entirety. Further, those skilled in the art will appreciate that various protecting groups may be used in the synthetic methods described herein without special description. As used herein, a “protecting group” is one or more functional groups such as reactive groups containing oxygen, sulfur, or nitrogen so that the reaction occurs selectively at another reactive site of the polyfunctional compound. Means a group used to block a group. In principle the use of protecting groups, availability and use of a particular functional group, for example TH Greene and PGM Wuts, Protective Groups in Organic Synthesis, 3 rd Edition, John Wiley &amp; Sons, according to New York (1999) Has been.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム１；エポキシド変異体。</u> <br class="style-scope patent-text">
  式IIで表される化合物（ＥＣＯ−０４６０１）から、過安息香酸、モノペルフタル酸等の多くのエポキシド化試薬(epoxidizing reagent)のいずれか、若しくはより好ましくは、テトラヒドロフラン（ＴＨＦ）ジクロロメタン又は１，２−ジクロロエタン等の不活性溶媒中のｍ−クロロ過安息香酸で処理を行って、本発明のエポキシド化合物（例えば、例として式VII〜XIVで表される化合物）を作製する。１分子等量より少し大きいエポキシド化試薬の場合は、モノエポキシドの収量が最大となり、試薬、溶媒、濃度及び反応温度によって、特定のモノエポキシドの形成率が決定されることは、当業者には理解されるであろう。モノエポキシドが鏡像体混合物であり、ジエポキシド及びトリエポキシドをジアステロマーとして作成することができ、反応条件によって生成率が決定されることも理解されるであろう。当業者であれば、ほとんどの反応条件下で、作製物があらゆる可能なエポキシドの混合物となり、これらはクロマトグラフィーの標準的な方法によって分離することを理解するであろう。モノエポキシド、ジエポキシド及びトリエポキシドの産生に関するアプローチの例を下記に示す。
</span> <u class="style-scope patent-text">Scheme 1: Epoxide variant.</u> <br class="style-scope patent-text"> From the compound of formula II (ECO-04601), any of a number of epoxidizing reagents such as perbenzoic acid, monoperphthalic acid, or more preferably tetrahydrofuran (THF) dichloromethane or 1,2- Treatment with m-chloroperbenzoic acid in an inert solvent such as dichloroethane produces the epoxide compounds of the invention (e.g., compounds represented by Formulas VII-XIV as examples). Those skilled in the art will appreciate that for epoxidation reagents slightly larger than one molecular equivalent, the yield of monoepoxide is maximized and the rate of formation of a particular monoepoxide is determined by the reagent, solvent, concentration and reaction temperature. Will be understood. It will also be appreciated that the monoepoxide is an enantiomeric mixture, diepoxides and triepoxides can be made as diasteromers, and the yield is determined by the reaction conditions. One skilled in the art will understand that, under most reaction conditions, the product will be a mixture of all possible epoxides, which are separated by standard methods of chromatography. Examples of approaches related to the production of monoepoxides, diepoxides and triepoxides are given below.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
Ａ）式IIで表される化合物のエポキシド化による式VII、VIII及びIXで表されるモノエポキシド。
</span>
A) Monoepoxides of formulas VII, VIII and IX by epoxidation of compounds of formula II.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン（ＴＨＦ）に溶解した式IIで表される化合物の溶液に、メタ−クロロ過安息酸の１．１等量を添加する。反応物を氷浴で冷却し、０℃で１〜２時間攪拌する。次に反応混合物を乾燥するまで蒸発させ、メタノールに再溶解し、Sephadex ＬＨ−2０のカラムで液体クロマトグラフィーを行い、非反応性の開始物質、ジエポキシド及びトリエポキシドで汚染されている式VII、VIII及びIXの化合物を主に含有する混合物を単離する。式VII、VIII及びXIXで表される化合物を分離し、実施例２に記載のシステムを使用して式IIで表される化合物をＨＰＬＣで精製する。式VII、VIII及びIXで表される各化合物に関して、標準的な実験では、１５〜２５％の収量が得られる。<br class="style-scope patent-text">
Ｂ）式IIで表される化合物のジ−エポキシド化による、式Ｘ、XI、及びXIIで表される化合物の合成。
</span>To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 1.1 equivalent of meta-chloroperbenzoic acid is added. The reaction is cooled in an ice bath and stirred at 0 ° C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol, liquid chromatographed on a Sephadex LH-20 column and contaminated with non-reactive starting materials, diepoxides and triepoxides. And a mixture mainly containing the compound of IX. The compounds of formula VII, VIII and XIX are separated and the compound of formula II is purified by HPLC using the system described in Example 2. For each compound of formula VII, VIII and IX, yields of 15-25% are obtained in standard experiments. <br class="style-scope patent-text"> B) Synthesis of compounds of formula X, XI and XII by di-epoxidation of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン（ＴＨＦ）に溶解した式IIで表される化合物の溶液に、メタ−クロロ過安息酸の２．３等量を添加する。反応物を氷浴で冷却し、０℃で１〜２時間攪拌する。次に反応混合物を乾燥するまで蒸発させ、メタノールに再溶解し、Sephadex ＬＨ−2０のカラムで液体クロマトグラフィーを行い、微量の非反応性の開始物質及びモノエポキシド並びにトリエポキシドをで汚染されている式Ｘ、XI及びXIIの化合物を主に含有する混合物を単離する。式Ｘ、XI及びXIIで表される化合物を分離し、実施例２に記載のシステムを使用して式IIで表される化合物をＨＰＬＣで精製する。標準的な実験では、式Ｘ、XI及びXIIの各化合物に関して１５〜２５％の収量が得られる。<br class="style-scope patent-text">
Ｃ）式IIで表される化合物のトリ−エポキシド化による、式XIIで表される化合物の合成。
</span>To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 2.3 equivalents of meta-chloroperbenzoic acid are added. The reaction is cooled in an ice bath and stirred at 0 ° C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol and liquid chromatographed on a Sephadex LH-20 column, contaminated with traces of non-reactive starting materials and monoepoxides and triepoxides. A mixture containing mainly compounds of the formulas X, XI and XII is isolated. The compounds of formula X, XI and XII are separated and the compound of formula II is purified by HPLC using the system described in Example 2. In standard experiments, yields of 15-25% are obtained for each compound of formula X, XI and XII. <br class="style-scope patent-text"> C) Synthesis of the compound of formula XII by tri-epoxidation of the compound of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="12" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン（ＴＨＦ）に溶解した式IIで表される化合物の溶液に、メタ−クロロ過安息酸の３．５等量を添加する。反応物を氷浴で冷却し、０℃で１〜２時間攪拌する。次に反応混合物を乾燥するまで蒸発させ、メタノールに再溶解し、Sephadex ＬＨ−2０のカラムで液体クロマトグラフィーを行い、式XIIIで表される化合物をジアステロマーの混合物として、８０＋％の収量で単離する。
</span>
&nbsp;&nbsp;To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 3.5 equivalents of meta-chloroperbenzoic acid are added. The reaction is cooled in an ice bath and stirred at 0 ° C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol, subjected to liquid chromatography on a Sephadex LH-20 column and the compound of formula XIII is isolated as a mixture of diasteromers in 80 +% yield. To do.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム２</u>：式IIで表される化合物のＮ−アセチル化による式IIIで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 2</u> : Synthesis of a compound represented by Formula III by N-acetylation of a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="13" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン（ＴＨＦ）に溶解した式IIで表される化合物の溶液に、１．２等量の無水酢酸と２〜３滴のトリエチルアミンとを添加する。反応混合物を室温で１〜２時間静置し、次に反応混合物を減圧下で乾燥するまで蒸発させ、式IIIで表される化合物を極めて純粋な形でほぼ定量的収量で得る。
</span>
&nbsp;&nbsp;To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 1.2 equivalents of acetic anhydride and 2-3 drops of triethylamine are added. The reaction mixture is allowed to stand at room temperature for 1-2 hours and then the reaction mixture is evaporated to dryness under reduced pressure to give the compound of formula III in a very quantitative form in almost quantitative yield.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム３</u>：式IIで表される化合物のＮ−アルキル化による式IV及びＶで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 3</u> : Synthesis of compounds of formulas IV and V by N-alkylation of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラクロロエチレンに溶解した式IIで表される化合物の溶液に、１．２等量の適当な臭化アルキル（式IVで表される化合物には臭化ベンジル又は式Ｖで表される化合物には臭化エチル）を添加する。反応混合物を還流下で１〜２時間加熱し、次に反応混合物を減圧下で乾燥するまで蒸発させ、式VI又はＶで表される化合物をそれぞれ極めて純粋な形でほぼ定量的収量で得る。
</span>
&nbsp;&nbsp;To a solution of the compound represented by Formula II dissolved in tetrachloroethylene, 1.2 equivalents of an appropriate alkyl bromide (benzyl bromide for compounds represented by Formula IV or odor for compounds represented by Formula V) Ethyl chloride) is added. The reaction mixture is heated under reflux for 1-2 hours and then the reaction mixture is evaporated to dryness under reduced pressure to give the compounds of formula VI or V, respectively, in very pure form and in almost quantitative yield.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム４</u>：式IIで表される化合物の、触媒を用いた還元による式XL、XLI、及びXLIIで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 4</u> : Synthesis of compounds of formulas XL, XLI, and XLII by catalytic reduction of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  パラジウム炭素（５％の２５ｍｇ）を含むエタノール（２００ｍｌ）中の式IIで表される化合物（４６２ｍｇ）の溶液を、水素雰囲気下水素化装置中で振盪する。反応による水素の取込みを慎重に測定し、水素１ｍＭが消費される時に振盪を停止し、容器を素早く空にし、雰囲気を窒素と交換する。触媒をろ過して除去し、ろ液を濃縮し、非反応性の開始物質や少量の過還元生成物(over reduced product)が混入した式XL、XLI、及びXLIIで表される化合物の未精製混合物を得る。式XL、XLI、及びXLIIで表される化合物を各約１００ｍｇを得るために、上記の実施例２に記載したシステムを用いて、ＨＰＬＣ又はＨＳＣＣクロマトグラフィーによって目的の生成物を分離し精製してもよい。
</span>
&nbsp;&nbsp;A solution of the compound of formula II (462 mg) in ethanol (200 ml) containing palladium on carbon (5 mg of 25 mg) is shaken in a hydrogenator under a hydrogen atmosphere. Carefully measure the hydrogen uptake by the reaction, stop shaking when 1 mM of hydrogen is consumed, quickly empty the vessel, and replace the atmosphere with nitrogen. Remove the catalyst by filtration, concentrate the filtrate, and unpurify the compounds of formula XL, XLI, and XLII contaminated with non-reactive starting materials and a small amount of over reduced product A mixture is obtained. In order to obtain about 100 mg of each of the compounds of the formulas XL, XLI and XLII, the product of interest is separated and purified by HPLC or HSCC chromatography using the system described in Example 2 above. Also good.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム５</u>：式IIで表される化合物の、触媒を用いた還元による式XLIII、XLIV、及びXLVで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 5</u> : Synthesis of compounds of formulas XLIII, XLIV and XLV by catalytic reduction of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  パラジウム炭素（５％の２５ｍｇ）を含むエタノール（２００ｍｌ）中の式IIで表される化合物（４６２ｍｇ）の溶液を、水素雰囲気下水素化装置中で振盪する。反応による水素の取込みを慎重に測定し、水素２ｍＭが消費される時に振盪を停止し、容器を素早く空にし、雰囲気を窒素と交換する。触媒をろ過して除去し、ろ液を濃縮し、少量の非反応性の開始物質や少量の還元中の又は過還元生成物(under and over reduced product)が混入した式XLIII、XLIV、及びXLVで表される化合物の未精製混合物を得る。式XLIII、XLIV、及びXLVで表される化合物を各約１００ｍｇ得るために、上記の実施例２のシステムを用いて、ＨＰＬＣ又はＨＳＣＣクロマトグラフィーによって目的の生成物を分離及び精製してもよい。
</span>
&nbsp;&nbsp;A solution of the compound of formula II (462 mg) in ethanol (200 ml) containing palladium on carbon (5 mg of 25 mg) is shaken in a hydrogenator under a hydrogen atmosphere. Carefully measure the uptake of hydrogen by the reaction, stop shaking when 2 mM of hydrogen is consumed, quickly empty the vessel and replace the atmosphere with nitrogen. The catalyst is removed by filtration, the filtrate is concentrated, and the formulas XLIII, XLIV, and XLV contaminated with a small amount of non-reactive starting material and a small amount of under-reducing or over-reduced product. To obtain a crude mixture of the compounds represented by: The desired product may be separated and purified by HPLC or HSCC chromatography using the system of Example 2 above to obtain about 100 mg of each of the compounds of formula XLIII, XLIV and XLV.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム６</u>：式IIで表される化合物の、触媒を用いた還元による式XLVIで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 6</u> : Synthesis of a compound represented by Formula XLVI by catalytic reduction of a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="17" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  パラジウム炭素（５％の２５ｍｇ）を含むエタノール（２００ｍｌ）中の式II化合物II（４６２ｍｇ）の溶液を、水素雰囲気下水素化装置中で振盪する。反応による水素の取込みを慎重に測定し、水素３ｍＭが消費される時に振盪を停止し、容器を素早く空にし、雰囲気を窒素と交換する。触媒をろ過して除去し、ろ液を濃縮し、式XLVIで表される化合物の極めて純粋なサンプルを得る。
</span>
&nbsp;&nbsp;A solution of Formula II Compound II (462 mg) in ethanol (200 ml) containing palladium on carbon (5 mg of 25 mg) is shaken in a hydrogenator under a hydrogen atmosphere. Carefully measure the hydrogen uptake by the reaction, stop shaking when 3 mM hydrogen is consumed, empty the vessel quickly, and replace the atmosphere with nitrogen. The catalyst is removed by filtration and the filtrate is concentrated to obtain a very pure sample of the compound of formula XLVI.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム７</u>：式IIで表される化合物の過アセチル化による式VIで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 7</u> : Synthesis of a compound represented by Formula VI by peracetylation of a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="18" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
無水酢酸（５ｍｌ）中の式IIで表される化合物（１００ｍｇ）の溶液をピリジン（２５０μｌ）で処理する。反応混合物を一晩室温で静置し、次にトルエン（１００ｍＬ）で希釈する。かかるトルエン溶液を５％重炭酸ナトリウム水溶液でよく洗浄し、続いて水でよく洗浄し、最後に減圧下で濃縮し、式VIで表される化合物の極めて純粋なサンプルをほぼ定量的収量で得る。<br class="style-scope patent-text">
<u class="style-scope patent-text">スキーム８</u>：式VIIで表される化合物のエポキシドを開放すること(opening the epoxide)による式<u class="style-scope patent-text">LIII</u>で表される化合物の合成。<br class="style-scope patent-text">
 
</span>A solution of the compound of formula II (100 mg) in acetic anhydride (5 ml) is treated with pyridine (250 μl). The reaction mixture is allowed to stand overnight at room temperature and then diluted with toluene (100 mL). Such a toluene solution is washed thoroughly with 5% aqueous sodium bicarbonate solution, followed by water, and finally concentrated under reduced pressure to obtain a very pure sample of the compound of formula VI in almost quantitative yield. . <br class="style-scope patent-text"> <u class="style-scope patent-text">Scheme 8</u> : Synthesis of compound of formula <u class="style-scope patent-text">LIII</u> by opening the epoxide of the compound of formula VII. <br class="style-scope patent-text"> </span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="19" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
      <br class="style-scope patent-text">
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
テトラヒドロフラン（５０ｍｌ）中の式VIIで表される化合物（１００ｍｇ）の溶液を、１Ｎの塩酸溶液（５ｍｌ）で処理する。反応混合物を室温で一晩攪拌し、トルエン（１００ｍｌ）で希釈し、続いて水（２００ｍｌ）で希釈する。トルエン層を分離し、水層を更に１００ｍｌのトルエンで抽出する。混合したトルエン層を水（５０ｍｌ）でもう一度洗浄し、分離し、真空で乾燥し、式<u class="style-scope patent-text">LIII</u>で表されるビシナルグリコール化合物を得る。<br class="style-scope patent-text">
<u class="style-scope patent-text">スキーム９</u>：式IIで表される化合物のオゾン分解による式XLVII、XLIX及びLIで表される化合物の合成。<br class="style-scope patent-text">
 
</span>A solution of the compound of formula VII (100 mg) in tetrahydrofuran (50 ml) is treated with a 1N hydrochloric acid solution (5 ml). The reaction mixture is stirred at room temperature overnight, diluted with toluene (100 ml) followed by water (200 ml). The toluene layer is separated and the aqueous layer is further extracted with 100 ml of toluene. The combined toluene layer is washed once more with water (50 ml), separated and dried in vacuo to give the vicinal glycol compound of formula <u class="style-scope patent-text">LIII</u> . <br class="style-scope patent-text"> <u class="style-scope patent-text">Scheme 9</u> : Synthesis of compounds of formulas XLVII, XLIX and LI by ozonolysis of compounds of formula II. <br class="style-scope patent-text"> </span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="20" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ドライエチルアセテート（２００ｍｌ）中の式IIで表される化合物（４６２ｇ）の溶液を、オゾン分解装置で−２０℃より低温まで冷却する。酸素を含むオゾンが、オゾン発生率がわかるように予めキャリブレーションされたオゾン発生装置からかかる溶液に流れ込む。主に式XLVIIで表される化合物を得るために、オゾン０．９ｍＭが発生した後オゾン経路を停止する。主に式XLIXで表される化合物を得るために、オゾン２ｍＭが発生した後オゾン経路を停止し、主な生成物として式LIで表される化合物を得るために、オゾン３．３ｍＭを発生させる。
</span>
&nbsp;&nbsp;A solution of the compound of formula II (462 g) in dry ethyl acetate (200 ml) is cooled to below -20 ° C. with an ozonolysis apparatus. Ozone containing oxygen flows into such a solution from an ozone generator calibrated in advance so that the ozone generation rate is known. In order to obtain a compound mainly represented by the formula XLVII, the ozone pathway is stopped after 0.9 mM of ozone is generated. In order to obtain the compound represented mainly by the formula XLIX, the ozone pathway is stopped after the generation of 2 mM ozone, and 3.3 mM ozone is generated to obtain the compound represented by the formula LI as the main product. .
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  オゾン分解が完了する時に、反応混合物を水素化装置に移し、５％パラジウム炭酸カルシウム触媒（０．２ｇ）を、−２０℃より低温に維持され、水素化された反応混合物に添加する。水素の取込みが完了する時に、水素雰囲気を窒素と交換し、反応混合物を室温にし、ろ過して触媒を除去し、ろ液を濃縮する。式XLVII、XLIX及びLIで表される化合物を得るために、実施例２に記載されるシステムとＨＰＬＣ又はＨＳＣＣのいずれかとを使用して、オゾンの使用量に応じてクロマトグラフィーで未精製の生成物を精製する。
</span>
&nbsp;&nbsp;When ozonolysis is complete, the reaction mixture is transferred to a hydrogenator and 5% palladium calcium carbonate catalyst (0.2 g) is added to the hydrogenated reaction mixture maintained below -20 ° C. When the hydrogen uptake is complete, the hydrogen atmosphere is replaced with nitrogen, the reaction mixture is allowed to reach room temperature, filtered to remove the catalyst, and the filtrate is concentrated. In order to obtain the compounds of the formulas XLVII, XLIX and LI, using the system described in Example 2 and either HPLC or HSCC, chromatographic crude production depending on the amount of ozone used. The product is purified.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム１０</u>：式XLVIIで表される化合物のアルデヒドの還元による式XLVIIIで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 10</u> : Synthesis of compound of formula XLVIII by reduction of aldehyde of compound of formula XLVII.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="21" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  イソプロパノール（５ｍｌ）中の式XLVIIIで表される化合物（５０ｍｇ）の溶液を、氷−塩浴で冷却し、ホウ酸ナトリウム（１０ｍｇ）を添加し、混合物を２０分間攪拌する。次に水（２０ｍｌ）で希釈し、トルエン（１０ｍｌポーション）を用いて外界温度で２回抽出する。混合したトルエン抽出物をろ過し、ろ液を濃縮し、式XLVIIで表される化合物を得る。
</span>
&nbsp;&nbsp;A solution of the compound of formula XLVIII (50 mg) in isopropanol (5 ml) is cooled in an ice-salt bath, sodium borate (10 mg) is added and the mixture is stirred for 20 minutes. It is then diluted with water (20 ml) and extracted twice with toluene (10 ml portion) at ambient temperature. The combined toluene extract is filtered and the filtrate is concentrated to give the compound of formula XLVII.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム１１</u>：式XLIIで表される化合物のエポキシ化による式XIV及びXVで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 11</u> : Synthesis of compounds of formulas XIV and XV by epoxidation of compounds of formula XLII.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="22" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン（ＴＨＦ）に溶解した式XLIIで表される化合物の溶液に、メタ−クロロ過安息酸の１．１等量を添加する。反応物を氷浴で冷却し、０℃で１〜２時間攪拌する。次に反応混合物を乾燥するまで蒸発させ、メタノールに再溶解し、Sephadex ＬＨ−2０のカラムで液体クロマトグラフィーを行い、非反応性の開始物質及びジエポキシドが混入している式XIV及びXVの化合物の混合物を主に単離する。式IIで表される化合物の精製について実施例２に記載した方法の１つを使用して、ＨＰＬＣ又はＨＳＣＣを用いて、式XIV及びXVで表される化合物を分離し、精製する。典型的な実験では、式XIV及びXVで表される各化合物それぞれについて３５〜４０％の収量が得られる。
</span>
&nbsp;&nbsp;To a solution of the compound of formula XLII dissolved in tetrahydrofuran (THF), 1.1 equivalent of meta-chloroperbenzoic acid is added. The reaction is cooled in an ice bath and stirred at 0 ° C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol, liquid chromatographed on a Sephadex LH-20 column and mixed with non-reactive starting materials and compounds of formulas XIV and XV contaminated with diepoxide. The mixture is mainly isolated. Using one of the methods described in Example 2 for purification of the compound of Formula II, the compounds of Formula XIV and XV are separated and purified using HPLC or HSCC. In a typical experiment, a yield of 35-40% is obtained for each of the compounds of formulas XIV and XV.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム１２</u>：式XLで表される化合物のエポキシ化による式XIXで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 12</u> : Synthesis of compound of formula XIX by epoxidation of compound of formula XL.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="23" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン（ＴＨＦ）に溶解した式XLで表される化合物の溶液に、メタ−クロロ過安息酸の２．２等量を添加する。反応物を氷浴で冷却し、０℃で１〜２時間攪拌する。次に反応混合物を乾燥するまで蒸発させ、メタノールに再溶解し、Sephadex ＬＨ−2０のカラムで液体クロマトグラフィーを行い、極めて純粋な高収量の式XIXで表される化合物を単離する。
</span>
&nbsp;&nbsp;To a solution of the compound of formula XL dissolved in tetrahydrofuran (THF), 2.2 equivalents of meta-chloroperbenzoic acid are added. The reaction is cooled in an ice bath and stirred at 0 ° C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol and subjected to liquid chromatography on a Sephadex LH-20 column to isolate a very pure, high yield compound of formula XIX.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム１３</u>：式IIで表される化合物のエステル化による式XXVI、XXVII及びXXVIIIで表される化合物の合成。
</span> <u class="style-scope patent-text">Scheme 13</u> : Synthesis of compounds of formulas XXVI, XXVII and XXVIII by esterification of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="24" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  トルエン（９部）テトラヒドロフラン（１部）に溶解し、氷浴で冷却した式IIで表される化合物の溶液に、無水酢酸の１．１等量と三フッ化ホウ素エーテル２滴とを添加する。反応物を氷浴中で低温に維持し、０℃で１〜２時間攪拌する。反応混合物を５％重炭酸ナトリウム水溶液に注ぎ入れて振盪し、トルエン層を除去する。水層をトルエンで再抽出し、混合したトルエン層を濃縮し、非反応性の開始物質及びジアセテートが混入した、式XXVI、XXVII、及びXXVIIIで表される化合物を主に含む混合物を作製する。式IIで表される化合物の精製について実施例２に記載した方法の１つを使用して、ＨＰＬＣ又はＨＳＣＣを用いて、式XXVI、XXVII、及びXXVIIIで表される化合物を分離し、精製する。典型的な実験では、式XXVI、XXVII、及びXXVIIIで表される各化合物それぞれについて２５〜３０％の収量が得られる。
</span>
&nbsp;&nbsp;To a solution of the compound of formula II dissolved in toluene (9 parts) tetrahydrofuran (1 part) and cooled in an ice bath, 1.1 equivalents of acetic anhydride and 2 drops of boron trifluoride ether are added. . The reaction is kept cold in an ice bath and stirred at 0 ° C. for 1-2 hours. The reaction mixture is poured into 5% aqueous sodium bicarbonate and shaken to remove the toluene layer. Re-extract the aqueous layer with toluene and concentrate the combined toluene layers to make a mixture mainly containing compounds of formulas XXVI, XXVII, and XXVIII mixed with non-reactive starting materials and diacetate. . Using one of the methods described in Example 2 for purification of the compound of formula II, the compounds of formula XXVI, XXVII, and XXVIII are separated and purified using HPLC or HSCC. . In typical experiments, yields of 25-30% are obtained for each of the compounds of formula XXVI, XXVII, and XXVIII.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">スキーム１４</u>：式IIで表される化合物のメチル化による式XXXIII、XXXIV及びXXXVで表される化合物の合成
</span> <u class="style-scope patent-text">Scheme 14</u> : Synthesis of compounds of formula XXXIII, XXXIV and XXXV by methylation of compounds of formula II</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="25" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  テトラヒドロフラン５０（ｍｌ）中の式IIで表される化合物（１ｇ）の溶液を、正確に１等量のナトリウムメトキシドで滴定し、３０分間室温で静置し、１．２等量の硫酸ジメチルで処理する。該混合物を１時間還流下で過熱し、室温まで冷却し、トルエン（２００ｍｌ）と水（２００ｍｌ）との混合物に注ぎ入れる。層を分離し、水層を等量のトルエンで再度抽出する。混合したトルエン層を酢酸溶液１Ｎで１回洗浄し、未精製の生成物にまで濃縮する。この未精製の生成物は、非反応性の開始物質や少量の過メチル化誘導体(over-methylated derivatives)と共に、式XXXIII、XXXIV、及びXXXVの化合物を主に含む混合物である。実施例２に記載した方法を使用し、ＨＰＬＣ又はＨＳＣＣクロマトグラフィーによって、望ましい生成物を分離し、精製し、式XXXIII、XXXIV及びXXXVで表される化合物がそれぞれ約２００ｇ得られる。
</span>
&nbsp;&nbsp;A solution of the compound of formula II (1 g) in 50 ml of tetrahydrofuran was titrated with exactly 1 equivalent of sodium methoxide, allowed to stand at room temperature for 30 minutes and 1.2 equivalents of dimethyl sulfate. Process with. The mixture is heated at reflux for 1 hour, cooled to room temperature and poured into a mixture of toluene (200 ml) and water (200 ml). The layers are separated and the aqueous layer is extracted again with an equal volume of toluene. The combined toluene layer is washed once with 1N acetic acid solution and concentrated to the crude product. This crude product is a mixture mainly comprising compounds of formula XXXIII, XXXIV and XXXV, together with non-reactive starting materials and small amounts of over-methylated derivatives. The desired product is isolated and purified by HPLC or HSCC chromatography using the method described in Example 2 to give about 200 g of compounds of formula XXXIII, XXXIV and XXXV, respectively.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１１：式で表される化合物を生成するための遺伝子及びタンパク質</u> <br class="style-scope patent-text">
  Micromonospora sp.０４６−ＥＣＯ１１株は、本発明の化合物を生成するために有用な微生物の代表である。２００３年３月７日に、カナダ保健省、微生物部、カナダ国際寄託当局（ＩＤＡＣ）、1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)に０４６−ＥＣＯ１１株を寄託した。ＩＤＡＣアクセッション番号は第０７０３０３−０１である。米国特許第１０／２３２，３７０号、カナダ国特許第２，３５２，４５１号、及びZazopoulos et. al., Nature Biotechnol., 21, 187-190 (2003) に記載されたゲノムのスキャン方法を用いて、式IIで表される化合物を生成するための生合成遺伝子座をMicromonospora sp.０４６−ＥＣＯ１１株のゲノム中に同定した。
</span> <u class="style-scope patent-text">Example 11: Gene and protein for producing the compound represented by the formula</u> <br class="style-scope patent-text"> Micromonospora sp. 046-ECO11 strain is a representative of microorganisms useful for producing the compounds of the present invention. On March 7, 2003, the 046-ECO11 strain was deposited at Health Canada, Department of Microbiology, Canadian International Depository Authority (IDAC), 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2). The IDAC accession number is 070303-01. Using the genome scanning method described in US Patent No. 10 / 232,370, Canadian Patent No. 2,352,451, and Zazopoulos et. Al., Nature Biotechnol., 21, 187-190 (2003) Thus, a biosynthetic locus for producing a compound represented by the formula II was identified in the genome of Micromonospora sp. 046-ECO11 strain.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  生合成遺伝子座は、ＤＮＡの約５２，４００の塩基対に及んでおり、４３のタンパク質をコードする。１０キロ塩基より長いＤＮＡ配列を、遺伝子座の各側で分析し、これらの領域について、一次遺伝子又は式IIで表される化合物の合成に関連していない遺伝子を含んでいるとみなした。図１２に示すように、遺伝子座は、連続した塩基対の３つの配列に含まれる。すなわち、配列番号１で表される３６，６０２の連続した塩基対を有し、ＯＲＦ１〜３１（配列番号３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、４１、４３、４５、４７、４９、５１、５３、５５、５７、５９、６１、及び６３）を含むコンティグ１、配列番号６４で表される５，９６０の連続した塩基対を有し、ＯＲＦ３２〜３５（配列番号６６、６８、７０、及び７２）を含むコンティグ２、及び配列番号７３で表される９，７６２の塩基対を有し、ＯＲＦ３６〜４３（配列番号７５、７７、７９、８１、８３、８５、８７、及び８９）を含むコンティグ３である。生合成遺伝子座のタンパク質を表す、４３のオープンリーディングフレームの順番、相対位置、及び配向を、図１２に模式的に示す。図１２の上の線は、塩基対のメモリを示す。灰色の横線は、遺伝子座にまたがる３つのＤＮＡコンティグ（配列番号１、６４、及び７３）を表す。中白の矢印は本生合成遺伝子座の４３のオープンリーディングフレームを示す。黒矢印は遺伝子座にまたがる寄託した２つのコスミドクローンを示す。
</span>
&nbsp;&nbsp;The biosynthetic locus spans approximately 52,400 base pairs of DNA and encodes 43 proteins. DNA sequences longer than 10 kilobases were analyzed on each side of the locus, and these regions were considered to contain primary genes or genes not involved in the synthesis of the compound represented by Formula II. As shown in FIG. 12, the locus is contained in three sequences of consecutive base pairs. That is, it has 36,602 consecutive base pairs represented by SEQ ID NO: 1, and ORF 1 to 31 (SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, and 63). Contig 2 containing ORF 32 to 35 (SEQ ID NOs: 66, 68, 70, and 72) and 9,762 base pairs represented by SEQ ID NO: 73 And Contig 3 including ORFs 36 to 43 (SEQ ID NOs: 75, 77, 79, 81, 83, 85, 87, and 89). The order, relative position, and orientation of 43 open reading frames representing proteins at the biosynthetic locus are schematically shown in FIG. The upper line in FIG. 12 shows base pair memory. The gray horizontal line represents three DNA contigs (SEQ ID NOs: 1, 64, and 73) that span the locus. The white arrow indicates 43 open reading frames of the biosynthetic locus. Black arrows indicate the two cosmid clones deposited across the locus.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  コンティグのヌクレオチド配列及び、Micromonospora sp.０４６−ＥＣＯ１１株の遺伝子座の推測されるアミノ酸配列を示す配列表を参照することにより、生合成遺伝子座を更に理解することができるであろう。コンティグのヌクレオチド配列は、生合成遺伝子座に見られるように、コンティグ１（配列番号１）がコンティグ２（配列番号６４）の５‘末端に近接し、同様にコンティグ３（配列番号７３）に近接するように配置されている。ＯＲＦは図１２に示され、コンティグ１、２、及び３のヌクレオチド配列（配列番号１、６４、及び７３）から推測されるオープンリーディングフレームを表す配列表を示している。配列表に関して、ＯＲＦ１（配列番号３）は、配列番号１の２１３９〜４２４残基に由来するポリヌクレオチドであり、配列番号２は、配列番号３から推測されるポリペプチドを表している。ＯＲＦ２（配列番号５）は配列番号１の２８９０〜４９５９残基に由来するポリヌクレオチドであり、配列番号４は、配列番号５から推測されるポリペプチドを表している。ＯＲＦ３（配列番号７）は、配列番号１の７７０１〜５０１４残基に由来するポリヌクレオチドであり、配列番号６は、配列番号７から推測されるポリペプチドを表している。ＯＲＦ４（配列番号９）は、配列番号１の８１０４〜９１９２残基に由来するポリヌクレオチドであり、配列番号８は、配列番号９から推測されるポリペプチドを表している。ＯＲＦ５（配列番号１１）は、配列番号１の９１９２〜１０２５６残基に由来するポリヌクレオチドであり、配列番号１０は、配列番号１１から推測されるポリペプチドを表している。ＯＲＦ６（配列番号１３）は、配列番号１の１０２４６〜１１２８６残基に由来するポリヌクレオチドであり、配列番号１２は、配列番号１３から推測されるポリペプチドを表している。ＯＲＦ７（配列番号１５）は、配列番号１の１１２８３〜１２３９２残基に由来するポリヌクレオチドであり、配列番号１４は、配列番号１５から推測されるポリペプチドを表している。ＯＲＦ８（配列番号１７）は、配列番号１の１２３８９〜１３４７１残基に由来するポリヌクレオチドであり、配列番号１６は、配列番号１７から推測されるポリペプチドを表している。ＯＲＦ９（配列番号１９）は、配列番号１の１３４６８〜１４５２３残基に由来するポリヌクレオチドであり、配列番号１８は、配列番号１９から推測されるポリペプチドを表している。ＯＲＦ１０（配列番号２１）は、配列番号１の１４５２６〜１５７０１残基に由来するポリヌクレオチドであり、配列番号２０は、配列番号２１から推測されるポリペプチドを表している。ＯＲＦ１１（配列番号２３）は、配列番号１の１５７７０〜１６６４２残基に由来するポリヌクレオチドであり、配列番号２２は、配列番号２３から推測されるポリペプチドを表している。ＯＲＦ１２（配列番号２５）は、配列番号１の１６７５６〜１７８６８残基に由来するポリヌクレオチドであり、配列番号２４は、配列番号２５から推測されるポリペプチドを表している。ＯＲＦ１３（配列番号２７）は、配列番号１の１７８６５〜１８５２７残基に由来するポリヌクレオチドであり、配列番号２６は、配列番号２７から推測されるポリペプチドを表している。ＯＲＦ１４（配列番号２９）は、配列番号１の１８７２４〜１９１１９残基に由来するポリヌクレオチドであり、配列番号２８は、配列番号２９から推測されるポリペプチドを表している。ＯＲＦ１５（配列番号３１）は、配列番号１の１９１７５〜１９６３９残基に由来するポリヌクレオチドであり、配列番号３０は、配列番号３１から推測されるポリペプチドを表している。ＯＲＦ１６（配列番号３３）は、配列番号１の１９６３６〜２１６２１残基に由来するポリヌクレオチドであり、配列番号３２は、配列番号３３から推測されるポリペプチドを表している。ＯＲＦ１７（配列番号３５）は、配列番号１の２１６３２〜２２０２１残基に由来するポリヌクレオチドであり、配列番号３４は、配列番号３５から推測されるポリペプチドを表している。ＯＲＦ１８（配列番号３７）は、配列番号１の残基２２６５８〜２２１２２に由来するポリヌクレオチドであり、配列番号３６は、配列番号３７から推測されるポリペプチドを表している。ＯＲＦ１９（配列番号３９）は、配列番号１の２４６６５〜２２６８０残基に由来するポリヌクレオチドであり、配列番号３８は、配列番号３９から推測されるポリペプチドを表している。ＯＲＦ２０（配列番号４１）は、配列番号１の２４８８０〜２６１６３残基に由来するポリヌクレオチドであり、配列番号４０は、配列番号４１から推測されるポリペプチドである。ＯＲＦ２１（配列番号４３）は、配列番号１の２６１７９〜２７００３残基に由来するポリヌクレオチドであり、配列番号４２は、配列番号４３から推測されるポリペプチドを表している。ＯＲＦ２２（配列番号４５）は、配列番号１の２７０３５〜２８１３８残基に由来するポリヌクレオチドであり、配列番号４４は、配列番号４５から推測されるポリペプチドを表している。ＯＲＦ２３（配列番号４７）は、配列番号１の２８１６４〜２８９２５残基に由来するポリヌクレオチドであり、配列番号４６は、配列番号４７から推測されるポリペプチドを表している。ＯＲＦ２４（配列番号４９）は、配列番号１の２８９２２〜３０２３８残基に由来するポリヌクレオチドであり、配列番号４８は、配列番号４９から推測されるポリペプチドを表している。ＯＲＦ２５（配列番号５１）は、配列番号１の３０２４９〜３１４３９残基に由来するポリヌクレオチドであり、配列番号５０は、配列番号５１から推測されるポリペプチドを表している。ＯＲＦ２６（配列番号５３）は、配列番号１の３１４３９〜３２２２４残基に由来するポリヌクレオチドであり、配列番号５２は、配列番号５３から推測されるポリペプチドを表している。ＯＲＦ２７（配列番号５５）は、配列番号１の３２２５７〜３２９３１残基に由来するポリヌクレオチドであり、配列番号５４は、配列番号５５から推測されるポリペプチドを表している。ＯＲＦ２８（配列番号５７）は、配列番号１の３２９４３〜３３６４４残基に由来するポリヌクレオチドであり、配列番号５６は、配列番号５７から推測されるポリペプチドを表している。ＯＲＦ２９（配列番号５９）は、配列番号１の３４３７７〜３３６３７残基に由来するポリヌクレオチドであり、配列番号５８は、配列番号５９から推測されるポリペプチドを表している。ＯＲＦ３０（配列番号６１）は、配列番号１の３４５７２〜３２９０７残基に由来するポリヌクレオチドであり、配列番号６０は、配列番号６１から推測されるポリペプチドを表している。ＯＲＦ３１（配列番号６３）は、配列番号１の３４９０４〜３６５８３残基に由来するポリヌクレオチドであり、配列番号６２は、配列番号６３から推測されるポリペプチドを表している。ＯＲＦ３２（配列番号６６）は、配列番号６４の残基２３〜１６２１に由来するポリヌクレオチドであり、配列番号６５は、配列番号６６から推測されるポリペプチドを表している。ＯＲＦ３３（配列番号６８）は、配列番号６４の１７０２〜２９７３残基に由来するポリヌクレオチドであり、配列番号６７は、配列番号６８から推測されるポリペプチドを表している。ＯＲＦ３４（配列番号７０）は、配列番号６４の３２４８〜４２７０残基に由来するポリヌクレオチドであり、配列番号６９は、配列番号７０から推測されるポリペプチドを表している。ＯＲＦ３５（配列番号７２）は、配列番号６４の４４５２〜５９３３残基に由来するポリヌクレオチドであり、配列番号７１は、配列番号７２から推測されるポリペプチドを表している。ＯＲＦ３６（配列番号７５）は、配列番号７３の３０〜３９８残基に由来するポリヌクレオチドであり、配列番号７４は、配列番号７５から推測されるポリペプチドを表している。ＯＲＦ３７（配列番号７７）は、配列番号７３の３９５〜１３７２残基に由来するポリヌクレオチドであり、配列番号７６は、配列番号７７から推測されるポリペプチドを表している。ＯＲＦ３８（配列番号７９）は、配列番号７３の３３８８〜１３９７残基に由来するポリヌクレオチドであり、配列番号７８は、配列番号７９から推測されるポリペプチドを表している。ＯＲＦ３９（配列番号８１）は、配列番号７３の３５６５〜５２８６残基に由来するポリヌクレオチドであり、配列番号８０は、配列番号８１から推測されるポリペプチドを表している。ＯＲＦ４０（配列番号８３）は、配列番号７３の５２８３〜７０７３残基に由来するポリヌクレオチドであり、配列番号８２は、配列番号８３から推測されるポリペプチドを表している。ＯＲＦ４１（配列番号８５）は、配列番号７３の７１０８〜８６３１残基に由来するポリヌクレオチドであり、配列番号８４は、配列番号８５から推測されるポリペプチドを表している。ＯＲＦ４２（配列番号８７）は、配列番号７３の９３７１〜８６７３残基に由来するポリヌクレオチドであり、配列番号８６は、配列番号８７から推測されるポリペプチドを表している。ＯＲＦ４３（配列番号８９）は、配列番号７３の残基９７６２〜９３６４に由来するポリヌクレオチドであり、配列番号８８は、配列番号８９から推測されるポリペプチドを表している。
</span>
&nbsp;&nbsp;A further understanding of the biosynthetic locus can be obtained by reference to the sequence listing showing the nucleotide sequence of the contig and the deduced amino acid sequence of the locus of Micromonospora sp. 046-ECO11. Contig's nucleotide sequence is that contig 1 (SEQ ID NO: 1) is close to the 5 'end of contig 2 (SEQ ID NO: 64) as well as contig 3 (SEQ ID NO: 73) as seen in the biosynthetic locus. Are arranged to be. The ORF is shown in FIG. 12 and shows a sequence listing representing the open reading frame deduced from the nucleotide sequences of contigs 1, 2, and 3 (SEQ ID NO: 1, 64, and 73). Regarding the sequence listing, ORF1 (SEQ ID NO: 3) is a polynucleotide derived from residues 2139 to 424 of SEQ ID NO: 1, and SEQ ID NO: 2 represents a polypeptide deduced from SEQ ID NO: 3. ORF2 (SEQ ID NO: 5) is a polynucleotide derived from residues 2890-4959 of SEQ ID NO: 1, and SEQ ID NO: 4 represents a polypeptide deduced from SEQ ID NO: 5. ORF3 (SEQ ID NO: 7) is a polynucleotide derived from residues 7701 to 5014 of SEQ ID NO: 1, and SEQ ID NO: 6 represents a polypeptide deduced from SEQ ID NO: 7. ORF4 (SEQ ID NO: 9) is a polynucleotide derived from residues 8104 to 9192 of SEQ ID NO: 1, and SEQ ID NO: 8 represents a polypeptide deduced from SEQ ID NO: 9. ORF5 (SEQ ID NO: 11) is a polynucleotide derived from residues 9192-10256 of SEQ ID NO: 1, and SEQ ID NO: 10 represents a polypeptide deduced from SEQ ID NO: 11. ORF6 (SEQ ID NO: 13) is a polynucleotide derived from residues 10246 to 11286 of SEQ ID NO: 1, and SEQ ID NO: 12 represents a polypeptide deduced from SEQ ID NO: 13. ORF7 (SEQ ID NO: 15) is a polynucleotide derived from residues 11283 to 12392 of SEQ ID NO: 1, and SEQ ID NO: 14 represents a polypeptide deduced from SEQ ID NO: 15. ORF8 (SEQ ID NO: 17) is a polynucleotide derived from residues 12389-13471 of SEQ ID NO: 1, and SEQ ID NO: 16 represents a polypeptide deduced from SEQ ID NO: 17. ORF9 (SEQ ID NO: 19) is a polynucleotide derived from residues 13468 to 14523 of SEQ ID NO: 1, and SEQ ID NO: 18 represents a polypeptide deduced from SEQ ID NO: 19. ORF10 (SEQ ID NO: 21) is a polynucleotide derived from residues 14526 to 15701 of SEQ ID NO: 1, and SEQ ID NO: 20 represents a polypeptide deduced from SEQ ID NO: 21. ORF11 (SEQ ID NO: 23) is a polynucleotide derived from residues 15770-16642 of SEQ ID NO: 1, and SEQ ID NO: 22 represents a polypeptide deduced from SEQ ID NO: 23. ORF12 (SEQ ID NO: 25) is a polynucleotide derived from residues 16756 to 17868 of SEQ ID NO: 1, and SEQ ID NO: 24 represents a polypeptide deduced from SEQ ID NO: 25. ORF13 (SEQ ID NO: 27) is a polynucleotide derived from residues 17865 to 18527 of SEQ ID NO: 1, and SEQ ID NO: 26 represents a polypeptide deduced from SEQ ID NO: 27. ORF14 (SEQ ID NO: 29) is a polynucleotide derived from residues 18724 to 19119 of SEQ ID NO: 1, and SEQ ID NO: 28 represents a polypeptide deduced from SEQ ID NO: 29. ORF15 (SEQ ID NO: 31) is a polynucleotide derived from residues 19175 to 19639 of SEQ ID NO: 1, and SEQ ID NO: 30 represents a polypeptide deduced from SEQ ID NO: 31. ORF16 (SEQ ID NO: 33) is a polynucleotide derived from residues 19636 to 21621 of SEQ ID NO: 1, and SEQ ID NO: 32 represents a polypeptide deduced from SEQ ID NO: 33. ORF17 (SEQ ID NO: 35) is a polynucleotide derived from residues 21632 to 22021 of SEQ ID NO: 1, and SEQ ID NO: 34 represents a polypeptide deduced from SEQ ID NO: 35. ORF18 (SEQ ID NO: 37) is a polynucleotide derived from residues 22658-22122 of SEQ ID NO: 1, and SEQ ID NO: 36 represents a polypeptide deduced from SEQ ID NO: 37. ORF19 (SEQ ID NO: 39) is a polynucleotide derived from residues 24665 to 22680 of SEQ ID NO: 1, and SEQ ID NO: 38 represents a polypeptide deduced from SEQ ID NO: 39. ORF20 (SEQ ID NO: 41) is a polynucleotide derived from 24880 to 26163 residues of SEQ ID NO: 1, and SEQ ID NO: 40 is a polypeptide deduced from SEQ ID NO: 41. ORF21 (SEQ ID NO: 43) is a polynucleotide derived from residues 26179 to 27003 of SEQ ID NO: 1, and SEQ ID NO: 42 represents a polypeptide deduced from SEQ ID NO: 43. ORF22 (SEQ ID NO: 45) is a polynucleotide derived from residues 27035 to 28138 of SEQ ID NO: 1, and SEQ ID NO: 44 represents a polypeptide deduced from SEQ ID NO: 45. ORF23 (SEQ ID NO: 47) is a polynucleotide derived from residues 28164 to 28925 of SEQ ID NO: 1, and SEQ ID NO: 46 represents a polypeptide deduced from SEQ ID NO: 47. ORF24 (SEQ ID NO: 49) is a polynucleotide derived from 28922-30238 residues of SEQ ID NO: 1, and SEQ ID NO: 48 represents a polypeptide deduced from SEQ ID NO: 49. ORF25 (SEQ ID NO: 51) is a polynucleotide derived from residues 30249 to 31439 of SEQ ID NO: 1, and SEQ ID NO: 50 represents a polypeptide deduced from SEQ ID NO: 51. ORF26 (SEQ ID NO: 53) is a polynucleotide derived from residues 31439 to 32224 of SEQ ID NO: 1, and SEQ ID NO: 52 represents a polypeptide deduced from SEQ ID NO: 53. ORF27 (SEQ ID NO: 55) is a polynucleotide derived from residues 32257 to 32931 of SEQ ID NO: 1, and SEQ ID NO: 54 represents a polypeptide deduced from SEQ ID NO: 55. ORF28 (SEQ ID NO: 57) is a polynucleotide derived from residues 32943 to 33644 of SEQ ID NO: 1, and SEQ ID NO: 56 represents a polypeptide deduced from SEQ ID NO: 57. ORF29 (SEQ ID NO: 59) is a polynucleotide derived from residues 34377 to 33637 of SEQ ID NO: 1, and SEQ ID NO: 58 represents a polypeptide deduced from SEQ ID NO: 59. ORF30 (SEQ ID NO: 61) is a polynucleotide derived from residues 34572 to 32907 of SEQ ID NO: 1, and SEQ ID NO: 60 represents a polypeptide deduced from SEQ ID NO: 61. ORF31 (SEQ ID NO: 63) is a polynucleotide derived from residues 34904 to 36583 of SEQ ID NO: 1, and SEQ ID NO: 62 represents a polypeptide deduced from SEQ ID NO: 63. ORF32 (SEQ ID NO: 66) is a polynucleotide derived from residues 23 to 1621 of SEQ ID NO: 64, and SEQ ID NO: 65 represents a polypeptide deduced from SEQ ID NO: 66. ORF33 (SEQ ID NO: 68) is a polynucleotide derived from residues 1702 to 2973 of SEQ ID NO: 64, and SEQ ID NO: 67 represents a polypeptide deduced from SEQ ID NO: 68. ORF34 (SEQ ID NO: 70) is a polynucleotide derived from residues 3248 to 4270 of SEQ ID NO: 64, and SEQ ID NO: 69 represents a polypeptide deduced from SEQ ID NO: 70. ORF35 (SEQ ID NO: 72) is a polynucleotide derived from residues 4452 to 5933 of SEQ ID NO: 64, and SEQ ID NO: 71 represents a polypeptide deduced from SEQ ID NO: 72. ORF36 (SEQ ID NO: 75) is a polynucleotide derived from residues 30 to 398 of SEQ ID NO: 73, and SEQ ID NO: 74 represents a polypeptide deduced from SEQ ID NO: 75. ORF37 (SEQ ID NO: 77) is a polynucleotide derived from residues 395 to 1372 of SEQ ID NO: 73, and SEQ ID NO: 76 represents a polypeptide deduced from SEQ ID NO: 77. ORF38 (SEQ ID NO: 79) is a polynucleotide derived from residues 3388 to 1397 of SEQ ID NO: 73, and SEQ ID NO: 78 represents a polypeptide deduced from SEQ ID NO: 79. ORF39 (SEQ ID NO: 81) is a polynucleotide derived from residues 3565 to 5286 of SEQ ID NO: 73, and SEQ ID NO: 80 represents a polypeptide deduced from SEQ ID NO: 81. ORF40 (SEQ ID NO: 83) is a polynucleotide derived from residues 5283 to 7073 of SEQ ID NO: 73, and SEQ ID NO: 82 represents a polypeptide deduced from SEQ ID NO: 83. ORF41 (SEQ ID NO: 85) is a polynucleotide derived from residues 7108 to 8631 of SEQ ID NO: 73, and SEQ ID NO: 84 represents a polypeptide deduced from SEQ ID NO: 85. ORF42 (SEQ ID NO: 87) is a polynucleotide derived from residues 9371 to 8673 of SEQ ID NO: 73, and SEQ ID NO: 86 represents a polypeptide deduced from SEQ ID NO: 87. ORF43 (SEQ ID NO: 89) is a polynucleotide derived from residues 9762 to 9364 of SEQ ID NO: 73, and SEQ ID NO: 88 represents a polypeptide deduced from SEQ ID NO: 89.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列表に示されるいくつかのオープンリーディングフレーム、すなわちＯＲＦ２（配列番号５）、ＯＲＦ５（配列番号１１）、ＯＲＦ１２（配列番号２５）、ＯＲＦ１３（配列番号２７）、ＯＲＦ１５（配列番号３１）、ＯＲＦ１７（配列番号３５）、ＯＲＦ１９（配列番号３９）、ＯＲＦ２０（配列番号４１）、ＯＲＦ２２（配列番号４５）、ＯＲＦ２４（配列番号４９）、ＯＲＦ２６（配列番号５３）、及びＯＲＦ２７（配列番号５５）は、標準的な開始コドンＡＴＧメチオニンではなく、標準的でない開始コドン（例えば、ＧＴＧ−バリン又はＣＴＧ−ロイシン）で始まる。該ＯＲＦの第一コドンの特異性を表すために、アミノ末端位置に適当なＭ、Ｖ又はＬアミノ酸を有する、全てのＯＲＦを例挙する。しかし、コードする遺伝子が標準的でない開始コドンをコードする場合であっても、細菌でのタンパク質合成はメチオニン（ホルミルメチオニン）で始まる（例えば、Stryer BioChemistry 3<sup class="style-scope patent-text">rd</sup> edition, 1998, W.H. Freeman and Co., New York, pp. 752-754）という、広く容認されている原理を踏まえると、いかなる場合にも、生合成されたタンパク質はそのアミノ末端位置にメチオニン残基、より具体的にはホルミルメチオニン残基を含むことが予想される。 
</span>Several open reading frames shown in the sequence listing, namely ORF2 (SEQ ID NO: 5), ORF5 (SEQ ID NO: 11), ORF12 (SEQ ID NO: 25), ORF13 (SEQ ID NO: 27), ORF15 (SEQ ID NO: 31), ORF17 ( SEQ ID NO: 35), ORF19 (SEQ ID NO: 39), ORF20 (SEQ ID NO: 41), ORF22 (SEQ ID NO: 45), ORF24 (SEQ ID NO: 49), ORF26 (SEQ ID NO: 53), and ORF27 (SEQ ID NO: 55) are standard It begins with a non-standard start codon (eg, GTG-valine or CTG-leucine) rather than the typical start codon ATG methionine. To illustrate the specificity of the first codon of the ORF, all ORFs with appropriate M, V or L amino acids at the amino terminal position are listed. However, even when the encoding start codon gene encoding the non-standard protein synthesis in bacteria begin with methionine (formylmethionine) <sup class="style-scope patent-text">(e.g., Stryer BioChemistry 3 rd edition, 1998</sup> , WH Freeman and Co., New York, pp. 752-754), in any case, the biosynthesized protein is in any case a methionine residue, more specifically a formylmethionine residue, at its amino terminal position. Is expected to contain.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＯＲＦ３２（配列番号６５）は不完全であり、アミノ酸１０〜２０がカルボキシ末端から切断されている。これは、コンティグ２と３との間の配列情報が不完全であるためである（それぞれ配列番号６４及び７３）。
</span>
&nbsp;&nbsp;ORF32 (SEQ ID NO: 65) is incomplete and amino acids 10-20 are truncated from the carboxy terminus. This is because the sequence information between contigs 2 and 3 is incomplete (SEQ ID NOs: 64 and 73, respectively).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Micromonospora sp.０４６−ＥＣＯ１１株の式IIで表される化合物の部分的な生合成遺伝子座のコスミドクローン（図１２中、それぞれ０４６ＫＭ及び０４６ＫＱとして示す）をそれぞれ含み、共に式IIで表される化合物を製造するための生合成遺伝子座の全長にまたがるE.coliＤＨ１０Ｂベクターを、２００３年２月２５日、カナダ保健省微生物部カナダ国際寄託当局（ＩＤＡＣ）(1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)に寄託した。０４６ＫＭと命名されたコスミドクローンを、ＩＤＡＣアクセッション番号第２５０２０３−０６として寄託し、０４６ＫＱと命名されたコスミドクローンを、ＩＤＡＣアクセッション番号第２５０２０３−０７として寄託した。コスミド０４６ＫＭは、コンティグ１（配列番号１）の１残基〜３２，２５０残基をカバーする。コスミド０４６ＫＱは、コンティグ１（配列番号１）の２１，７００残基〜コンティグ３（配列番号７３）の９，７６２残基をカバーする。本明細書の配列の記載のいずれかに抵触する場合には、寄託した菌株に含まれるポリヌクレオチド配列と、それによってコードされるポリペプチドのいずれかのアミノ酸配列とがコントロールする。
</span>
&nbsp;&nbsp;Micromonospora sp. 046-ECO11 strain of a compound represented by formula II, each containing a cosmid clone of a partial biosynthetic locus (shown as 046KM and 046KQ, respectively in FIG. 12), both of which are represented by formula II The E. coli DH10B vector, which spans the entire length of the biosynthetic locus for the production of Escherichia coli, was obtained on February 25, 2003 from the Canadian Department of Health Canada International Depository Authority (IDAC) (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2 ). The cosmid clone designated 046KM was deposited as IDAC accession number 250203-06, and the cosmid clone designated 046KQ was deposited as IDAC accession number 250203-07. Cosmid 046KM covers residues 1 to 32,250 of contig 1 (SEQ ID NO: 1). Cosmid 046KQ covers from 21,700 residues of contig 1 (SEQ ID NO: 1) to 9,762 residues of contig 3 (SEQ ID NO: 73). In case of conflict with any of the sequence descriptions herein, the polynucleotide sequence contained in the deposited strain and any amino acid sequence of the polypeptide encoded thereby are controlled.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  菌株の寄託は、特許手続き上の微生物の寄託の国際的承認に関するブダペスト条約に従って行われた。寄託株は、取り消すことはできず、制限や条件がない限り、特許が付与された際に公開される。寄託株は単に当業者に便利であるので提供されるものであって、米国特許法第１１２条に求められるように寄託が実施可能要件に必要とされていることを認めるものではない。寄託株及び寄託株に由来する化合物を製造、使用、又は販売する場合は、許可が必要であり、本明細書によって付与されるそのような許可はない。
</span>
&nbsp;&nbsp;Deposits of strains were made in accordance with the Budapest Treaty on the International Approval of Deposits of Microorganisms in Patent Procedures. Deposited shares cannot be canceled and will be published when the patent is granted, unless there are restrictions or conditions. The deposited strain is provided merely as is convenient to those skilled in the art and does not acknowledge that the deposit is required for enablement requirements as required by 35 USC 112. Permission is required for making, using, or selling the deposited strain and compounds derived from the deposited strain, and there is no such permission granted by this specification.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式IIで表される化合物を製造するための生合成遺伝子座を形成する遺伝子によってコードされるタンパク質の機能を同定するために、デフォルトパラメータを用いたＢＬＡＳＴＰバージョン２．２．１０アルゴリズムを使用して、ＯＲＦ１〜４３の遺伝子生成物、すなわち配列番号２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、４２、４４、４６、４８、５０、５２、５４、５６、５８、６０、６２、６５、６７、６９、７１、７４、７６、７８、８０、８２、８４、８６及び８８と、国立バイオテクノロジー情報センター（ＮＣＢＩ）のノンリダンダントタンパク質データベース(nonredundant protein database)並びに微生物遺伝子、経路及び天然生成物のＤＥＣＩＰＨＥＲ<sup class="style-scope patent-text">Ｒ</sup>データベース（エコピアバイオサイエンスインク、サンローラン、ケベック、カナダ）とを比較した。
</span>Using the BLASTP version 2.2.10 algorithm with default parameters to identify the function of the protein encoded by the gene that forms the biosynthetic locus to produce the compound of formula II , ORF1-43 gene products, ie SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 71, 74, 76, 78, 80, 82, 84, 86 and 88, national Biotechnology Information Center (NCBI) nonredundant protein database and DECIPHE of microbial genes, pathways and natural products <sup class="style-scope patent-text">R</sup> database were compared (Ekopia Bioscience ink, Saint Laurent, Quebec, Canada) and.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  このＢＬＡＳＴ解析でヒットしたＧｅｎＢａｎｋ<sup class="style-scope patent-text">ＴＭ</sup>のアクセッション番号の上位を、対応するＥ値と共に表１４に示す。Ｅ値は、アラインメントスコアが観察されたアラインメントスコアと少なくとも等しい、チャンスアラインメントの予測数値に関する。Ｅ値が０．００であれば、完全なホモログであることを示す。Ｅ値は、Altschul et al. J. Mol. Biol., 215, 403-410 (1990) に記載されるように計算される。Ｅ値は、ホモロジーの推論を証明するために、２つの配列が十分な類似性を示すかどうかを決定する際の裏付けとなる。
</span>Table 14 shows the upper ranks of GenBank <sup class="style-scope patent-text">™</sup> accession numbers that were hit in this BLAST analysis, along with the corresponding E values. The E value relates to a predicted value of chance alignment, where the alignment score is at least equal to the observed alignment score. An E value of 0.00 indicates a complete homologue. E values are calculated as described in Altschul et al. J. Mol. Biol., 215, 403-410 (1990). The E value supports the determination of whether two sequences show sufficient similarity to prove homology reasoning.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式IIで表される化合物の生合成に関与するタンパク質をコードするＯＲＦに、推定した機能を割り当て、既知のタンパク質に類似する配列に基づき、ファミリーの中で共に分類する。構造と機能とを相関させるために、表１５に示すように、本明細書及び図面を通して使用する４文字の呼称をタンパク質ファミリーに付ける。４文字の呼称の意味は、次の通りである。ＡＡＫＤはアミノ酸キナーゼ、ＡＢＣＡ及びＡＢＣＣはＡＢＣトランスポーター、ＡＤＳＡはアミドシンターゼ、ＡＬＤＢはアルドラーゼ機能、ＣＳＭＢはコリスミ酸トランスアミナーゼ、ＤＡＨＰは３，４−ジデオキシ−４−アミノ−Ｄ−アラビノ−ヘプツロソン酸７−リン酸シンターゼ活性、ＤＨＢＳは２，３−ジヒドロ−２，３−ジヒドロキシ安息香酸シンターゼ活性、ＤＭＤＡはジホスホメバロン酸デカルボキシラーゼ、ＥＦＦＴは流出タンパク質、ＨＭＧＡは３−ヒドロキシ−３−メチルグルタリル−ＣｏＡリダクターゼ、ＨＯＸＶはモノオキシゲナーゼ活性、ＨＯＹＨはヒドロキシラーゼ／デカルボキシラーゼ活性、ＨＹＤＫはヒドロラーゼ活性、ＩＤＳＡはイソペンテニル二リン酸シンターゼ、ＩＰＰＩはイソペンテニル二リン酸イソメラーゼ、ＩＰＴＮはイソプレニルトランスフェラーゼ、ＫＡＳＨは３−ヒドロキシ−３−メチルグルタリル−ＣｏＡシンターゼ、ＭＶＫＡはメバロン酸キナーゼ、ＭＶＰＫはホスホメバロン酸キナーゼ、ＯＸＡＨはアシルＣｏＡオキシダーゼ、ＯＸＤＳはオキシドリダクターゼ、ＲＥＣＨ、ＲＥＣＩ、ＲＥＧＤ、ＲＥＧＧ及びＲＲＥＢはレギュレーター、ＳＤＲＡはデヒドロゲナーゼ／ケトリダクターゼ、ＳＰＫＧは感受性プロテインキナーゼ、ＵＮＥＳ、ＵＮＥＺ、ＵＮＦＡ、ＵＮＦＣ、ＵＮＦＤ、ＵＮＦＥ、ＵＮＦＪ及びＵＮＩＱは未知の機能を持つタンパク質を意味する。
</span>
&nbsp;&nbsp;ORFs that encode proteins involved in the biosynthesis of compounds of formula II are assigned putative functions and grouped together in families based on sequences similar to known proteins. To correlate structure and function, the four letter designations used throughout the specification and drawings are given to protein families as shown in Table 15. The meaning of the four-character designation is as follows. AAKD is amino acid kinase, ABCA and ABCC are ABC transporters, ADSA is amide synthase, ALDB is aldolase function, CSMB is chorismate transaminase, DAHP is 3,4-dideoxy-4-amino-D-arabino-heptulosonate 7-phosphorus Acid synthase activity, DHBS is 2,3-dihydro-2,3-dihydroxybenzoate synthase activity, DMDA is diphosphomevalonate decarboxylase, EFFT is efflux protein, HMGA is 3-hydroxy-3-methylglutaryl-CoA reductase, HOXV Is monooxygenase activity, HOYH is hydroxylase / decarboxylase activity, HYDK is hydrolase activity, IDSA is isopentenyl diphosphate synthase, IPPI is isopentenyl diphosphate Acid isomerase, IPTN is isoprenyl transferase, KASH is 3-hydroxy-3-methylglutaryl-CoA synthase, MVKA is mevalonate kinase, MVPK is phosphomevalonate kinase, OXAH is acyl CoA oxidase, OXDS is oxidoreductase, RECH, RECI , REGD, REGG and RREB are regulators, SDRA is a dehydrogenase / ketoliductase, SPKG is a sensitive protein kinase, UNES, UNEZ, UNFA, UNFC, UNFD, UNFE, UNFJ and UNIQ are proteins with unknown functions.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式IIで表される化合物の生合成は、その後縮合して最終的な化合物（図１５）を形成する、該化合物の３つの構成単位、すなわちファルネシル二リン酸成分（図１３）、３−ヒドロキシ−アントラニル酸−アデニレート成分（図１４ａ）、及び２−アミノ−６−ヒドロキシ−ベンゾキノン成分（図１４ｂ）を合成する様々な酵素の作用を伴う。
</span>
&nbsp;&nbsp;The biosynthesis of the compound of formula II is then condensed to form the final compound (Figure 15), the three building blocks of the compound: the farnesyl diphosphate component (Figure 13), 3-hydroxy With the action of various enzymes that synthesize the anthranilic acid-adenylate component (FIG. 14a) and the 2-amino-6-hydroxy-benzoquinone component (FIG. 14b).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ファルネシル−二リン酸生合成は、７つの酵素（図１３）の協奏的な作用を伴う。ＯＲＦ１０（ＫＡＳＨ）（配列番号２０）は、アセトアシル−ＣｏＡへのアセチル−ＣｏＡのアルドール付加を触媒し、３−ヒドロキシ−３−メチルグルタリル−ＣｏＡ（ＨＭＧ−ＣｏＡ）を産生するヒドロキシメチルグルタリル−ＣｏＡシンターゼをコードする。この生成物は、その後ＯＲＦ９（ＨＭＧＡ）（配列番号１８）の作用によって還元し、メバロン酸（ＭＶＡ）を形成する。ＯＲＦ５（ＭＶＫＡ）（配列番号１０）は、リン酸供与体としてＡＴＰを使用して、メバロン酸を５´−ホスホメバロン酸にリン酸化する。ファルネシル二リン酸化生合成の次のステップは、５´−ホスホメバロン酸の、５´−ピロホスホメバロン酸（ＤＰＭＶＡ）へのリン酸化反応であり、これはＯＲＦ７（ＭＶＫＰ）（配列番号１４）によって触媒される。これに続き、ＯＲＦ６（ＤＭＤＡ）（配列番号１２）によって触媒された５´−ピロホスホメバロン酸の脱カルボキシル化反応の結果、イソペンテニル二リン酸（ＩＰＰ）が生じる。これは、この後イソメラーゼ酵素活性を有するＯＲＦ８（ＩＰＰＩ）（配列番号１６）の作用によってジメチルアリル二リン酸（ＤＭＡＤＰ）に変化する。ファルネシル二リン酸生合成の最終ステップは、イソプレニル二リン酸シンターゼＯＲＦ４（ＩＤＳＡ）（配列番号８）によって触媒されたイソペンテニル二リン酸の２分子でジメチルアリル二リン酸の１分子の縮合を行うことである。記載したファルネシル二リン酸の生合成に関与する経路は、他のActinomycete種において記載された関連するメバロン酸経路(Takagi et al., J Bacteriol. 182, 4153-4157, (2000))と完全に一致している。
</span>
&nbsp;&nbsp;Farnesyl-diphosphate biosynthesis is accompanied by concerted actions of seven enzymes (FIG. 13). ORF10 (KASH) (SEQ ID NO: 20) catalyzes the aldol addition of acetyl-CoA to acetoacyl-CoA to produce 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) Encodes CoA synthase. This product is then reduced by the action of ORF9 (HMGA) (SEQ ID NO: 18) to form mevalonic acid (MVA). ORF5 (MVKA) (SEQ ID NO: 10) phosphorylates mevalonic acid to 5'-phosphomevalonic acid using ATP as the phosphate donor. The next step in farnesyl diphosphorylation biosynthesis is the phosphorylation of 5'-phosphomevalonic acid to 5'-pyrophosphomevalonic acid (DPMVA), which is catalyzed by ORF7 (MVKP) (SEQ ID NO: 14). Is done. This is followed by the decarboxylation reaction of 5'-pyrophosphomevalonic acid catalyzed by ORF6 (DMDA) (SEQ ID NO: 12) resulting in isopentenyl diphosphate (IPP). This is then converted to dimethylallyl diphosphate (DMADP) by the action of ORF8 (IPPI) (SEQ ID NO: 16), which has isomerase enzyme activity. The final step of farnesyl diphosphate biosynthesis involves the condensation of one molecule of dimethylallyl diphosphate with two molecules of isopentenyl diphosphate catalyzed by isoprenyl diphosphate synthase ORF4 (IDSA) (SEQ ID NO: 8). That is. The pathway involved in the biosynthesis of farnesyl diphosphate described is completely different from the related mevalonate pathway described in other Actinomycete species (Takagi et al., J Bacteriol. 182, 4153-4157, (2000)). Match.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ３−ヒドロキシ−アントラニル酸成分の生合成は、シキミ酸経路に由来する前駆物質の使用を伴う（図１４ａ）。コリスミ酸は、ＯＲＦ１９（ＣＳＭＢ）（配列番号３８）の作用によってアミノ基転移し、アミノデオキシイソコリスミ酸を形成する。この酵素はアントラニル酸シンターゼに類似しており、アミノ供与体としてグルタミンを使用して、アミノ基の転移を特異的に触媒するようである。次のステップは、isochorismatase活性を伴い、ＯＲＦ２７（ＤＨＢＳ）（配列番号５４）によって媒介される。この反応の意義は、アミノデオキシイソコリスミ酸からピルビン酸側鎖を除去して、６−アミノ−５−ヒドロキシ−シクロヘキサ−１，３−ジエンカルボン酸を形成することにある。次に、該化合物をＯＲＦ２６（ＳＤＲＡ）（配列番号５２）の作用によって酸化し、３−ヒドロキシ−アントラニル酸を産生する。ＯＲＦ２４（ＡＤＳＡ）（配列番号４８）は、３−ヒドロキシ−アントラニル酸−アデニレート成分を産生するアデニル化によって、３−ヒドロキシ−アントラニル酸の活性化を触媒する（図１４ａ）。
</span>
&nbsp;&nbsp;Biosynthesis of the 3-hydroxy-anthranilic acid component involves the use of precursors derived from the shikimic acid pathway (FIG. 14a). Chorismate is transaminated by the action of ORF19 (CSMB) (SEQ ID NO: 38) to form aminodeoxyisochorismate. This enzyme is similar to anthranilate synthase and appears to specifically catalyze the transfer of amino groups using glutamine as the amino donor. The next step involves isochorismatase activity and is mediated by ORF27 (DHBS) (SEQ ID NO: 54). The significance of this reaction is to remove the pyruvate side chain from aminodeoxyisochorismic acid to form 6-amino-5-hydroxy-cyclohexa-1,3-dienecarboxylic acid. The compound is then oxidized by the action of ORF26 (SDRA) (SEQ ID NO: 52) to produce 3-hydroxy-anthranilic acid. ORF24 (ADSA) (SEQ ID NO: 48) catalyzes the activation of 3-hydroxy-anthranilic acid by adenylation to produce a 3-hydroxy-anthranilic acid-adenylate component (FIG. 14a).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  式IIで表される化合物の２−アミノ−６−ヒドロキシ−ベンゾキノン成分の生合成は、アミノシキミ酸経路に由来する成分を必要とする。図１４ｂは、この構成成分の生合成に関与する一連の酵素反応について説明している。ＯＲＦ２１（ＡＬＤＢ）（配列番号４２）は、２−アミノ−６−ヒドロキシ［１，４］−ベンゾキノンの産生に使用されるアミノシキミ酸の経路の一部であるＤ−エリトロース−４−リン酸の前駆物質の産生に関与するアルドラーゼに類似している。ＯＲＦ３３（ＤＡＨＰ）（配列番号６７）は、ホスホエノールピルビン酸（ＰＥＰ）及びエリトース４−リン酸（Ｅ−４Ｐｈ）の３，４−ジデオキシ−４−アミノ−Ｄ−アラビノ−ヘプツロソン酸７−リン酸（アミノＤＡＨＰ）の形成に対応する、アミノシキミ酸経路における最初のステップを触媒する。３−アミノ−５−ヒドロキシ−安息香酸につながる次の反応を、Micromonospora sp.０４６−ＥＣＯ１１株に存在する一次代謝生合成経路でもたらされる酵素で触媒する。ＯＲＦ２５（ＨＯＸＶ）（配列番号５０）は、３−アミノ−５−ヒドロキシ−安息香酸を部位２で水酸化し、３−アミノ−２，５−ジヒドロキシ−安息香酸を産生する。６−アミノ−ベンゼン−１，２，４−トリオールを産生する脱カルボキシル化酸化反応を触媒するＯＲＦ３２（ＨＯＹＨ）（配列番号６５）によって、更にこの中間生成物を修飾する。２−アミノ−６−ヒドロキシ−［１，４］−ベンゾキノン（図１４ｂ）を産生する最後の酸化反応が、ＯＲＦ１６（ＯＸＤＳ）（配列番号３２）によって行われる。
</span>
&nbsp;&nbsp;Biosynthesis of the 2-amino-6-hydroxy-benzoquinone component of the compound represented by Formula II requires components derived from the amino shikimate pathway. FIG. 14b illustrates a series of enzymatic reactions involved in the biosynthesis of this component. ORF21 (ALDB) (SEQ ID NO: 42) is a precursor of D-erythrose-4-phosphate that is part of the aminoshikimate pathway used to produce 2-amino-6-hydroxy [1,4] -benzoquinone. Similar to aldolase involved in the production of substances. ORF33 (DAHP) (SEQ ID NO: 67) is a 3,4-dideoxy-4-amino-D-arabino-heptulosonic acid 7-phosphate of phosphoenolpyruvate (PEP) and erythose 4-phosphate (E-4Ph) Catalyze the first step in the aminoshikimate pathway, corresponding to the formation of (aminoDAHP). The next reaction leading to 3-amino-5-hydroxy-benzoic acid is catalyzed by an enzyme provided by the primary metabolic biosynthetic pathway present in Micromonospora sp. 046-ECO11 strain. ORF25 (HOXV) (SEQ ID NO: 50) hydroxylates 3-amino-5-hydroxy-benzoic acid at site 2 to produce 3-amino-2,5-dihydroxy-benzoic acid. This intermediate product is further modified by ORF32 (HOYH) (SEQ ID NO: 65), which catalyzes the decarboxylation oxidation reaction to produce 6-amino-benzene-1,2,4-triol. The final oxidation reaction producing 2-amino-6-hydroxy- [1,4] -benzoquinone (FIG. 14b) is performed by ORF16 (OXDS) (SEQ ID NO: 32).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  結果として式IIで表される化合物となる３つの成分の集合を、ＯＲＦ２４及び１１（図１５）によって触媒する。ＯＲＦ２４（ＡＤＳＡ）（配列番号４８）は、アデニル化３−ヒドロキシ−アントラニル酸と２−アミノ−６−ヒドロキシ［１，４］−ベンゾキノン成分との縮合を触媒する。３−ヒドロキシ−アントラニル酸の遊離アミノ基と２−アミノ−６−ヒドロキシ−［１，４］−ベンゾキノン成分に存在するカルボニル基の１つとの間に自然縮合が発生し、ジベンゾジアゼピノン中間生成物が生じる。この化合物を、ＯＲＦ１１（ＩＰＴＮ）（配列番号２２）で触媒されたジベンゾジアゼピノンのアミドの窒素に、ファルネシル二リン酸中間生成物のファルネシル基を転移させて更に修飾し、式IIで表される化合物を生成する（図１５）。
</span>
&nbsp;&nbsp;A set of three components resulting in a compound of formula II is catalyzed by ORFs 24 and 11 (FIG. 15). ORF24 (ADSA) (SEQ ID NO: 48) catalyzes the condensation of adenylated 3-hydroxy-anthranilic acid with a 2-amino-6-hydroxy [1,4] -benzoquinone component. Spontaneous condensation occurs between the free amino group of 3-hydroxy-anthranilic acid and one of the carbonyl groups present in the 2-amino-6-hydroxy- [1,4] -benzoquinone component, resulting in intermediate formation of dibenzodiazepinone Things arise. This compound was further modified by transferring the farnesyl group of the farnesyl diphosphate intermediate to the nitrogen of the amide of dibenzodiazepinone catalyzed by ORF11 (IPTN) (SEQ ID NO: 22), and represented by Formula II Is produced (FIG. 15).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  更なるＯＲＦ、すなわちＯＲＦ２（ＲＥＣＨ）（配列番号４）、ＯＲＦ３（ＲＥＧＤ）（配列番号６）、ＯＲＦ１２（ＳＰＫＧ）（配列番号２４）、ＯＲＦ１３（ＲＲＥＢ）（配列番号２６）、ＯＲＦ３４（ＲＥＧＧ）（配列番号６９）、及びＯＲＦ３６（ＲＥＣＩ）（配列番号７４）は、式IIで表される化合物をコードする生合成遺伝子座の制御に関与する。他のＯＲＦ、すなわちＯＲＦ１（ＡＢＣＣ）（配列番号２）、ＯＲＦ３１（ＥＦＦＴ）（配列番号６２）、ＯＲＦ３９及び４０（ＡＢＣＡ）（それぞれ配列番号８０及び８２）、及びＯＲＦ４２（配列番号８６）は、輸送に関与する。式IIで表される化合物の生合成に関与する他のＯＲＦには、機能が不明であるＯＲＦ１４、１５、１７、１８、２２、２９、３０、３５、３７、４１及び４３（それぞれ配列番号２８、３０、３４、３４、４４、５８、６０、７１、７６、８４、及び８８）の他、ＯＲＦ２０（ＡＡＫＤ）（配列番号４０）、ＯＲＦ２３（ＨＹＤＫ）（配列番号４６）、ＯＲＦ３８（ＯＸＡＨ）（配列番号７８）が含まれる。
</span>
&nbsp;&nbsp;Further ORFs, namely ORF2 (RECH) (SEQ ID NO: 4), ORF3 (REGD) (SEQ ID NO: 6), ORF12 (SPKG) (SEQ ID NO: 24), ORF13 (RREB) (SEQ ID NO: 26), ORF34 (REGG) ( SEQ ID NO: 69) and ORF36 (RECI) (SEQ ID NO: 74) are involved in the control of the biosynthetic locus encoding the compound represented by Formula II. The other ORFs, ORF1 (ABCC) (SEQ ID NO: 2), ORF31 (EFFT) (SEQ ID NO: 62), ORF39 and 40 (ABCA) (SEQ ID NO: 80 and 82, respectively), and ORF42 (SEQ ID NO: 86) Involved in. Other ORFs involved in the biosynthesis of the compound of formula II include ORFs 14, 15, 17, 18, 22, 29, 30, 35, 37, 41 and 43 (SEQ ID NO: 28, respectively) whose functions are unknown. , 30, 34, 34, 44, 58, 60, 71, 76, 84, and 88), ORF20 (AAKD) (SEQ ID NO: 40), ORF23 (HYDK) (SEQ ID NO: 46), ORF38 (OXAH) ( SEQ ID NO: 78) is included.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他に特別な記載がない限り、全ての成分の単位はｇｍ／Ｌである。<br class="style-scope patent-text">
<sup class="style-scope patent-text">＊３</sup>微量元素溶液には、１リットル当たり、ＺｎＣｌ<sub class="style-scope patent-text">２</sub>（４０ｍｇ）、ＦｅＣｌ<sub class="style-scope patent-text">３</sub>６Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（２００ｍｇ）、ＣｕＣｌ<sub class="style-scope patent-text">２</sub>２Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（１０ｍｇ）、ＭｎＣｌ<sub class="style-scope patent-text">２</sub>．４Ｈ<sub class="style-scope patent-text">２</sub>Ｏ、Ｎａ<sub class="style-scope patent-text">２</sub>Ｂ<sub class="style-scope patent-text">４</sub>Ｏ<sub class="style-scope patent-text">７</sub>．１０Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（１０ｍｇ）、（ＮＨ<sub class="style-scope patent-text">４</sub>）<sub class="style-scope patent-text">６</sub>ＭＯ<sub class="style-scope patent-text">７</sub>Ｏ<sub class="style-scope patent-text">２４</sub>．４Ｈ<sub class="style-scope patent-text">２</sub>Ｏ（１０ｍｇ）が含まれる。  <br class="style-scope patent-text">
<sup class="style-scope patent-text">*５</sup>ｐＨは、記載されているように、ＣａＣｏ<sub class="style-scope patent-text">３</sub>の添加前に調整される。
</span>Unless otherwise specified, all component units are gm / L. <br class="style-scope patent-text"> <sup class="style-scope patent-text">* 3 For the</sup> trace element solution, ZnCl <sub class="style-scope patent-text">2</sub> (40 mg), FeCl <sub class="style-scope patent-text">3</sub> 6H <sub class="style-scope patent-text">2</sub> O (200 mg), CuCl <sub class="style-scope patent-text">2</sub> 2H <sub class="style-scope patent-text">2</sub> O (10 mg), MnCl <sub class="style-scope patent-text">2</sub> . <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">4H 2 O, Na 2 B 4</sub> </sub> </sub> </sub> O 7. <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">10H 2 O (10mg), (</sub> </sub> </sub> NH 4) 6 MO 7 O 24. 4H <sub class="style-scope patent-text">2</sub> O (10 mg) is included. <br class="style-scope patent-text"> <sup class="style-scope patent-text">* 5 The</sup> pH is adjusted before addition of CaCo <sub class="style-scope patent-text">3</sub> as described.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書に引用したすべての特許、特許出願、及び参考文献は、参照することによって全体として本明細書に組み込まれる。好ましい実施例を参照することによって、本発明を特に示し、説明してきたが、添付の請求の範囲に包含される本発明の範囲から逸脱することなく形態や詳細を様々に変化させることは、当業者には理解されるであろう。
</span>
&nbsp;&nbsp;All patents, patent applications, and references cited herein are hereby incorporated by reference in their entirety. While the invention has been particularly shown and described by reference to preferred embodiments, it will be understood that various changes in form and detail may be made without departing from the scope of the invention as encompassed by the appended claims. The merchant will understand.
</span>
    </p>
  </disclosure>
  <description-of-drawings class="style-scope patent-text">
    <p class="style-scope patent-text">
      <figref num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１は、エレクトロスプレー質量分析法で、４６２．６と定量された、ＥＣＯ−０４６０１の質量を示す。</span>FIG. 1 shows the mass of ECO-04601 determined by electrospray mass spectrometry as 462.6.</span>
      </figref>
      <figref num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図２は、ＵＶｍａｘが２３０ｎｍ、ショルダーが２９０ｎｍである、精製されたＥＣＯ−０４６０１の吸収スペクトルを示す。</span>FIG. 2 shows the absorption spectrum of purified ECO-04601 with a UVmax of 230 nm and a shoulder of 290 nm.</span>
      </figref>
      <figref num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図３は、ＭｅＯＨ−ｄ<sub class="style-scope patent-text">４</sub>に溶解した化合物のプロトンＮＭＲデータを示す。</span>Figure 3 shows the proton NMR data of the compound was dissolved in <sub class="style-scope patent-text">MeOH-d 4.</sub> </span>
      </figref>
      <figref num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図４は、ｇＤＱＣＯＳＹ多次元パルスシーケンスを示す。</span>FIG. 4 shows a gDQCOSY multidimensional pulse sequence.</span>
      </figref>
      <figref num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図５は、ｇＨＳＱＣ多次元パルスシーケンスを示す。</span>FIG. 5 shows a gHSQC multidimensional pulse sequence.</span>
      </figref>
      <figref num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図６は、ｇＨＭＢＣ多次元パルスシーケンスを示す。</span>FIG. 6 shows a gHMBC multidimensional pulse sequence.</span>
      </figref>
      <figref num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図７は、ＮＯＥＳＹ多次元パルスシーケンスを示す。</span>FIG. 7 shows a NOESY multidimensional pulse sequence.</span>
      </figref>
      <figref num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図８は、ＥＣＯ−０４６０１のインビトロ抗炎症活性を示す。グラフは、ＥＣＯ−０４６０１及びＮＤＧＡのＬｏｇμＭ濃度に対する５−リポキシゲナーゼ活性阻害パーセントを示す。グラフは、ＥＣＯ−０４６０１のＥＣ<sub class="style-scope patent-text">５０</sub>が０．９３μＭであることを示している。</span>FIG. 8 shows the in vitro anti-inflammatory activity of ECO-04601. The graph shows the percent inhibition of 5-lipoxygenase activity versus Log μM concentrations of ECO-04601 and NDGA. The graph shows that the EC <sub class="style-scope patent-text">50 of</sub> ECO-04601 is 0.93 μM.</span>
      </figref>
      <figref num="9" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図９は、グリア芽種を有するマウスに、１０〜３０ｍｇ／ｋｇのＥＣＯ−０４６０１を、腫瘍細胞接種１日後から投与した結果、腫瘍の増殖が阻害されたことを示す。</span>FIG. 9 shows that tumor growth was inhibited as a result of administering 10-30 mg / kg ECO-04601 1 day after tumor cell inoculation to mice with glial buds.</span>
      </figref>
      <figref num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１０は、グリア芽種を有するマウスに、２０〜３０ｍｇ／ｋｇのＥＣＯ−０４６０１を、腫瘍細胞接種１０日後から投与した結果、腫瘍の増殖が阻害されたことを示す。</span>FIG. 10 shows that 20 to 30 mg / kg ECO-04601 was administered to mice with glial bud seeds 10 days after tumor cell inoculation, resulting in inhibition of tumor growth.</span>
      </figref>
      <figref num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１１は、グリア芽種の腫瘍を有し、生理食塩水又はＥＣＯ−０４６０１で処理されたマウスの腫瘍断片の顕微鏡写真を示す。ＥＣＯ−０４６０１で処理した腫瘍の細胞密度は低下しているように見え、ＥＣＯ−０４６０１処理腫瘍細胞の核はより大きく、核濃縮している。これは細胞毒性を示す。</span>FIG. 11 shows micrographs of tumor fragments of mice with glial bud tumors and treated with saline or ECO-04601. The cell density of tumors treated with ECO-04601 appears to decrease, and the nuclei of ECO-04601-treated tumor cells are larger and more concentrated. This indicates cytotoxicity.</span>
      </figref>
      <figref num="12" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１２は、Micromonospora sp.０４６−ＥＣＯ１１株から単離され、コスミド０４６ＫＭ及び０４６ＫＱの位置を含む、ＥＣＯ−０４６０１の生合成遺伝子座を示す。</span>Figure 12 shows the biosynthetic locus of ECO-04601 isolated from Micromonospora sp. 046-ECO11 strain and containing the positions of cosmids 046KM and 046KQ.</span>
      </figref>
      <figref num="13" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１３は、ＯＲＦ番号及びファミリーの名称を示した生合成酵素による、ファルネシル−二リン酸基の生成の生合成経路の概略図を示す。</span>FIG. 13 shows a schematic diagram of the biosynthetic pathway for the production of farnesyl-diphosphate groups by biosynthetic enzymes with ORF numbers and family names.</span>
      </figref>
      <figref num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１４は、ＥＣＯ−０４６０１をコードする遺伝子座に存在するＯＲＦによって特定される、（ａ）３−ヒドロキシ−アントラニル酸−アデニレート成分及び（ｂ）２−アミノ−６−ヒドロキシ−［１，４］ベンゾキノン成分の生成の生合成経路の概略図を示す。生合成酵素を、ＯＲＦ番号及びファミリーの名称で示す。</span>FIG. 14 shows (a) 3-hydroxy-anthranilic acid-adenylate component and (b) 2-amino-6-hydroxy- [1,4] identified by the ORF present at the locus encoding ECO-04601. 1 shows a schematic diagram of the biosynthetic pathway for the production of benzoquinone components. Biosynthetic enzymes are indicated by ORF number and family name.</span>
      </figref>
      <figref num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１５は、ＥＣＯ−０４６０１前駆物質、ファルネシル−二リン酸、３−ヒドロキシ−アントラニル酸−アデニレート、及び２−アミノ−６−ヒドロキシ−［１，４］ベンゾキノンのアセンブリの生合成経路の概略図を示す。生合成酵素を、ＯＲＦ番号及びファミリーの名称で示す。</span>FIG. 15 shows a schematic diagram of the biosynthetic pathway of the assembly of ECO-04601 precursor, farnesyl-diphosphate, 3-hydroxy-anthranilic acid-adenylate, and 2-amino-6-hydroxy- [1,4] benzoquinone. Show. Biosynthetic enzymes are indicated by ORF number and family name.</span>
      </figref>
      <figref num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１６は、０４６Ｄ生合成遺伝子座の各オープンリーディングフレーム（ＯＲＦ）の配列番号及び機能、並びにそれらに対応する遺伝子生成物を示す配列表を示す。</span>FIG. 16 shows a sequence listing showing the sequence number and function of each open reading frame (ORF) of the 046D biosynthetic locus and the gene products corresponding to them.</span>
      </figref>
      <figref num="17" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１７は、Micromonospora sp.０４６ＥＣＯ１１.株（ＩＤＡＣアクセッション番号第０７０３０３−０１）の脂肪酸分析の結果を示す。脂肪酸メチルエステル（ＦＡＭＥ）にガスクロマトグラフィーを使用し、分析を行った。</span>FIG. 17 shows the results of fatty acid analysis of Micromonospora sp. 046ECO11. Strain (IDAC Accession No. 070303-01). Analysis was performed using fatty acid methyl ester (FAME) using gas chromatography.</span>
      </figref>
      <figref num="18" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１８は、Micromonospora sp.０４６ＥＣＯ１１株（ＩＤＡＣアクセッション番号第０７０３０３−０１）の１６ＳリボゾームＲＮＡ分析を示す。１６ＳリボゾームＲＮＡ配列の配置は、Micromonospora sp.０４６ＥＣＯ１１株（ＭＩＤ３５２  ＥＣＯＰＩＡ♯１ｃｏｎとして示される）の、Micromonospora chalceaに対する系統発生的な関連性を示す。</span>FIG. 18 shows 16S ribosomal RNA analysis of Micromonospora sp. 046 ECO11 strain (IDAC accession number 070303-01). The arrangement of the 16S ribosomal RNA sequence shows a phylogenetic relationship of Micromonospora sp. 046ECO11 strain (shown as MID352 ECOPIA # 1con) to Micromonospora chalcea.</span>
      </figref>
      <figref num="19" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１９は、ＭｅＯＨ−ｄ４で測定した場合の、ＥＣＯ−０４６０１の完全な<sup class="style-scope patent-text">１</sup>Ｈ及び<sup class="style-scope patent-text">１３</sup>ＣＮＭＲの配置を示す。</span>FIG. 19 shows the complete <sup class="style-scope patent-text">1</sup> H and <sup class="style-scope patent-text">13</sup> C NMR configuration of ECO-04601 as measured by MeOH-d4.</span>
      </figref>
    </p>
  </description-of-drawings>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(28)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Japanese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM40549636" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">下記式で表される化合物又はその薬学的に許容される塩。<br class="style-scope patent-text">
<chemistry id="" num="1" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>A compound represented by the following formula or a pharmaceutically acceptable salt thereof. <br class="style-scope patent-text"> <chemistry id="" num="1" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">下記式で表される化合物又はその薬学的に許容される塩と薬学的に許容されるキャリアとを含む医薬組成物。<br class="style-scope patent-text">
<chemistry id="" num="2" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>A pharmaceutical composition comprising a compound represented by the following formula or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. <br class="style-scope patent-text"> <chemistry id="" num="2" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">式Iで表される化合物<br class="style-scope patent-text">
<chemistry id="" num="3" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry>（式中、Ｗ<sup class="style-scope patent-text">１</sup>、Ｗ<sup class="style-scope patent-text">２</sup>及びＷ<sup class="style-scope patent-text">３</sup>は、それぞれ独立して下記式<br class="style-scope patent-text">
<chemistry id="" num="4" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry>から選択されるか、三環からの側鎖は、Ｗ３、Ｗ２又はＷ１がそれぞれ−ＣＨ＝Ｏ又は−ＣＨ<sub class="style-scope patent-text">２</sub>ＯＨであって、Ｗ３、Ｗ２又はＷ１で終わっていてもよく、<br class="style-scope patent-text">
Ａは、−ＮＨ−、−ＮＣＨ<sub class="style-scope patent-text">２</sub>Ｒ<sup class="style-scope patent-text">１</sup>、−ＮＣ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">１</sup>は、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−６</sub>アルケン(alkene)、アリール又はヘテロアリールから選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>は、それぞれ独立してＨ、Ｒ<sup class="style-scope patent-text">５</sup>、−Ｃ（Ｏ）Ｒ<sup class="style-scope patent-text">６</sup>から選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">５</sup>は、それぞれ独立してＣ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルカレン(alkalene)、アリール又はヘテロアリールから選択され、<br class="style-scope patent-text">
Ｒ<sup class="style-scope patent-text">６</sup>は、それぞれ独立してＨ、Ｃ<sub class="style-scope patent-text">１−６</sub>アルキル、Ｃ<sub class="style-scope patent-text">２−７</sub>アルカレン、アリール又はヘテロアリールから選択されるか、その薬学的に許容される塩である）。</span>Compound of formula I <br class="style-scope patent-text"> <chemistry id="" num="3" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> (W <sup class="style-scope patent-text">1</sup> , W <sup class="style-scope patent-text">2</sup> and W <sup class="style-scope patent-text">3</sup> are each independently represented by the following formula: <br class="style-scope patent-text"> <chemistry id="" num="4" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> Or the side chain from the tricycle may be terminated with W3, W2 or W1, wherein W3, W2 or W1 is —CH═O or —CH <sub class="style-scope patent-text">2</sub> OH, respectively, <br class="style-scope patent-text"> A is selected from —NH—, —NCH <sub class="style-scope patent-text">2</sub> R <sup class="style-scope patent-text">1</sup> , —NC (O) R <sup class="style-scope patent-text">1</sup> , <br class="style-scope patent-text"> R <sup class="style-scope patent-text">1</sup> is selected from C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkene, aryl or heteroaryl; <br class="style-scope patent-text"> R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each independently selected from H, R <sup class="style-scope patent-text">5</sup> , —C (O) R <sup class="style-scope patent-text">6</sup> ; <br class="style-scope patent-text"> Each R <sup class="style-scope patent-text">5</sup> is independently selected from C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkalene, aryl or heteroaryl; <br class="style-scope patent-text"> Each R <sup class="style-scope patent-text">6</sup> is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkane, aryl or heteroaryl, or a pharmaceutically acceptable salt thereof).</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＡがＮＨであることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound or pharmaceutically acceptable salt thereof according to claim 3, wherein A is NH.</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ａが−ＮＣＨ<sub class="style-scope patent-text">２</sub>Ｒ<sup class="style-scope patent-text">１</sup>であることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>Compound or a pharmaceutically acceptable salt thereof according to claim 3, characterized in that A is -NCH <sub class="style-scope patent-text">2</sub> R <sup class="style-scope patent-text">1.</sup> </span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ａが−ＮＣ（Ｏ）Ｒ<sup class="style-scope patent-text">１</sup>であることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound or pharmaceutically acceptable salt thereof according to claim 3, wherein A is -NC (O) R <sup class="style-scope patent-text">1</sup> .</span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｒ<sup class="style-scope patent-text">２</sup>がＨであることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>Compound or a pharmaceutically acceptable salt thereof according to claim 3 in which R <sup class="style-scope patent-text">2</sup> is equal to or is H.</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｒ<sup class="style-scope patent-text">３</sup>がＨであることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">3</sup> is H.</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｒ<sup class="style-scope patent-text">４</sup>がＨであることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3, wherein R <sup class="style-scope patent-text">4</sup> is H, or a pharmaceutically acceptable salt thereof.</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであり、Ｗ<sup class="style-scope patent-text">１</sup>が−ＣＨ＝ＣＨ−であることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H, and W <sup class="style-scope patent-text">1</sup> is —CH═CH—.</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであり、Ｗ<sup class="style-scope patent-text">２</sup>が−ＣＨ＝ＣＨ−であることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H, and W <sup class="style-scope patent-text">2</sup> is —CH═CH—.</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであり、Ｗ<sup class="style-scope patent-text">３</sup>が−ＣＨ＝ＣＨ−であることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H, and W <sup class="style-scope patent-text">3</sup> is —CH═CH—.</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＡがＮＨであり、Ｒ<sup class="style-scope patent-text">２</sup>、Ｒ<sup class="style-scope patent-text">３</sup>及びＲ<sup class="style-scope patent-text">４</sup>がそれぞれＨであることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein A is NH and R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＡがＮＨであり、Ｗ<sup class="style-scope patent-text">１</sup>、Ｗ<sup class="style-scope patent-text">２</sup>及びＷ<sup class="style-scope patent-text">３</sup>がそれぞれ−ＣＨ＝ＣＨ−であることを特徴とする請求項３に記載の化合物又はその薬学的に許容される塩。</span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein A is NH, and W <sup class="style-scope patent-text">1</sup> , W <sup class="style-scope patent-text">2,</sup> and W <sup class="style-scope patent-text">3</sup> are each —CH═CH—.</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">下記の群から選択される化合物。<br class="style-scope patent-text">
<chemistry id="" num="5" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> <span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
</span>A compound selected from the following group. <br class="style-scope patent-text"> <chemistry id="" num="5" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> </span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">少なくとも１つの炭素原子源と少なくとも１つの窒素原子源とを含む培地でＩＤＡＣ（カナダ国際寄託当局）アクセッション番号第０７０３０３−０１を有するミクロモノスポラ  エスピーを培養するステップ、及び請求項１に記載の化合物を単離し精製するステップを含む、該化合物の製造方法。</span>Incubating micromonospora sp having IDAC accession number 070303-01 in a medium comprising at least one carbon atom source and at least one nitrogen atom source, and A method for producing the compound, comprising the step of isolating and purifying the compound.</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">少なくとも１つの炭素原子源と少なくとも１つの窒素原子源とを含む培地でＩＤＡＣ（カナダ国際寄託当局）アクセッション番号第２３１２０３−０１を有するミクロモノスポラ  エスピーを培養するステップ、及び請求項１に記載の化合物を単離し精製するステップを含む、該化合物の製造方法。</span>Culturing a micromonospora sp having IDAC (Canadian International Depository Authority) accession number 231203-01 in a medium comprising at least one carbon atom source and at least one nitrogen atom source, and A method for producing the compound, comprising the step of isolating and purifying the compound.</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">前記培養が好気条件下で行われることを特徴とする請求項１８記載の方法。</span>The method according to claim 18, wherein the culturing is performed under aerobic conditions.</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">前記炭素原子源及び前記窒素原子源が、表１６に示される成分から選択されることを特徴とする、請求項１８に記載の方法。</span>19. The method of claim 18, wherein the carbon atom source and the nitrogen atom source are selected from the components shown in Table 16.</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">前記培養が１８〜４０℃の温度で行われることを特徴とする、請求項１８に記載の方法。</span>The method according to claim 18, wherein the culturing is performed at a temperature of 18 to 40 ° C.</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">前記培養がｐＨ６〜９で行われることを特徴とする、請求項１８に記載の方法。</span>The method according to claim 18, wherein the culture is performed at pH 6-9.</span>
    </claim-text>
  </claim>
  <claim num="23" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＩＤＡＣ（カナダ国際寄託当局）アクセッション番号第２３１２０３−０１又はＩＤＡＣアクセッション番号第０７０３０３−０１を有するミクロモノスポラ  エスピー。</span>Micromonospora SP with IDAC (Canadian International Depositary Authority) accession number 231203-01 or IDAC accession number 070303-01.</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">癌細胞の増殖を阻害するために、癌細胞を請求項１に記載の化合物に接触させるステップを有する、<u class="style-scope patent-text">インビトロで</u>癌細胞の増殖を阻害する方法<u class="style-scope patent-text">、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">又は、</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">非ヒト哺乳動物の癌細胞の増殖を阻害するために、非ヒト哺乳動物の癌細胞を請求項１に記載の化合物に接触させるステップを有する、非ヒト哺乳動物の癌細胞の増殖を阻害する方法</u>。</span>A method for inhibiting the growth <u class="style-scope patent-text">of</u> cancer cells in <u class="style-scope patent-text">vitro, comprising the</u> step of contacting the cancer cells with a compound according to claim 1 to inhibit the growth <u class="style-scope patent-text">of</u> cancer cells <u class="style-scope patent-text">,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">Or</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">A method for inhibiting the growth of a cancer cell of a non-human mammal comprising the step of contacting the cancer cell of a non-human mammal with the compound of claim 1 to inhibit the growth of the cancer cell of the non-human mammal.</u> .</span>
    </claim-text>
  </claim>
  <claim num="25" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項１に記載の化合物を含む、哺乳動物における癌細胞の増殖阻害剤。</span>A cancer cell growth inhibitor in a mammal comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
  <claim num="26" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項１に記載の化合物を含む、哺乳動物における前癌状態又は癌疾患の治療剤。</span>A therapeutic agent for a precancerous condition or cancer disease in a mammal, comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
  <claim num="27" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項１に記載の化合物を含む、哺乳動物における細菌感染の治療剤。</span>A therapeutic agent for bacterial infection in mammals comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
  <claim num="28" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項１に記載の化合物を含む、哺乳動物における炎症の抑制剤。</span>An inhibitor of inflammation in a mammal, comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (18)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5541181A/en"><a id="link" href="#" class="style-scope state-modifier">US5541181A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-05-26</span>
                    <span class="td style-scope patent-result">1996-07-30</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Compound produced by a strain of micromonospora 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3854480A/en"><a id="link" href="#" class="style-scope state-modifier">US3854480A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1969-04-01</span>
                    <span class="td style-scope patent-result">1974-12-17</span>
                    <span class="td style-scope patent-result">Alza Corp</span>
                    <span class="td style-scope patent-result">Drug-delivery system 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4452775A/en"><a id="link" href="#" class="style-scope state-modifier">US4452775A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-12-03</span>
                    <span class="td style-scope patent-result">1984-06-05</span>
                    <span class="td style-scope patent-result">Syntex (U.S.A.) Inc.</span>
                    <span class="td style-scope patent-result">Cholesterol matrix delivery system for sustained release of macromolecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5039660A/en"><a id="link" href="#" class="style-scope state-modifier">US5039660A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-03-02</span>
                    <span class="td style-scope patent-result">1991-08-13</span>
                    <span class="td style-scope patent-result">Endocon, Inc.</span>
                    <span class="td style-scope patent-result">Partially fused peptide pellet 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0354727A3/en"><a id="link" href="#" class="style-scope state-modifier">EP0354727A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-08-08</span>
                    <span class="td style-scope patent-result">1990-11-22</span>
                    <span class="td style-scope patent-result">Eli Lilly And Company</span>
                    <span class="td style-scope patent-result">Novel single stranded phasmid vectors and methods for transforming streptomyces and other actinomycetes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5283173A/en"><a id="link" href="#" class="style-scope state-modifier">US5283173A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-01-24</span>
                    <span class="td style-scope patent-result">1994-02-01</span>
                    <span class="td style-scope patent-result">The Research Foundation Of State University Of New York</span>
                    <span class="td style-scope patent-result">System to detect protein-protein interactions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0618972A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0618972A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-12-16</span>
                    <span class="td style-scope patent-result">1994-10-12</span>
                    <span class="td style-scope patent-result">E.I. Du Pont De Nemours And Company</span>
                    <span class="td style-scope patent-result">CONSTITUTIVE EXPRESSION OF P450SOY AND FERREDOXIN-SOY IN $i(STREPTOMYCES), AND BIOTRANSFORMATION OF CHEMICALS BY RECOMBINANT ORGANISMS 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU695814B2/en"><a id="link" href="#" class="style-scope state-modifier">AU695814B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-22</span>
                    <span class="td style-scope patent-result">1998-08-20</span>
                    <span class="td style-scope patent-result">Xoma Corporation</span>
                    <span class="td style-scope patent-result">Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5556772A/en"><a id="link" href="#" class="style-scope state-modifier">US5556772A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-12-08</span>
                    <span class="td style-scope patent-result">1996-09-17</span>
                    <span class="td style-scope patent-result">Stratagene</span>
                    <span class="td style-scope patent-result">Polymerase compositions and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK0754050T3/en"><a id="link" href="#" class="style-scope state-modifier">DK0754050T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-01-14</span>
                    <span class="td style-scope patent-result">2002-10-21</span>
                    <span class="td style-scope patent-result">Xoma Technology Ltd</span>
                    <span class="td style-scope patent-result">
  Anti-gram-positive bacterial methods and materials
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5561122A/en"><a id="link" href="#" class="style-scope state-modifier">US5561122A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-12-22</span>
                    <span class="td style-scope patent-result">1996-10-01</span>
                    <span class="td style-scope patent-result">Arizona Board Of Regents Acting On Behalf Of Arizona State University</span>
                    <span class="td style-scope patent-result">Combretastatin A-4 prodrug 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CZ291991B6/en"><a id="link" href="#" class="style-scope state-modifier">CZ291991B6</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-11-29</span>
                    <span class="td style-scope patent-result">2003-07-16</span>
                    <span class="td style-scope patent-result">Sankyo Company Limited</span>
                    <span class="td style-scope patent-result">Actinomycete promoter 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6333322B1/en"><a id="link" href="#" class="style-scope state-modifier">US6333322B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-13</span>
                    <span class="td style-scope patent-result">2001-12-25</span>
                    <span class="td style-scope patent-result">Eisai Co., Ltd.</span>
                    <span class="td style-scope patent-result">Nitrogen-containing tricyclic compounds and drugs containing the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7257562B2/en"><a id="link" href="#" class="style-scope state-modifier">US7257562B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-10-13</span>
                    <span class="td style-scope patent-result">2007-08-14</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">High throughput method for discovery of gene clusters 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1392824B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1392824B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-06</span>
                    <span class="td style-scope patent-result">2008-08-20</span>
                    <span class="td style-scope patent-result">DSM IP Assets B.V.</span>
                    <span class="td style-scope patent-result">Improved isoprenoid production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2352451C/en"><a id="link" href="#" class="style-scope state-modifier">CA2352451C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-24</span>
                    <span class="td style-scope patent-result">2003-04-08</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences Inc.</span>
                    <span class="td style-scope patent-result">High throughput method for discovery of gene clusters 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6683300B2/en"><a id="link" href="#" class="style-scope state-modifier">US6683300B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-17</span>
                    <span class="td style-scope patent-result">2004-01-27</span>
                    <span class="td style-scope patent-result">Science &amp; Engineering Services, Inc.</span>
                    <span class="td style-scope patent-result">Method and apparatus for mass spectrometry analysis of common analyte solutions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ561169A/en"><a id="link" href="#" class="style-scope state-modifier">NZ561169A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2008-06-30</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (17)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ561169A/en"><a id="link" href="#" class="style-scope state-modifier">NZ561169A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2008-06-30</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7297524B2/en"><a id="link" href="#" class="style-scope state-modifier">US7297524B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2007-11-20</span>
                    <span class="td style-scope patent-result">Thallion Pharmceuticals Inc.</span>
                    <span class="td style-scope patent-result">Polynucleotides for production of farnesyl dibenzodiazepinones 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7186713B2/en"><a id="link" href="#" class="style-scope state-modifier">US7186713B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2007-03-06</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones and methods of treating cancer using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2008514551A/en"><a id="link" href="#" class="style-scope state-modifier">JP2008514551A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-09-27</span>
                    <span class="td style-scope patent-result">2008-05-08</span>
                    <span class="td style-scope patent-result">エコピア  バイオサイエンシーズ  インク</span>
                    <span class="td style-scope patent-result">
  Dibenzodiazepinone analogues, their production and use as pharmaceuticals
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1733758A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1733758A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-05-16</span>
                    <span class="td style-scope patent-result">2006-12-20</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences Inc.</span>
                    <span class="td style-scope patent-result">Methods for administration of a farnesyl dibenzodiazepinone 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7763604B2/en"><a id="link" href="#" class="style-scope state-modifier">US7763604B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-05-16</span>
                    <span class="td style-scope patent-result">2010-07-27</span>
                    <span class="td style-scope patent-result">Thallion Pharma Ceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Methods for administration of a farnesyl dibenzodiazepinone 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1898920A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1898920A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-06-02</span>
                    <span class="td style-scope patent-result">2008-03-19</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090186878A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090186878A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-01-31</span>
                    <span class="td style-scope patent-result">2009-07-23</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Crystalline forms of a farnesyl dibenzodiazepinone 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2007118320A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2007118320A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-04-14</span>
                    <span class="td style-scope patent-result">2007-10-25</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Process for producing farnesylated dibenzodiazepinone by fermentation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20100144715A1/en"><a id="link" href="#" class="style-scope state-modifier">US20100144715A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-02-28</span>
                    <span class="td style-scope patent-result">2010-06-10</span>
                    <span class="td style-scope patent-result">Hoyt Scott B</span>
                    <span class="td style-scope patent-result">Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090170837A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090170837A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-08-17</span>
                    <span class="td style-scope patent-result">2009-07-02</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Methods for treating ras driven cancer in a subject 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090062255A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090062255A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-08-17</span>
                    <span class="td style-scope patent-result">2009-03-05</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Tumor-targeting evaluation methodology and compounds related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2729486B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2729486B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-07-09</span>
                    <span class="td style-scope patent-result">2017-12-13</span>
                    <span class="td style-scope patent-result">The Regents of The University of California</span>
                    <span class="td style-scope patent-result">Leukemia stem cell targeting ligands and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2019082125A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2019082125A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-10-27</span>
                    <span class="td style-scope patent-result">2019-05-02</span>
                    <span class="td style-scope patent-result">Amo Pharma Ltd.</span>
                    <span class="td style-scope patent-result">Methods of treating phelan mcdermid syndrome using farnesyl dibenzodiazepinones 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109504689B/en"><a id="link" href="#" class="style-scope state-modifier">CN109504689B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-01-16</span>
                    <span class="td style-scope patent-result">2021-09-17</span>
                    <span class="td style-scope patent-result">河南省商业科学研究所有限责任公司</span>
                    <span class="td style-scope patent-result">Transporter coding gene involved in regulating and controlling ACT yield in streptomycete 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102087786B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102087786B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-19</span>
                    <span class="td style-scope patent-result">2020-03-12</span>
                    <span class="td style-scope patent-result">국립낙동강생물자원관</span>
                    <span class="td style-scope patent-result">Micromonospora sp. M2 isolated from Monochoria korsakowii in fresh water having antibacterial and anticancer activity and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2021281280A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2021281280A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-05-29</span>
                    <span class="td style-scope patent-result">2023-01-05</span>
                    <span class="td style-scope patent-result">Amo Pharma Ltd</span>
                    <span class="td style-scope patent-result">Methods of synthesizing farnesyl dibenzodiazepinones 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4913588B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4913588B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-11</span>
                    <span class="td style-scope patent-result">
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9138447B2/en"><a id="link" href="#" class="style-scope state-modifier">US9138447B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-09-22</span>
                    <span class="td style-scope patent-result">Antimicrobial agent and method for the production thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT1979375E/en"><a id="link" href="#" class="style-scope state-modifier">PT1979375E</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-03-06</span>
                    <span class="td style-scope patent-result">Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080182302A2/en"><a id="link" href="#" class="style-scope state-modifier">US20080182302A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-07-31</span>
                    <span class="td style-scope patent-result">The Gene Cluster Involved in Safracin Biosynthesis and Its Uses for Genetic Engineering 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1585752B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1585752B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-21</span>
                    <span class="td style-scope patent-result">Polyene polyketides, processes for their production and their use as a pharmaceutical 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/17080285851883547199"><a id="link" href="#" class="style-scope state-modifier">Jayasuriya et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007</span>
                    <span class="td style-scope patent-result">Isolation and structure elucidation of thiazomycin</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/6795996976670966929"><a id="link" href="#" class="style-scope state-modifier">Igarashi et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008</span>
                    <span class="td style-scope patent-result">Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2008501342A/en"><a id="link" href="#" class="style-scope state-modifier">JP2008501342A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-01-24</span>
                    <span class="td style-scope patent-result">
  Biosynthetic gene cluster for generating complex polyketides
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2010513512A/en"><a id="link" href="#" class="style-scope state-modifier">JP2010513512A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-30</span>
                    <span class="td style-scope patent-result">
  Aminothiazole macrocycles, their use as antimicrobial compounds and their preparation
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110041187B/en"><a id="link" href="#" class="style-scope state-modifier">CN110041187B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-04-14</span>
                    <span class="td style-scope patent-result">Novel aromatic polyketone compounds, preparation method and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20190127313A1/en"><a id="link" href="#" class="style-scope state-modifier">US20190127313A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-05-02</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8058455B2/en"><a id="link" href="#" class="style-scope state-modifier">US8058455B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-11-15</span>
                    <span class="td style-scope patent-result">Compound signamycin, method for production thereof, and use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7300921B2/en"><a id="link" href="#" class="style-scope state-modifier">US7300921B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-27</span>
                    <span class="td style-scope patent-result">Polyene polyketides and methods of production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2321322B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2321322B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-19</span>
                    <span class="td style-scope patent-result">Streptospirole derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2538147A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2538147A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-08-09</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015145152A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015145152A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-01</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11912742B2/en"><a id="link" href="#" class="style-scope state-modifier">US11912742B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-02-27</span>
                    <span class="td style-scope patent-result">Heterologous production of leupeptin protease inhibitors and analogs thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012093192A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012093192A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-12</span>
                    <span class="td style-scope patent-result">Coly-mycin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ZA200504214B/en"><a id="link" href="#" class="style-scope state-modifier">ZA200504214B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-08-30</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as phamaceuticals 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012062906A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012062906A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-18</span>
                    <span class="td style-scope patent-result">Peptides as bioactive compounds 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (7)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US44112603P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/441,126<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US49299703P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-08-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/492,997<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-08-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US51828603P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-11-10</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/518,286<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-11-10</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065591A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/CA2004/000069</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2004-01-21</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2006-03-01</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20060228</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2007-01-11</span>
                    <span class="td nowrap style-scope patent-result">A621</span>
                    <span class="td nowrap style-scope patent-result">Written request for application examination</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A621</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20070110</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-07-30</span>
                    <span class="td nowrap style-scope patent-result">A711</span>
                    <span class="td nowrap style-scope patent-result">Notification of change in applicant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A712</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20090729</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-04-13</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100412</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-06-30</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100629</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-07-07</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100706</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-07-31</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100730</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-08-09</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100806</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-09-01</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100831</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-09-08</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100907</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-10-09</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20101008</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-02-04</span>
                    <span class="td nowrap style-scope patent-result">A02</span>
                    <span class="td nowrap style-scope patent-result">Decision of refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A02</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110203</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-06-03</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110602</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-06-18</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A821</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110602</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-08-02</span>
                    <span class="td nowrap style-scope patent-result">A911</span>
                    <span class="td nowrap style-scope patent-result">Transfer to examiner for re-examination before appeal (zenchi)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A911</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110801</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-08-30</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110830</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-11-30</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20111129</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-12-28</span>
                    <span class="td nowrap style-scope patent-result">TRDD</span>
                    <span class="td nowrap style-scope patent-result">Decision of grant or rejection written</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-10</span>
                    <span class="td nowrap style-scope patent-result">A01</span>
                    <span class="td nowrap style-scope patent-result">Written decision to grant a patent or to grant a registration (utility model)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A01</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20120110</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-12</span>
                    <span class="td nowrap style-scope patent-result">A01</span>
                    <span class="td nowrap style-scope patent-result">Written decision to grant a patent or to grant a registration (utility model)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A01</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-26</span>
                    <span class="td nowrap style-scope patent-result">A61</span>
                    <span class="td nowrap style-scope patent-result">First payment of annual fees (during grant procedure)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A61</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20120119</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-27</span>
                    <span class="td nowrap style-scope patent-result">R150</span>
                    <span class="td nowrap style-scope patent-result">Certificate of patent or registration of utility model</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 4913588</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: JP</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R150</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R150</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-30</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Renewal fee payment (event date is renewal date of database)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PAYMENT UNTIL: 20150127</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 3</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-01-13</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-01-12</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-01-10</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-01-09</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-01-08</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-01-07</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-01-04</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-12-24</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2023-01-04</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2024-01-21</span>
                    <span class="td nowrap style-scope patent-result">EXPY</span>
                    <span class="td nowrap style-scope patent-result">Cancellation because of completion of term</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu">·</span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Anatomy</div>
          
            <div class="item style-scope dropdown-menu">Chemical class</div>
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          
            <div class="item style-scope dropdown-menu">Chemical group</div>
          
            <div class="item style-scope dropdown-menu">Diseases</div>
          
            <div class="item style-scope dropdown-menu">Drugs</div>
          
            <div class="item style-scope dropdown-menu">Effects</div>
          
            <div class="item style-scope dropdown-menu">Human genes</div>
          
            <div class="item style-scope dropdown-menu">Inorganic materials</div>
          
            <div class="item style-scope dropdown-menu">Methods</div>
          
            <div class="item style-scope dropdown-menu">Natural products</div>
          
            <div class="item style-scope dropdown-menu">Nutrition</div>
          
            <div class="item style-scope dropdown-menu">Polymers</div>
          
            <div class="item style-scope dropdown-menu">Proteins</div>
          
            <div class="item style-scope dropdown-menu">Species</div>
          
            <div class="item style-scope dropdown-menu">Substances</div>
          
            <div class="item style-scope dropdown-menu">Toxicity</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">132</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">farnesyl benzodiazepinone</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">39</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,description</span>
                        <span class="td nowrap style-scope patent-result">22</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">compounds</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">262</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">49</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">salts</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">41</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">aryl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">diseases, disorders, signs and symptoms</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">heteroaryl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">23</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">manufacturing process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">23</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hydrogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">20</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">culturing</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nitrogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Species style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Mammalia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alkyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inhibitory effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Bacterial infection</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">bacterial infectious disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pharmaceutical composition</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug carrier</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Inflammation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Species style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Micromonospora</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inflammatory process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbon</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">in vitro</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nitrogen atom</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tungsten</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cell growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inhibitor</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">therapeutic agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbon atom</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Precancerous Conditions</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">aliphatic alkanes</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alkenes</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">growth inhibitor</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3622360128" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3622360128" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=1241765625" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>